TWI384029B - Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element - Google Patents
Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element Download PDFInfo
- Publication number
- TWI384029B TWI384029B TW97137949A TW97137949A TWI384029B TW I384029 B TWI384029 B TW I384029B TW 97137949 A TW97137949 A TW 97137949A TW 97137949 A TW97137949 A TW 97137949A TW I384029 B TWI384029 B TW I384029B
- Authority
- TW
- Taiwan
- Prior art keywords
- formula
- group
- liquid crystal
- carbon atoms
- compound
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims description 299
- 239000003795 chemical substances by application Substances 0.000 title claims description 136
- 150000001875 compounds Chemical class 0.000 claims description 213
- 125000004432 carbon atom Chemical group C* 0.000 claims description 159
- 150000004985 diamines Chemical class 0.000 claims description 149
- 125000000217 alkyl group Chemical group 0.000 claims description 87
- 239000000203 mixture Substances 0.000 claims description 81
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims description 77
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims description 72
- 125000002947 alkylene group Chemical group 0.000 claims description 55
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 55
- 108010094020 polyglycine Proteins 0.000 claims description 53
- 229920000232 polyglycine polymer Polymers 0.000 claims description 53
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 52
- 229910052799 carbon Inorganic materials 0.000 claims description 52
- 239000000758 substrate Substances 0.000 claims description 49
- 125000003118 aryl group Chemical group 0.000 claims description 43
- -1 difluoromethylene group Chemical group 0.000 claims description 42
- 150000003254 radicals Chemical class 0.000 claims description 39
- 229920000642 polymer Polymers 0.000 claims description 38
- 229920005575 poly(amic acid) Polymers 0.000 claims description 37
- 125000003545 alkoxy group Chemical group 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 33
- 229910052739 hydrogen Inorganic materials 0.000 claims description 33
- 239000001257 hydrogen Substances 0.000 claims description 32
- 108010026466 polyproline Proteins 0.000 claims description 32
- 125000003342 alkenyl group Chemical group 0.000 claims description 31
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 24
- 101100452593 Caenorhabditis elegans ina-1 gene Proteins 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 16
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 16
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 15
- 150000002431 hydrogen Chemical class 0.000 claims description 15
- 229920000037 Polyproline Polymers 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 13
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 12
- 125000002345 steroid group Chemical group 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 150000001491 aromatic compounds Chemical class 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 8
- 229910052731 fluorine Inorganic materials 0.000 claims description 8
- 239000011737 fluorine Substances 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 claims description 6
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims description 6
- 101100459319 Arabidopsis thaliana VIII-2 gene Proteins 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 6
- 125000006289 hydroxybenzyl group Chemical group 0.000 claims description 6
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 claims description 5
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 4
- 125000005529 alkyleneoxy group Chemical group 0.000 claims description 3
- 125000000732 arylene group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 238000010304 firing Methods 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- XUYXBYHCFIDZBT-UHFFFAOYSA-N C(C)(C=CC(=O)NO)C=CC(=O)NO Chemical compound C(C)(C=CC(=O)NO)C=CC(=O)NO XUYXBYHCFIDZBT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 description 71
- 239000010408 film Substances 0.000 description 62
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 41
- 239000000243 solution Substances 0.000 description 41
- 239000002904 solvent Substances 0.000 description 38
- 230000015572 biosynthetic process Effects 0.000 description 32
- 238000003786 synthesis reaction Methods 0.000 description 31
- 238000000034 method Methods 0.000 description 29
- 229920000656 polylysine Polymers 0.000 description 26
- 108010039918 Polylysine Proteins 0.000 description 25
- 150000002500 ions Chemical class 0.000 description 25
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 22
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 20
- 239000012046 mixed solvent Substances 0.000 description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 15
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 15
- 229920000768 polyamine Polymers 0.000 description 15
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 12
- 150000002466 imines Chemical class 0.000 description 11
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 230000007774 longterm Effects 0.000 description 10
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 10
- 239000001294 propane Substances 0.000 description 10
- 229920000954 Polyglycolide Polymers 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 239000004633 polyglycolic acid Substances 0.000 description 9
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 8
- 206010047571 Visual impairment Diseases 0.000 description 8
- 239000000654 additive Substances 0.000 description 8
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 8
- 150000004060 quinone imines Chemical class 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000000704 physical effect Effects 0.000 description 7
- 239000002966 varnish Substances 0.000 description 7
- KMBSSXSNDSJXCG-UHFFFAOYSA-N 1-[2-(2-hydroxyundecylamino)ethylamino]undecan-2-ol Chemical compound CCCCCCCCCC(O)CNCCNCC(O)CCCCCCCCC KMBSSXSNDSJXCG-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 6
- 239000012024 dehydrating agents Substances 0.000 description 6
- 238000005227 gel permeation chromatography Methods 0.000 description 6
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 6
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 6
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical class C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000003607 modifier Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 229920001721 polyimide Polymers 0.000 description 5
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical group N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 4
- 239000007822 coupling agent Substances 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 4
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- XQUPVDVFXZDTLT-UHFFFAOYSA-N 1-[4-[[4-(2,5-dioxopyrrol-1-yl)phenyl]methyl]phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C(C=C1)=CC=C1CC1=CC=C(N2C(C=CC2=O)=O)C=C1 XQUPVDVFXZDTLT-UHFFFAOYSA-N 0.000 description 3
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 3
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- 101100132433 Arabidopsis thaliana VIII-1 gene Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000004566 IR spectroscopy Methods 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004642 Polyimide Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000003495 polar organic solvent Substances 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920002098 polyfluorene Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000006798 ring closing metathesis reaction Methods 0.000 description 3
- 229910052707 ruthenium Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 238000010420 art technique Methods 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 210000002858 crystal cell Anatomy 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- HVAAHUDGWQAAOJ-UHFFFAOYSA-N n-benzylethanamine Chemical compound CCNCC1=CC=CC=C1 HVAAHUDGWQAAOJ-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 2
- 125000003884 phenylalkyl group Chemical group 0.000 description 2
- 229920003192 poly(bis maleimide) Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 150000003222 pyridines Chemical group 0.000 description 2
- 150000003248 quinolines Chemical group 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- KNDQHSIWLOJIGP-UMRXKNAASA-N (3ar,4s,7r,7as)-rel-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione Chemical class O=C1OC(=O)[C@@H]2[C@H]1[C@]1([H])C=C[C@@]2([H])C1 KNDQHSIWLOJIGP-UMRXKNAASA-N 0.000 description 1
- OLQWMCSSZKNOLQ-ZXZARUISSA-N (3s)-3-[(3r)-2,5-dioxooxolan-3-yl]oxolane-2,5-dione Chemical compound O=C1OC(=O)C[C@H]1[C@@H]1C(=O)OC(=O)C1 OLQWMCSSZKNOLQ-ZXZARUISSA-N 0.000 description 1
- GGSKIJWYJBXQFV-UHFFFAOYSA-N 1,3,4,5-tetramethylimidazolidin-2-one Chemical compound CC1C(C)N(C)C(=O)N1C GGSKIJWYJBXQFV-UHFFFAOYSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- IPJGAEWUPXWFPL-UHFFFAOYSA-N 1-[3-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC(N2C(C=CC2=O)=O)=C1 IPJGAEWUPXWFPL-UHFFFAOYSA-N 0.000 description 1
- SMLNDVNTPWRZJH-UHFFFAOYSA-N 1-chloro-4-(trimethoxymethyl)dodecane Chemical compound ClCCCC(C(OC)(OC)OC)CCCCCCCC SMLNDVNTPWRZJH-UHFFFAOYSA-N 0.000 description 1
- YQSZMTOTNQWHOW-UHFFFAOYSA-N 1-cyclohexyl-2-(1-cyclohexyloxycyclohexyl)oxybenzene Chemical group C1(CCCCC1)C1=C(C=CC=C1)OC1(CCCCC1)OC1CCCCC1 YQSZMTOTNQWHOW-UHFFFAOYSA-N 0.000 description 1
- RESPXSHDJQUNTN-UHFFFAOYSA-N 1-piperidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCCC1 RESPXSHDJQUNTN-UHFFFAOYSA-N 0.000 description 1
- WLPAQAXAZQUXBG-UHFFFAOYSA-N 1-pyrrolidin-1-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCCC1 WLPAQAXAZQUXBG-UHFFFAOYSA-N 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- MFAWEYJGIGIYFH-UHFFFAOYSA-N 2-[4-(trimethoxymethyl)dodecoxymethyl]oxirane Chemical compound C(C1CO1)OCCCC(C(OC)(OC)OC)CCCCCCCC MFAWEYJGIGIYFH-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- JJOYJOCWEDSDOO-UHFFFAOYSA-N 2-methyl-n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound CC(=C)C(=O)NCC1CCCO1 JJOYJOCWEDSDOO-UHFFFAOYSA-N 0.000 description 1
- TURITJIWSQEMDB-UHFFFAOYSA-N 2-methyl-n-[(2-methylprop-2-enoylamino)methyl]prop-2-enamide Chemical compound CC(=C)C(=O)NCNC(=O)C(C)=C TURITJIWSQEMDB-UHFFFAOYSA-N 0.000 description 1
- IJSVVICYGLOZHA-UHFFFAOYSA-N 2-methyl-n-phenylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=CC=C1 IJSVVICYGLOZHA-UHFFFAOYSA-N 0.000 description 1
- YQIGLEFUZMIVHU-UHFFFAOYSA-N 2-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C(C)=C YQIGLEFUZMIVHU-UHFFFAOYSA-N 0.000 description 1
- LBIHNTAFJVHBLJ-UHFFFAOYSA-N 3-(triethoxymethyl)undec-1-ene Chemical compound C(=C)C(C(OCC)(OCC)OCC)CCCCCCCC LBIHNTAFJVHBLJ-UHFFFAOYSA-N 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- JFUOAGBSDGCVES-UHFFFAOYSA-N 3-but-2-enyl-4-methylpyrrolidine-2,5-dione Chemical compound CC=CCC1C(C)C(=O)NC1=O JFUOAGBSDGCVES-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- SXPGQGNWEWPWQZ-UHFFFAOYSA-N 4-(triethoxymethyl)dodecan-1-amine Chemical compound NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SXPGQGNWEWPWQZ-UHFFFAOYSA-N 0.000 description 1
- DFYGYTNMHPUJBY-UHFFFAOYSA-N 4-(trimethoxymethyl)dodecane-1-thiol Chemical compound SCCCC(C(OC)(OC)OC)CCCCCCCC DFYGYTNMHPUJBY-UHFFFAOYSA-N 0.000 description 1
- UHNUHZHQLCGZDA-UHFFFAOYSA-N 4-[2-(4-aminophenyl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=CC=C(N)C=C1 UHNUHZHQLCGZDA-UHFFFAOYSA-N 0.000 description 1
- PLCLIPCLSAAXDR-UHFFFAOYSA-N 4-[4-[1-[4-(4-aminophenoxy)phenyl]-4-[2-(4-heptylcyclohexyl)ethyl]cyclohexyl]phenoxy]aniline Chemical compound C1CC(CCCCCCC)CCC1CCC1CCC(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)CC1 PLCLIPCLSAAXDR-UHFFFAOYSA-N 0.000 description 1
- KDDANMXDPWKKFS-UHFFFAOYSA-N 4-[[4-[1-[4-[(4-aminophenyl)methyl]phenyl]-4-pentylcyclohexyl]phenyl]methyl]aniline Chemical compound C1CC(CCCCC)CCC1(C=1C=CC(CC=2C=CC(N)=CC=2)=CC=1)C(C=C1)=CC=C1CC1=CC=C(N)C=C1 KDDANMXDPWKKFS-UHFFFAOYSA-N 0.000 description 1
- SJRIRLKYSUAXCX-UHFFFAOYSA-N 4-[[4-[3-[4-[(4-aminophenyl)methyl]phenyl]propyl]phenyl]methyl]aniline Chemical compound C1=CC(N)=CC=C1CC(C=C1)=CC=C1CCCC(C=C1)=CC=C1CC1=CC=C(N)C=C1 SJRIRLKYSUAXCX-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- GCNTZFIIOFTKIY-UHFFFAOYSA-N 4-hydroxypyridine Chemical compound OC1=CC=NC=C1 GCNTZFIIOFTKIY-UHFFFAOYSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- JZHKIUBMQMDQRG-UHFFFAOYSA-N C(=C)C(C(OC)(OC)OC)CCCCCCCC Chemical compound C(=C)C(C(OC)(OC)OC)CCCCCCCC JZHKIUBMQMDQRG-UHFFFAOYSA-N 0.000 description 1
- DBJFSFSBHGPDPG-UHFFFAOYSA-N C(C(=C)C)(=O)OCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C(=C)C)(=O)OCCCC(C(OC)(OC)OC)CCCCCCCC DBJFSFSBHGPDPG-UHFFFAOYSA-N 0.000 description 1
- GKLXZYMUWOOVDQ-UHFFFAOYSA-N C(C1CO1)OCCCC(C(OC)(OC)C)CCCCCCCC Chemical compound C(C1CO1)OCCCC(C(OC)(OC)C)CCCCCCCC GKLXZYMUWOOVDQ-UHFFFAOYSA-N 0.000 description 1
- VPLKXGORNUYFBO-UHFFFAOYSA-N C1(CC2C(CC1)O2)CCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C1(CC2C(CC1)O2)CCC(C(OC)(OC)OC)CCCCCCCC VPLKXGORNUYFBO-UHFFFAOYSA-N 0.000 description 1
- GCHAGADUHSMFBL-UHFFFAOYSA-N C1CC(CC)CCC1CCC1CCC(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)CC1 Chemical compound C1CC(CC)CCC1CCC1CCC(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)(C=2C=CC(OC=3C=CC(N)=CC=3)=CC=2)CC1 GCHAGADUHSMFBL-UHFFFAOYSA-N 0.000 description 1
- YLVIEPOWAZMYOD-UHFFFAOYSA-N COC(CCCCCCCCCCCCNCCNCCCCCCCCCCCCC(OC)(OC)OC)(OC)OC Chemical compound COC(CCCCCCCCCCCCNCCNCCCCCCCCCCCCC(OC)(OC)OC)(OC)OC YLVIEPOWAZMYOD-UHFFFAOYSA-N 0.000 description 1
- BGPRILKWLAIMJP-UHFFFAOYSA-N ClCCCC(C(OC)(OC)C)CCCCCCCC Chemical compound ClCCCC(C(OC)(OC)C)CCCCCCCC BGPRILKWLAIMJP-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 1
- HBFZXXRVKBPZMP-UHFFFAOYSA-N NC1=CC=C(C=C1)C(C(OC)(OC)OC)CCCCCCCC Chemical compound NC1=CC=C(C=C1)C(C(OC)(OC)OC)CCCCCCCC HBFZXXRVKBPZMP-UHFFFAOYSA-N 0.000 description 1
- BFVFLIHGBZUOGS-UHFFFAOYSA-N NC1=CC=C(C=C1)C(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound NC1=CC=C(C=C1)C(C(OCC)(OCC)OCC)CCCCCCCC BFVFLIHGBZUOGS-UHFFFAOYSA-N 0.000 description 1
- CEXAUEGEXJQTFI-UHFFFAOYSA-N NC=1C=C(C=CC1)C(C(OC)(OC)OC)CCCCCCCC Chemical compound NC=1C=C(C=CC1)C(C(OC)(OC)OC)CCCCCCCC CEXAUEGEXJQTFI-UHFFFAOYSA-N 0.000 description 1
- VEBISLDJMHOEEX-UHFFFAOYSA-N NC=1C=C(C=CC1)C(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound NC=1C=C(C=CC1)C(C(OCC)(OCC)OCC)CCCCCCCC VEBISLDJMHOEEX-UHFFFAOYSA-N 0.000 description 1
- XJDCHDFUMGSEHD-UHFFFAOYSA-N NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCCC(C(OC)(OC)OC)CCCCCCCC XJDCHDFUMGSEHD-UHFFFAOYSA-N 0.000 description 1
- KTGXWDZUZLWXOF-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)C)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)C)CCCCCCCC KTGXWDZUZLWXOF-UHFFFAOYSA-N 0.000 description 1
- MLGYDIXISVOZKC-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)OC)(CCCCCCCC)C Chemical compound NCCNCCCC(C(OC)(OC)OC)(CCCCCCCC)C MLGYDIXISVOZKC-UHFFFAOYSA-N 0.000 description 1
- 239000004988 Nematic liquid crystal Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004954 Polyphthalamide Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- VCFFZAQQHCLMNH-UHFFFAOYSA-N [3-(6-prop-2-enoyloxyhexanoyloxy)-2-[[3-(6-prop-2-enoyloxyhexanoyloxy)-2,2-bis(6-prop-2-enoyloxyhexanoyloxymethyl)propoxy]methyl]-2-(6-prop-2-enoyloxyhexanoyloxymethyl)propyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(COC(=O)CCCCCOC(=O)C=C)(COC(=O)CCCCCOC(=O)C=C)COCC(COC(=O)CCCCCOC(=O)C=C)(COC(=O)CCCCCOC(=O)C=C)COC(=O)CCCCCOC(=O)C=C VCFFZAQQHCLMNH-UHFFFAOYSA-N 0.000 description 1
- HTMMMSIQFWMMIJ-UHFFFAOYSA-N [3-[2,2-dimethyl-3-(6-prop-2-enoyloxyhexanoyloxy)propanoyl]oxy-2,2-dimethylpropyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(C)(C)COC(=O)C(C)(C)COC(=O)CCCCCOC(=O)C=C HTMMMSIQFWMMIJ-UHFFFAOYSA-N 0.000 description 1
- YNTQTLGBCMXNFX-UHFFFAOYSA-N [5-ethyl-2-(2-methyl-1-prop-2-enoyloxypropan-2-yl)-1,3-dioxan-5-yl]methyl prop-2-enoate Chemical compound C=CC(=O)OCC1(CC)COC(C(C)(C)COC(=O)C=C)OC1 YNTQTLGBCMXNFX-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- ARHLGYPMTUEJEN-UHFFFAOYSA-N acetic acid;phenoxybenzene Chemical compound CC(O)=O.C=1C=CC=CC=1OC1=CC=CC=C1 ARHLGYPMTUEJEN-UHFFFAOYSA-N 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005089 alkenylaminocarbonyl group Chemical group 0.000 description 1
- 125000005090 alkenylcarbonyl group Chemical group 0.000 description 1
- 125000005193 alkenylcarbonyloxy group Chemical group 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 description 1
- 125000005095 alkynylaminocarbonyl group Chemical group 0.000 description 1
- 125000005087 alkynylcarbonyl group Chemical group 0.000 description 1
- 125000005198 alkynylcarbonyloxy group Chemical group 0.000 description 1
- 125000005133 alkynyloxy group Chemical group 0.000 description 1
- 125000005225 alkynyloxycarbonyl group Chemical group 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- YJXGADCZMLHGLV-UHFFFAOYSA-N aniline;pyridine Chemical group C1=CC=NC=C1.NC1=CC=CC=C1 YJXGADCZMLHGLV-UHFFFAOYSA-N 0.000 description 1
- 150000001448 anilines Chemical group 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Natural products C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical group CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000005027 hydroxyaryl group Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- WDWDWGRYHDPSDS-UHFFFAOYSA-N methanimine Chemical compound N=C WDWDWGRYHDPSDS-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N mono-n-propyl amine Natural products CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- ZDEZEWYGGFXUAT-UHFFFAOYSA-N n,n'-ethylenebis-(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide) Chemical compound C1=CC2CC1(CC=C)C(C1=O)C2C(=O)N1CCN(C1=O)C(=O)C2C1C1CC2(CC=C)C=C1 ZDEZEWYGGFXUAT-UHFFFAOYSA-N 0.000 description 1
- QRWZCJXEAOZAAW-UHFFFAOYSA-N n,n,2-trimethylprop-2-enamide Chemical compound CN(C)C(=O)C(C)=C QRWZCJXEAOZAAW-UHFFFAOYSA-N 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 1
- KAKALCZDCFZYRN-UHFFFAOYSA-N n-(2-ethoxyethyl)-2-methylprop-2-enamide Chemical compound CCOCCNC(=O)C(C)=C KAKALCZDCFZYRN-UHFFFAOYSA-N 0.000 description 1
- YLQHOUDDHYMERA-UHFFFAOYSA-N n-(2-ethoxyethyl)prop-2-enamide Chemical compound CCOCCNC(=O)C=C YLQHOUDDHYMERA-UHFFFAOYSA-N 0.000 description 1
- XZSZONUJSGDIFI-UHFFFAOYSA-N n-(4-hydroxyphenyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=C(O)C=C1 XZSZONUJSGDIFI-UHFFFAOYSA-N 0.000 description 1
- DNTMQTKDNSEIFO-UHFFFAOYSA-N n-(hydroxymethyl)-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCO DNTMQTKDNSEIFO-UHFFFAOYSA-N 0.000 description 1
- YOZHLACIXDCHPV-UHFFFAOYSA-N n-(methoxymethyl)-2-methylprop-2-enamide Chemical compound COCNC(=O)C(C)=C YOZHLACIXDCHPV-UHFFFAOYSA-N 0.000 description 1
- DCBBWYIVFRLKCD-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]-2-methylprop-2-enamide Chemical compound CN(C)CCNC(=O)C(C)=C DCBBWYIVFRLKCD-UHFFFAOYSA-N 0.000 description 1
- AYGYHGXUJBFUJU-UHFFFAOYSA-N n-[2-(prop-2-enoylamino)ethyl]prop-2-enamide Chemical compound C=CC(=O)NCCNC(=O)C=C AYGYHGXUJBFUJU-UHFFFAOYSA-N 0.000 description 1
- UBTYFVJZTZYJHZ-UHFFFAOYSA-N n-[2-(prop-2-enoylamino)propyl]prop-2-enamide Chemical compound C=CC(=O)NC(C)CNC(=O)C=C UBTYFVJZTZYJHZ-UHFFFAOYSA-N 0.000 description 1
- CEBFLGHPYLIZSC-UHFFFAOYSA-N n-benzyl-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NCC1=CC=CC=C1 CEBFLGHPYLIZSC-UHFFFAOYSA-N 0.000 description 1
- VQGWOOIHSXNRPW-UHFFFAOYSA-N n-butyl-2-methylprop-2-enamide Chemical compound CCCCNC(=O)C(C)=C VQGWOOIHSXNRPW-UHFFFAOYSA-N 0.000 description 1
- FIBUWQFQYAAXHD-UHFFFAOYSA-N n-cyclopropyl-2-methylprop-2-enamide Chemical compound CC(=C)C(=O)NC1CC1 FIBUWQFQYAAXHD-UHFFFAOYSA-N 0.000 description 1
- LCXIFAOALNZGDO-UHFFFAOYSA-N n-cyclopropylprop-2-enamide Chemical compound C=CC(=O)NC1CC1 LCXIFAOALNZGDO-UHFFFAOYSA-N 0.000 description 1
- ZOTWHNWBICCBPC-UHFFFAOYSA-N n-ethyl-n-methylprop-2-enamide Chemical compound CCN(C)C(=O)C=C ZOTWHNWBICCBPC-UHFFFAOYSA-N 0.000 description 1
- SWPMNMYLORDLJE-UHFFFAOYSA-N n-ethylprop-2-enamide Chemical compound CCNC(=O)C=C SWPMNMYLORDLJE-UHFFFAOYSA-N 0.000 description 1
- COYVWKMZTCAFHO-UHFFFAOYSA-N n-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)N(C)C(=O)C=C COYVWKMZTCAFHO-UHFFFAOYSA-N 0.000 description 1
- RGNKVBUBMHKKJP-UHFFFAOYSA-N n-methyl-n-propylprop-2-enamide Chemical compound CCCN(C)C(=O)C=C RGNKVBUBMHKKJP-UHFFFAOYSA-N 0.000 description 1
- QJQAMHYHNCADNR-UHFFFAOYSA-N n-methylpropanamide Chemical compound CCC(=O)NC QJQAMHYHNCADNR-UHFFFAOYSA-N 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- WDFKEEALECCKTJ-UHFFFAOYSA-N n-propylprop-2-enamide Chemical compound CCCNC(=O)C=C WDFKEEALECCKTJ-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N omega-Hydroxydodecanoic acid Natural products OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- 125000002071 phenylalkoxy group Chemical group 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920006375 polyphtalamide Polymers 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003304 ruthenium compounds Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000005628 tolylene group Chemical group 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 125000006839 xylylene group Chemical group 0.000 description 1
Landscapes
- Liquid Crystal (AREA)
- Polymerisation Methods In General (AREA)
- Graft Or Block Polymers (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Description
本發明涉及一種液晶配向劑,該液晶配向劑是在聚醯胺酸(polyamic acid)中組合了烯基取代納迪克醯亞胺(nadiimide)化合物和具有自由基聚合性不飽和雙鍵的化合物。 The present invention relates to a liquid crystal alignment agent which is a compound in which an alkenyl-substituted nadiimide compound and a radical polymerizable unsaturated double bond are combined in a polyamic acid.
液晶顯示元件被用於以筆記型電腦(note personal computer)或臺式電腦(desktop personal computer)的監視器(monitor)為代表的攝像機(video camera)的取景器(viewfinder)、投影式顯示器等的各種液晶顯示裝置,近來也被用作電視。另外,液晶顯示元件也被用作光學噴印頭(optical printer head)、光學傅立葉變換元件(optical Fourier transform device)、光閥(light valve)等光電子相關元件。 The liquid crystal display element is used for a viewfinder, a projection display, or the like of a video camera represented by a monitor of a notebook personal computer or a desktop personal computer. Various liquid crystal display devices have recently been used as televisions. Further, the liquid crystal display element is also used as an optoelectronic related element such as an optical printer head, an optical Fourier transform device, or a light valve.
液晶顯示元件通常具有:1)對向配置著的一對基板、2)在所述一對基板各自的相對向的面中的一面或者兩面上形成的電極、3)在所述一對基板各自的相對向的面上形成的液晶配向膜、以及4)在所述一對基板間形成的液晶層。 The liquid crystal display device usually has: 1) a pair of substrates arranged in the opposite direction, 2) electrodes formed on one or both of the opposing faces of the pair of substrates, and 3) respective ones of the pair of substrates a liquid crystal alignment film formed on the opposite surface, and 4) a liquid crystal layer formed between the pair of substrates.
現有的液晶顯示元件的主流是利用向列型液晶(nematic liquid crystal)的顯示元件,已將1)扭轉90度 的扭轉向列(Twisted Nematic,TN)型液晶顯示元件、2)通常扭轉180度或180度以上的超扭轉向列(Super Twisted Nematic,STN)型液晶顯示元件、3)使用薄膜電晶體的所謂薄膜電晶體(Thin Film Transistor,TFT)型液晶顯示元件付諸實用。這些液晶顯示元件具有下述缺點:能夠恰當地看見圖像的視角狹窄,從傾斜方向觀看時,會產生亮度或對比度(contrast)的下降以及半色調下的亮度反轉。 The mainstream of the existing liquid crystal display elements is a display element using a nematic liquid crystal, which has been 1) twisted by 90 degrees. Twisted Nematic (TN) type liquid crystal display element, 2) Super Twisted Nematic (STN) type liquid crystal display element which is usually twisted by 180 degrees or more, 3) so-called thin film transistor A Thin Film Transistor (TFT) type liquid crystal display element is put into practical use. These liquid crystal display elements have a drawback in that the angle of view of the image can be appropriately seen, and when viewed from the oblique direction, a decrease in brightness or contrast and a brightness inversion in halftone are generated.
近年來,利用下述技術來改良上述視角問題:1)使用光學補償膜的TN-TFT型液晶顯示元件、2)應用垂直配向和光學補償膜的垂直配向(Vertical Alignment,VA)型液晶顯示元件、3)並用垂直配向和突起結構物技術的多領域垂直配向(Multi Domain Vertical Alignment,MVA)型液晶顯示元件、或者4)橫向電場方式的共面轉換(In-Plane Switching,IPS)型液晶顯示元件、5)電控雙折射(Electrically Controlled Birefringence,ECB)型液晶顯示元件、6)光學補償彎曲(Optically Compensated Bend或者Optically self-Compensated Birefringence,OCB)型液晶顯示元件等。而且,將改良後的技術付諸實用,或者正在對將這些技術付諸實用進行研究。 In recent years, the above-mentioned viewing angle problems have been improved by the following techniques: 1) a TN-TFT type liquid crystal display element using an optical compensation film, 2) a vertical alignment (VA) type liquid crystal display element using a vertical alignment and an optical compensation film. 3) Multi-domain Vertical Alignment (MVA) type liquid crystal display elements using vertical alignment and protruding structure technology, or 4) In-Plane Switching (IPS) type liquid crystal display Element, 5) Electrostatically Controlled Birefringence (ECB) type liquid crystal display element, 6) Optically Compensated Bend or Optically Self-Compensated Birefringence (OCB) type liquid crystal display element. Moreover, the improved technology is put into practical use, or research is being carried out to put these technologies into practical use.
液晶顯示元件的技術發展,不僅是通過對這些驅動方式或元件結構進行改良來實現的,而且也是通過對液晶顯示元件所使用的構成構件進行改良來實現的。在液晶顯示元件所使用的構成構件中,特別是液晶配向膜,是與液晶顯示元件的顯示品質相關的一個重要的要素,液晶配向膜 的作用隨著液晶顯示元件的品質提高而逐年變得重要。 The technical development of the liquid crystal display element is realized not only by improving these driving methods or element structures, but also by modifying the constituent members used for the liquid crystal display element. Among the constituent members used in the liquid crystal display element, in particular, the liquid crystal alignment film is an important element related to the display quality of the liquid crystal display element, and the liquid crystal alignment film The role of the liquid crystal display element has become important year by year.
液晶配向膜是由液晶配向劑製備的。目前,主要使用的液晶配向劑是將聚醯胺酸或者可溶性的聚醯亞胺(polyimide)溶解在有機溶劑中的溶液。將這樣的溶液塗布在基板上之後,利用加熱等方法進行成膜而形成聚醯亞胺系配向膜。對聚醯胺酸以外的各種液晶配向劑也進行了研究,但是,從耐熱性、耐化學性(耐液晶性)、塗布性、液晶配向性、電特性、光學特性、顯示特性等方面來看,大部分都不能付諸實用。 The liquid crystal alignment film is prepared from a liquid crystal alignment agent. Currently, a liquid crystal alignment agent mainly used is a solution in which polylysine or a soluble polyimide is dissolved in an organic solvent. After such a solution is applied onto a substrate, a film is formed by heating or the like to form a polyimide film. Various liquid crystal alignment agents other than polyglycolic acid have also been studied, but from the viewpoints of heat resistance, chemical resistance (liquid crystal resistance), coating properties, liquid crystal alignment properties, electrical properties, optical properties, and display properties, Most of them can't be put into practical use.
為了提高液晶顯示元件的顯示品質,液晶配向膜所需要的重要特性可以列舉離子密度。如果離子密度高,那麼有時在幀(frame)期間中施加給液晶的電壓會下降,結果亮度下降而妨礙正常的灰度顯示。而且,即使初期的離子密度低但高溫加速試驗後的離子密度(長期可靠性)變高之類的情況成問題。另一方面,如果殘留電荷大,那麼即使在施加電壓之後已關閉了電壓(OFF),也會產生所謂的“殘像”,即應消失的像殘留。長期可靠性的下降或殘像的產生會使液晶的顯示品質下降,因此成問題。 In order to improve the display quality of the liquid crystal display element, important characteristics required for the liquid crystal alignment film include ion density. If the ion density is high, sometimes the voltage applied to the liquid crystal during the frame period is lowered, and as a result, the luminance is lowered to hinder the normal gradation display. Further, even if the initial ion density is low, the ion density (long-term reliability) after the high-temperature acceleration test becomes high, which is a problem. On the other hand, if the residual charge is large, even if the voltage (OFF) is turned off after the voltage is applied, a so-called "after-image", that is, an image residue that should disappear, is generated. A decrease in long-term reliability or generation of an afterimage causes a deterioration in the display quality of the liquid crystal, which is a problem.
近來,提出了一些方法來嘗試解決所述的長期可靠性問題。 Recently, some methods have been proposed to try to solve the long-term reliability problem described.
1)已知一種聚醯胺酸組成物,其用來形成液晶配向膜,且組合含有物性不同的兩種或兩種以上的聚醯胺酸(例如,日本專利特開平11-193345號公報和日本專利特開平11-193347號)。 1) A polyglycine composition for forming a liquid crystal alignment film and combining two or more kinds of polyaminic acid having different physical properties (for example, Japanese Patent Laid-Open No. Hei 11-193345 Japanese Patent Laid-Open No. 11-193347).
2)已知一種清漆組成物,其含有包含聚醯胺酸以及聚醯胺的聚合物成分和溶劑(例如,國際公開00/61684號小冊子)。 2) A varnish composition containing a polymer component containing polyphthalic acid and polyamine and a solvent (for example, International Publication No. 00/61684 pamphlet) is known.
3)已知一種清漆組成物,其含有物性不同的兩種或兩種以上的聚醯胺酸以及聚醯胺和溶劑(例如,國際公開01/000733號小冊子)。 3) A varnish composition containing two or more kinds of polyaminic acid having different physical properties, and polyamine and a solvent (for example, International Publication 01/000733 pamphlet) is known.
4)已知一種含有高分子材料的清漆組成物,所述高分子材料包含使用具有特定結構的二胺(diamine)化合物而合成的聚醯胺酸等(例如,日本專利特開2002-162630號公報)。 4) A varnish composition containing a polymer material containing a polyamine acid or the like synthesized using a diamine compound having a specific structure (for example, Japanese Patent Laid-Open Publication No. 2002-162630) is known. Bulletin).
5)已知一種在聚醯亞胺以及聚醯胺酸清漆中添加低分子環氧樹脂的技術(例如,日本專利特開2005-189270號公報)。 5) A technique of adding a low molecular weight epoxy resin to a polyimide and a polyamid varnish is known (for example, Japanese Patent Laid-Open Publication No. Hei No. 2005-189270).
另外,提出了一些通過在聚醯胺酸中加入添加劑來解決包括液晶顯示元件的性能改善的課題的技術。這樣的技術例如可以列舉:一種含有聚醯胺酸和具有吡啶(pyridine)結構或者喹啉(quinoline)結構的硬化促進劑的液晶配向劑(例如,日本專利特開平9-302225號公報),一種含有聚醯胺酸和烯基取代納迪克醯亞胺化合物的液晶配向劑(例如,日本專利特開2004-341030號公報和日本專利特開平9-269491號公報),以及一種含有聚醯胺酸和含環氧基的化合物的液晶配向劑(例如,日本專利特開平7-234410號公報和日本專利特開2002-323701號公報)。 Further, some techniques for solving the problem of improving the performance of liquid crystal display elements by adding an additive to polyamic acid have been proposed. Such a technique, for example, a liquid crystal alignment agent containing a poly-proline and a hardening accelerator having a pyridine structure or a quinoline structure (for example, Japanese Patent Laid-Open Publication No. Hei 9-302225), A liquid crystal alignment agent containing a polyamic acid and an alkenyl group substituted with a nadic ylidene compound (for example, Japanese Patent Laid-Open No. 2004-341030 and Japanese Patent Laid-Open No. Hei 9-269491), and a poly-proline And a liquid crystal aligning agent of the epoxy group-containing compound (for example, Japanese Patent Laid-Open No. Hei 7-234410 and Japanese Patent Laid-Open Publication No. 2002-323701).
但是,利用這些現有技術無法充分地解決離子密度和 長期可靠性的問題。例如,在日本專利特開平9-302225號公報中,所述硬化促進劑在製作液晶配向膜時的醯亞胺化過程中會蒸發、昇華、分解,在使用這種液晶配向劑來製作的液晶配向膜中,硬化促進劑對液晶配向膜的電特性的影響尚未進行研究。 However, the use of these prior art techniques does not adequately address ion density and Long-term reliability issues. For example, in the Japanese Patent Publication No. Hei 9-302225, the curing accelerator evaporates, sublimes, and decomposes during the hydrazine imidization process in the production of a liquid crystal alignment film, and liquid crystals produced by using the liquid crystal alignment agent. In the alignment film, the influence of the hardening accelerator on the electrical characteristics of the liquid crystal alignment film has not been studied.
另外,例如在日本專利特開2002-323701號公報中,離子性雜質的吸附包括在課題之內,並將所製造的液晶顯示元件的電壓保持率記載在實施例中。但是,電壓保持率與離子密度雖然有時也相關,但初期的電壓保持率與隨時間的離子密度有時並不相關。一般認為這是因為,離子性雜質不僅是在製作液晶顯示元件時包含在元件中,而且例如也會通過伴隨著液晶顯示元件運作的液晶分解而產生,並隨時間變動。因此,吸附離子性雜質的日本專利特開2002-323701號公報的技術,雖然被認為是有效地減少製作液晶顯示元件時元件中所含有的離子性雜質的技術,但是從抑制離子性雜質的隨時間產生的方面來看,尚留有研究的餘地。 Further, for example, in Japanese Laid-Open Patent Publication No. 2002-323701, the adsorption of ionic impurities is included in the problem, and the voltage holding ratio of the produced liquid crystal display element is described in the examples. However, although the voltage holding ratio and the ion density are sometimes related, the initial voltage holding ratio may not be correlated with the ion density with time. This is considered to be because the ionic impurities are not only included in the element when the liquid crystal display element is produced, but also generated by, for example, liquid crystal decomposition accompanying the operation of the liquid crystal display element, and vary with time. Therefore, the technique of the Japanese Patent Publication No. 2002-323701, which is an ionic impurity, is considered to be a technique for effectively reducing the ionic impurities contained in the element when the liquid crystal display element is produced, but suppressing the ionic impurities. In terms of time generation, there is still room for research.
近來,提出了一些方法來嘗試解決所述的“殘像”問題。 Recently, some methods have been proposed to try to solve the "after-image" problem described.
1)已知一種聚醯胺酸組成物,其用來形成液晶配向膜,且組合含有物性不同的兩種或兩種以上的聚醯胺酸(日本專利特開平11-193345號公報和日本專利特開平11-193347號公報)。 1) A polyglycine composition for forming a liquid crystal alignment film and combining two or more kinds of polyaminic acid having different physical properties (Japanese Patent Laid-Open No. Hei 11-193345 and Japanese Patent) Japanese Patent Laid-Open No. Hei 11-193347).
2)已知一種清漆組成物,其含有包含聚醯胺酸以及聚醯胺的聚合物成分和溶劑(國際公開00/61684號小冊子)。 2) A varnish composition containing a polymer component containing a poly-proline and a polyamine and a solvent (International Publication No. 00/61684 pamphlet) is known.
3)已知一種清漆組成物,其含有物性不同的兩種或兩種以上的聚醯胺酸以及聚醯胺和溶劑。(國際公開01/000733號小冊子)。 3) A varnish composition containing two or more kinds of polyaminic acid having different physical properties, and polyamine and a solvent are known. (International Publication 01/000733 brochure).
4)已知一種含有高分子材料的清漆組成物,所述高分子材料包含使用具有特定結構的二胺化合物而合成的聚醯胺酸等(日本專利特開2002-162630號公報)。 4) A varnish composition containing a polymer material containing a polyamine acid or the like synthesized using a diamine compound having a specific structure (Japanese Patent Laid-Open Publication No. 2002-162630).
但是,使用這些現有技術無法充分地解決由殘留電荷大所引起的“殘像”問題。 However, the "after-image" problem caused by the large residual charge cannot be sufficiently solved by using these prior art techniques.
考慮到上述狀況,人們期望開發出一種離子密度和與離子密度的隨時間變動相伴的電特性相對應的長期可靠性問題、殘像特性問題得到改善的液晶顯示元件用的液晶配向劑、使用該液晶配向劑而形成的液晶配向膜、以及具備該液晶配向膜的液晶顯示元件。 In view of the above circumstances, it has been desired to develop a liquid crystal alignment agent for a liquid crystal display element having an ion density and a long-term reliability problem corresponding to an electrical characteristic accompanying a change in ion density with time variation, and using the liquid crystal display element. A liquid crystal alignment film formed by a liquid crystal alignment agent, and a liquid crystal display element including the liquid crystal alignment film.
本發明者們為了解決所述課題而進行了潛心研究。結果發現,使用將烯基取代納迪克醯亞胺化合物和具有自由基聚合性不飽和雙鍵的化合物作為改良劑並與聚醯胺酸組合而成的液晶配向劑時,可以對具有所製作的液晶配向膜的液晶顯示元件賦予良好的離子密度和長期可靠性、得到改善的殘像特性,從而完成了本發明。 The present inventors conducted intensive studies in order to solve the above problems. As a result, it has been found that when a liquid crystal alignment agent obtained by combining an alkenyl group substituted with a nadic ylidene compound and a compound having a radical polymerizable unsaturated double bond as a modifier and polylysine is used, it can be produced. The liquid crystal display element of the liquid crystal alignment film imparts good ion density and long-term reliability, and has improved afterimage characteristics, thereby completing the present invention.
本發明的液晶配向劑如以下的[1]項所示。 The liquid crystal alignment agent of the present invention is as shown in the following item [1].
[1]一種液晶配向劑,其是含有烯基取代納迪克醯亞胺化合物、具有自由基聚合性不飽和雙鍵的化合物、以及聚醯胺酸或者其衍生物的組成物,並且烯基取代納迪克醯亞
胺化合物是以式(Ina)表示的化合物,烯基取代納迪克醯亞胺化合物的比例以相對於聚醯胺酸或者其衍生物的重量比計為0.01~1.00,具有自由基聚合性不飽和雙鍵的化合物的比例以相對於聚醯胺酸或者其衍生物的重量比計為0.01~1.00,並且聚醯胺酸或者其衍生物的比例為所述組成物中的0.5 wt%~30 wt%(重量百分比):
其中,L1和L2各自獨立為氫、碳數為1~12的烷基、碳數為3~6的烯基、碳數為5~8的環烷基、碳數為6~12的芳基或者苄基;n為1或者2;當n=1時,W是碳數為1~12的烷基、碳數為2~6的烯基、碳數為5~8的環烷基、碳數為6~12的芳基、苄基、以-Z1-(O)q-(Z2O)r-Z3-H表示的基團(該基團中,Z1、Z2和Z3獨立為碳數為2~6的亞烷基,q為0或者1,並且r為1~30的整數)、以-(Z4)s-B-Z5-H表示的基團(該基團中,Z4和Z5獨立為碳數為1~4的亞烷基或者碳數為5~8的亞環烷基,B為亞苯基,並且s為0或者1)、或者以-B-T-B-H表示的基團(該基團中,B為亞苯基,並且T為-CH2-、-C(CH3)2-、-O-、-CO-、-S-或者-SO2-),這樣的W中的1個~3個氫可以經 羥基取代;當n=2時,W是碳數為2~20的亞烷基、碳數為5~8的亞環烷基、碳數為6~12的亞芳基、以-Z1-(O)q-(Z2O)r-Z3-表示的基團(該基團中的Z1~Z3、q和r的含義如上所述)、以-(Z4)s-B-Z5-表示的基團(該基團中的Z4、Z5、B和s的含義如上所述)、或者以-B-T-B-表示的基團(該基團中的B和T的含義如上所述),這樣的W中的1個~3個氫可以經羥基取代。 Wherein, L 1 and L 2 are each independently hydrogen, an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 3 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, and a carbon number of 6 to 12; Aryl or benzyl; n is 1 or 2; when n=1, W is an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, and a cycloalkyl group having 5 to 8 carbon atoms. An aryl group having a carbon number of 6 to 12, a benzyl group, and a group represented by -Z 1 -(O) q -(Z 2 O) r -Z 3 -H (in the group, Z 1 , Z 2 And Z 3 independently are an alkylene group having 2 to 6 carbon atoms, q is 0 or 1, and r is an integer of 1 to 30), and a group represented by -(Z 4 ) s -BZ 5 -H (this In the group, Z 4 and Z 5 are independently an alkylene group having 1 to 4 carbon atoms or a cycloalkylene group having 5 to 8 carbon atoms, B is a phenylene group, and s is 0 or 1), or a group represented by -BTBH (wherein B is a phenylene group, and T is -CH 2 -, -C(CH 3 ) 2 -, -O-, -CO-, -S- or -SO 2 -), one to three hydrogens in such W may be substituted by a hydroxyl group; when n = 2, W is an alkylene group having 2 to 20 carbon atoms, a cycloalkylene group having 5 to 8 carbon atoms, An arylene group having 6 to 12 carbon atoms and a group represented by -Z 1 -(O) q -(Z 2 O) r -Z 3 - (Z 1 to Z 3 , q and r in the group) The meaning of Described later), to - (Z 4) s -BZ 5 - group represented by (in the group Z 4, meaning Z 5, B and s as described above), or a group represented by at -BTB- ( The meaning of B and T in the group is as described above, and one to three hydrogens in such W may be substituted with a hydroxyl group.
根據本發明,可以提供一種離子密度低、與離子密度的隨時間變動相對應的長期可靠性良好、並且殘像特性問題得到改善的液晶顯示元件。 According to the present invention, it is possible to provide a liquid crystal display element having a low ion density, good long-term reliability corresponding to variations in ion density with time, and improved afterimage characteristics.
首先,最先對本發明中使用的術語進行說明。 First, the terms used in the present invention are first explained.
“納迪克醯亞胺化合物”是指具有下述納迪克醯亞胺基的化合物。 The "nadic ylidene compound" means a compound having the following nadic amide group.
而且,“烯基取代納迪克醯亞胺化合物”是指所述納迪克醯亞胺基的氫經烯基取代的化合物。烯基的取代位置是5位、6位或者7位。具有自由基聚合性不飽和雙鍵的化合物,被定義為不包括烯基取代納迪克醯亞胺化合物的化合物。(甲基)丙烯酸用作丙烯酸和甲基丙烯酸的總稱。有時將以式(1)表示的化合物稱為化合物(1)。對於以其他式表示的化合物也相同。 Further, the "alkenyl-substituted nadic ylidene compound" means a compound in which the hydrogen of the nadic amide group is substituted with an alkenyl group. The substitution position of the alkenyl group is 5, 6 or 7 positions. A compound having a radical polymerizable unsaturated double bond is defined as a compound which does not include an alkenyl-substituted nadic ylidene compound. (Meth)acrylic acid is used as a general term for acrylic acid and methacrylic acid. The compound represented by the formula (1) is sometimes referred to as the compound (1). The same applies to the compounds represented by other formulas.
關於側鏈型二胺和非側鏈型二胺,將在本發明中使用的二胺的相關說明的一開始對這些術語的定義進行描述。 With regard to the side chain type diamines and the non-side chain type diamines, the definitions of these terms will be described at the outset of the relevant description of the diamines used in the present invention.
本發明是由所述[1]項和以下的[2]~[22]項所構成的。 The present invention is constituted by the above item [1] and the following items [2] to [22].
[2]根據[1]項所記載的液晶配向劑,其是含有烯基取代納迪克醯亞胺化合物、聚醯胺酸或者其衍生物、以及具有自由基聚合性不飽和雙鍵的化合物的組成物,並且烯基取代納迪克醯亞胺化合物是以式(Ina-1)~式(Ina-3)表示的化合物中的至少一種:
[3]根據[1]項或者[2]項所記載的液晶配向劑,其是含有烯基取代納迪克醯亞胺化合物、具有自由基聚合性不飽和雙鍵的化合物、以及聚醯胺酸或者其衍生物的組成物,並且具有自由基聚合性不飽和雙鍵的化合物是(甲基)丙烯酸衍生物。 [3] The liquid crystal alignment agent according to [1] or [2], which is an alkenyl-substituted nadicilide compound, a compound having a radical polymerizable unsaturated double bond, and a poly-proline Or a composition of a derivative thereof, and a compound having a radical polymerizable unsaturated double bond is a (meth)acrylic acid derivative.
[4]根據[1]項或者[2]項所記載的液晶配向劑,其是含有烯基取代納迪克醯亞胺化合物、具有自由基聚合性不飽和雙鍵的化合物、以及聚醯胺酸或者其衍生物的組成物,並且具有自由基聚合性不飽和雙鍵的化合物是具有兩個或兩個以上的自由基聚合性不飽和雙鍵的化合物、或者含有所述化合物的混合物。 [4] The liquid crystal alignment agent according to [1] or [2], which is an alkenyl-substituted nadic ylidene compound, a compound having a radical polymerizable unsaturated double bond, and a poly-proline Or a composition of a derivative thereof, and a compound having a radical polymerizable unsaturated double bond is a compound having two or more radically polymerizable unsaturated double bonds, or a mixture containing the compound.
[5]根據[4]項所記載的液晶配向劑,其是含有烯基取代納迪克醯亞胺化合物、具有自由基聚合性不飽和雙鍵的化合物、以及聚醯胺酸或者其衍生物的組成物,並且具有自由基聚合性不飽和雙鍵的化合物是N,N'-亞甲基雙丙烯醯胺(N,N'-methylene bisacrylamide)、N,N'-二羥基亞乙基-雙丙烯醯胺(N,N'-dihydroethylene bisacrylamide)、雙丙烯酸乙二酯(ethylene bisacrylate)、以及4,4'-亞甲基雙(N,N-二羥基亞乙基丙烯酸酯苯胺)(4,4'-methylene bis(N,N-dihydroethylene aerylate aniline))中的至少一種。 [5] The liquid crystal alignment agent according to [4], which is an alkenyl-substituted nadic ylidene compound, a compound having a radical polymerizable unsaturated double bond, and a polyglycine or a derivative thereof The composition, and the compound having a radical polymerizable unsaturated double bond is N,N'-methylene bisacrylamide, N,N'-dihydroxyethylene-bis N,N'-dihydroethylene bisacrylamide, ethylene bisacrylate, and 4,4'-methylenebis(N,N-dihydroxyethylene acrylate aniline) (4, At least one of 4'-methylene bis (N, N-dihydroethylene aerylate aniline).
[6]根據[1]項所記載的液晶配向劑,其中聚醯胺酸是通過使以式(1)、式(2)、式(5)~式(7)以及式(14)表示的芳香族四羧酸二酐中的至少一種與二胺反應而獲得的聚合物,並且所述二胺是選自以式(I)~式(Ⅶ)表示的非側鏈型二胺的族群中的至少一種:
H2N-X1-NH2 (I) H 2 NX 1 -NH 2 (I)
其中,X1是碳數為2~12的直鏈亞烷基;X2是碳數為1~12的直鏈亞烷基;X3獨立為單鍵、-O-、-CO-、-CONH-、-NHCO-、-C(CH3)2-、-C(CF3)2-、-O-(CH2)t-O-、-S-、-S-S-、-SO2-、-S-(CH2)t-S-或者碳數為1~12的直鏈亞烷基,t為1~12的整數;環己烷環或者苯環上的任意氫可以經-F、 -CH3或者-OH、-COOH、-SO3H、或者-PO3H2、苄基或者羥基苄基取代。 Wherein X 1 is a linear alkylene group having 2 to 12 carbon atoms; X 2 is a linear alkylene group having 1 to 12 carbon atoms; and X 3 is independently a single bond, -O-, -CO-, - CONH-, -NHCO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -O-(CH 2 ) t -O-, -S-, -SS-, -SO 2 -, -S-(CH 2 ) t -S- or a linear alkylene group having a carbon number of 1 to 12, and t is an integer of 1 to 12; any hydrogen on the cyclohexane ring or the benzene ring may be subjected to -F, - CH 3 is substituted with -OH, -COOH, -SO 3 H, or -PO 3 H 2 , benzyl or hydroxybenzyl.
[7]根據[1]項所記載的液晶配向劑,其中聚醯胺酸是通過使以式(1)表示的芳香族四羧酸二酐與二胺反應而獲得的聚合物,並且所述二胺是選自以式(Ⅳ-1)、式(Ⅳ-2)、式(Ⅳ-15)、式(Ⅳ-16)、式(V-1)~式(V-12)、式(V-33)以及式(Ⅶ-2)表示的非側鏈型二胺中的至少一種。 [7] The liquid crystal alignment agent according to [1], wherein the polyamic acid is a polymer obtained by reacting an aromatic tetracarboxylic dianhydride represented by the formula (1) with a diamine, and the The diamine is selected from the group consisting of formula (IV-1), formula (IV-2), formula (IV-15), formula (IV-16), formula (V-1) to formula (V-12), formula ( At least one of V-33) and a non-side chain type diamine represented by the formula (VII-2).
[8]根據[1]項所記載的液晶配向劑,其中聚醯胺酸是通過使以式(1)、式(2)、式(5)~式(7)以及式(14)表示的芳香族四羧酸二酐中的至少一種和芳香族以外的四羧酸二酐的混合物與二胺反應而獲得的聚合物,並且所述 二胺是選自以式(I)~式(Ⅶ)表示的非側鏈型二胺的族群中的至少一種。 [8] The liquid crystal alignment agent according to [1], wherein the polyamic acid is represented by the formula (1), the formula (2), the formula (5) to the formula (7), and the formula (14). a polymer obtained by reacting at least one of an aromatic tetracarboxylic dianhydride and a tetracarboxylic dianhydride other than an aromatic compound with a diamine, and The diamine is at least one selected from the group consisting of non-side chain type diamines represented by the formulae (I) to (VII).
H2N-X1-NH2 (I) H 2 NX 1 -NH 2 (I)
其中,X1是碳數為2~12的直鏈亞烷基;X2是碳數為1~12的直鏈亞烷基;X3獨立為單鍵、-O-、-CO-、-CONH-、-NHCO-、-C(CH3)2-、-C(CF3)2-、-O-(CH2)t-O-、-S-、-S-S-、 -SO2-、-S-(CH2)t-S-或者碳數為1~12的直鏈亞烷基,並且t為1~12的整數;環己烷環或者苯環上的任意氫可以經-F、-CH3或者-OH、-COOH、-SO3H、或者-PO3H2、苄基或者羥基芳基取代。 Wherein X 1 is a linear alkylene group having 2 to 12 carbon atoms; X 2 is a linear alkylene group having 1 to 12 carbon atoms; and X 3 is independently a single bond, -O-, -CO-, - CONH-, -NHCO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -O-(CH 2 ) t -O-, -S-, -SS-, -SO 2 -, -S-(CH 2 ) t -S- or a linear alkylene group having a carbon number of 1 to 12, and t is an integer of 1 to 12; any hydrogen on the cyclohexane ring or the benzene ring may be subjected to -F, -CH 3 or -OH, -COOH, -SO 3 H, or -PO 3 H 2 , benzyl or hydroxyaryl.
[9]根據[8]項所記載的液晶配向劑,其中芳香族以外的四羧酸二酐是以式(19)、式(23)、式(25)、式(35)~式(37)、式(39)、式(44)以及式(49)表示的化合物中的至少一種。 [9] The liquid crystal alignment agent according to [8], wherein the tetracarboxylic dianhydride other than the aromatic compound is a formula (19), a formula (23), a formula (25), and a formula (35) to a formula (37). At least one of the compounds represented by the formula (39), the formula (44), and the formula (49).
[10]根據[1]項所記載的液晶配向劑,其中聚醯胺酸是通過使以式(1)表示的芳香族四羧酸二酐和芳香族以外的四羧酸二酐的混合物與二胺反應而獲得的聚合物,並且所述二胺是選自以式(Ⅳ-1)、式(Ⅳ-2)、式(Ⅳ-15)、式(Ⅳ-16)、式(V-1)~式(V-12)、式(V-33) 以及式(Ⅶ-2)表示的非側鏈型二胺中的至少一種。 [10] The liquid crystal alignment agent according to [1], wherein the polyphthalic acid is a mixture of an aromatic tetracarboxylic dianhydride represented by the formula (1) and a tetracarboxylic dianhydride other than the aromatic compound a polymer obtained by reacting a diamine, and the diamine is selected from the group consisting of formula (IV-1), formula (IV-2), formula (IV-15), formula (IV-16), and formula (V-). 1)~(V-12), (V-33) And at least one of the non-side chain type diamines represented by the formula (VII-2).
[11]根據[10]項所記載的液晶配向劑,其中芳香族以外的四羧酸二酐是以式(19)、式(23)、式(25)、式(35)~式(37)、式(39)、式(44)以及式(49)表示的化合物中的至少一種。 [11] The liquid crystal alignment agent according to [10], wherein the tetracarboxylic dianhydride other than aromatic is a formula (19), a formula (23), a formula (25), and a formula (35) to a formula (37). At least one of the compounds represented by the formula (39), the formula (44), and the formula (49).
[12]根據[10]項所記載的液晶配向劑,其中芳香族以外的四羧酸二酐是以式(19)表示的化合物。 [12] The liquid crystal alignment agent according to [10], wherein the tetracarboxylic dianhydride other than the aromatic compound is a compound represented by the formula (19).
[13]根據[1]項所記載的液晶配向劑,其中聚醯胺酸是通過使以式(1)、式(2)、式(5)~式(7)以及式(14)表示的芳香族四羧酸二酐中的至少一種與二胺反應而獲得的聚合物,並且所述二胺是至少一種非側鏈型二胺和至少一種側鏈型二胺的混合物,其中所述非側鏈型二胺是選自以式(I)~式(Ⅶ)表示的非側鏈型二胺的族群中,所述側鏈型二胺具有選自碳數為3或3以上的烷基、碳數為
3或3以上的烷氧基、碳數為3或3以上的烷氧基烷基、具有類固醇骨架的基團、以及末端具有含有碳數為1或1以上的烷基、碳數為1或1以上的烷氧基或者碳數為2或2以上的烷氧基烷基的環的基團中的側鏈基團:
H2N-X1-NH2 (I) H 2 NX 1 -NH 2 (I)
其中,X1是碳數為2~12的直鏈亞烷基;X2是碳數為1~12的直鏈亞烷基;X3獨立為單鍵、-O-、-CO-、-CONH-、-NHCO-、-C(CH3)2-、-C(CF3)2-、-O-(CH2)t-O-、-S-、-S-S-、-SO2-、-S-(CH2)t-S-或者碳數為1~12的直鏈亞烷基,並且t為1~12的整數;環己烷環或者苯環上的任意氫可以經-F、-CH3或者-OH、-COOH、-SO3H、或者-PO3H2、苄基或者羥基苄基取代。 Wherein X 1 is a linear alkylene group having 2 to 12 carbon atoms; X 2 is a linear alkylene group having 1 to 12 carbon atoms; and X 3 is independently a single bond, -O-, -CO-, - CONH-, -NHCO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -O-(CH 2 ) t -O-, -S-, -SS-, -SO 2 -, -S-(CH 2 ) t -S- or a linear alkylene group having a carbon number of 1 to 12, and t is an integer of 1 to 12; any hydrogen on the cyclohexane ring or the benzene ring may be subjected to -F, -CH 3 or -OH, -COOH, -SO 3 H, or -PO 3 H 2, benzyl or hydroxybenzyl.
[14]根據[13]項所記載的液晶配向劑,其中側鏈型二胺是選自以式(VIII)~式(XII)表示的化合物的族群中的二胺。 [14] The liquid crystal alignment agent according to [13], wherein the side chain type diamine is a diamine selected from the group consisting of compounds represented by formula (VIII) to formula (XII).
(其中,R1為單鍵、-O-、-CO-、-COO-、-OCO-、-CONH-、-CH2O-、-CF2O-、或者碳數為1~6的亞烷基,並且該亞烷基中的任意-CH2-可以經-O-、-CH=CH-或者-C≡C-取代;R2是具有類固醇骨架的基團、碳數為3~30的烷基、具有碳數為3~30的烷基或者碳數為3~30的烷氧基作為取代基的苯基、或者以式(D-1)表示的基團,並且所述烷基中的任意-CH2-可以經-O-、-CH=CH-或者-C≡C-取代;
其中,R13、R14和R15獨立為單鍵、-O-、-COO-、-OCO-、-CONH-、碳數為1~4的亞烷基、碳數為1~3的氧亞烷基、或者碳數為1~3的亞烷氧基;環B和環C獨立為1,4-亞苯基或者1,4-亞環己基;R16和R17獨立為氟或者甲基,並且m1和m2獨立為0、1或者2;e、f和g獨立為0~3的整數,並且它们的合計值為1或1以上;R18是碳數為1~30的烷基、碳數為1~30的烷氧基、或者碳數為2~30的烷氧基烷基,這些烷基、烷氧基以及烷氧基烷基中,任意氫可以氟取代,並且任意-CH2-可以二氟亞甲基或者以式(D-2)表示的基團取代;
其中,R19、R20、R21和R22獨立為碳數為1~10的烷基或者苯基,並且n為1~100的整數。) Wherein R 19 , R 20 , R 21 and R 22 are independently an alkyl group having 1 to 10 carbon atoms or a phenyl group, and n is an integer of 1 to 100. )
(其中,R3獨立為氫或者甲基;R4為氫、碳數為1~30的烷基、或者碳數為2~30的烯基;並且R5獨立為單鍵、-CO-或者-CH2-。) (wherein R 3 is independently hydrogen or methyl; R 4 is hydrogen, an alkyl group having 1 to 30 carbon atoms, or an alkenyl group having 2 to 30 carbon atoms; and R 5 is independently a single bond, -CO- or -CH 2 -.)
(其中,R3獨立為氫或者甲基;R4為氫、碳數為1~30的烷基、或者碳數為2~30的烯基;R5獨立為單鍵、-CO-或者-CH2-;並且R6和R7獨立為氫、碳數為1~30的烷基、或者苯基。) (wherein R 3 is independently hydrogen or methyl; R 4 is hydrogen, an alkyl group having 1 to 30 carbon atoms, or an alkenyl group having 2 to 30 carbon atoms; and R 5 is independently a single bond, -CO- or - CH 2 -; and R 6 and R 7 are independently hydrogen, an alkyl group having 1 to 30 carbon atoms, or a phenyl group.)
(其中,R8是碳數為1~30的烷基,並且所述烷基的任意-CH2-可以-O-、-CH=CH-或者-C≡C-取代;R9獨立為-O-或者碳數為1~6的亞烷基;環A為1,4-亞苯基或者1,4-亞環己基;a為0或者1;b為0、1或者2;並且c獨立為0或者1。) (wherein R 8 is an alkyl group having 1 to 30 carbon atoms, and any -CH 2 - of the alkyl group may be substituted by -O-, -CH=CH- or -C≡C-; R 9 is independently - O- or an alkylene group having a carbon number of 1 to 6; ring A is a 1,4-phenylene group or a 1,4-cyclohexylene group; a is 0 or 1; b is 0, 1 or 2; and c is independent Is 0 or 1.)
(其中,R10是碳數為3~30的烷基或者碳數為3~30的氟化烷基;R11為氫、碳數為1~30的烷基或者碳數為1~30的氟化烷基;R12獨立為-O-或者碳數為1~6的亞烷基;並且d獨立為0或者1。) (wherein R 10 is an alkyl group having 3 to 30 carbon atoms or a fluorinated alkyl group having 3 to 30 carbon atoms; and R 11 is hydrogen, an alkyl group having 1 to 30 carbon atoms or a carbon number of 1 to 30; A fluorinated alkyl group; R 12 is independently -O- or an alkylene group having a carbon number of 1 to 6; and d is independently 0 or 1.)
[15]根據[13]項所記載的液晶配向劑,其中側鏈型二胺是選自以式(VIII-2)、式(VIII-4)、式(VIII-5)、式(VIII-6)、式(X-2)以及式(X-4)表示的化合物中的二胺。 [15] The liquid crystal alignment agent according to [13], wherein the side chain type diamine is selected from the group consisting of formula (VIII-2), formula (VIII-4), formula (VIII-5), and formula (VIII-). 6) A diamine in the compound represented by the formula (X-2) and the formula (X-4).
(其中,R23和R24獨立為碳數為3~30的烷基或者碳數為3~30的烷氧基,R29和R30獨立為碳數為1~30的烷基或者碳數為1~30的烷氧基。) (wherein R 23 and R 24 are independently an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms; and R 29 and R 30 are independently an alkyl group having 1 to 30 carbon atoms or a carbon number; It is an alkoxy group of 1 to 30.)
[16]根據[13]項所記載的液晶配向劑,其中非側鏈型二胺是選自以式(Ⅳ-1)、式(Ⅳ-2)、式(Ⅳ-15)、式(Ⅳ-16)、式(V-1)~式(V-12)、式(V-33)以及式(Ⅶ-2)表示的化合物中的二胺,側鏈型二胺是選自以式(Ⅷ-2)、式(Ⅷ-4)、式(Ⅷ-5)、式(Ⅷ-6)、式(XI-2)以及式(XI-4)表示的化合物中的二胺。 [16] The liquid crystal alignment agent according to [13], wherein the non-side chain type diamine is selected from the group consisting of formula (IV-1), formula (IV-2), formula (IV-15), and formula (IV). -16), a diamine in the compound represented by the formula (V-1) to the formula (V-12), the formula (V-33), and the formula (VII-2), and the side chain type diamine is selected from the formula ( a diamine in the compound represented by VIII-2), formula (VIII-4), formula (VIII-5), formula (VIII-6), formula (XI-2), and formula (XI-4).
(其中,R23和R24獨立為碳數為3~30的烷基或者碳數為3~30的烷氧基,R29和R30獨立為碳數為1~30的烷基或者碳數為1~30的烷氧基。) (wherein R 23 and R 24 are independently an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms; and R 29 and R 30 are independently an alkyl group having 1 to 30 carbon atoms or a carbon number; It is an alkoxy group of 1 to 30.)
[17]根據[1]項所記載的液晶配向劑,其中聚醯胺酸是選自通過使至少一種芳香族四羧酸二酐和至少一種芳香族以外的四羧酸二酐的混合物與至少一種非側鏈型二胺反應而獲得的聚合物、以及通過使所述的四羧酸二酐的混合物與至少一種側鏈型二胺和至少一種所述非側鏈型二胺的混合物反應而獲得的聚合物中的至少一種,其中所述芳香族 四羧酸二酐是以式(1)、式(2)、式(5)~式(7)以及式(14)表示,所述芳香族以外的四羧酸二酐是以式(19)、式(23)、式(25)、式(35)~式(37)、式(39)、式(44)以及式(49)表示,所述非側鏈型二胺是以式(Ⅳ-1)、式(Ⅳ-2)、式(Ⅳ-15)、式(Ⅳ-16)、式(V-1)~式(V-12)、式(V-33)以及式(Ⅶ-2)表示,所述側鏈型二胺是以式(Ⅷ-2)、式(ⅧI-4)、式(Ⅷ-5)、式(Ⅷ-6)、式(XI-2)以及式(XI-4)表示。 [17] The liquid crystal alignment agent according to [1], wherein the polyproline is selected from the group consisting of at least one aromatic tetracarboxylic dianhydride and at least one aromatic tetracarboxylic dianhydride and at least a polymer obtained by reacting a non-side chain type diamine, and by reacting a mixture of the tetracarboxylic dianhydride with a mixture of at least one side chain type diamine and at least one of the non-side chain type diamines At least one of the obtained polymers, wherein the aromatic The tetracarboxylic dianhydride is represented by the formula (1), the formula (2), the formula (5) to the formula (7), and the formula (14), and the tetracarboxylic dianhydride other than the aromatic compound is the formula (19). , the formula (23), the formula (25), the formula (35) to the formula (37), the formula (39), the formula (44) and the formula (49), wherein the non-side chain type diamine is of the formula (IV) -1), Formula (IV-2), Formula (IV-15), Formula (IV-16), Formula (V-1) to Formula (V-12), Formula (V-33), and Formula (VII- 2) indicates that the side chain type diamine is a formula (VIII-2), a formula (VIIII-4), a formula (VIII-5), a formula (VIII-6), a formula (XI-2), and a formula ( XI-4) indicates.
(其中,R23和R24獨立為碳數為3~30的烷基或者碳數為3~30的烷氧基,R29和R30獨立為碳數為1~30的烷基或者碳數為1~30的烷氧基。) (wherein R 23 and R 24 are independently an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms; and R 29 and R 30 are independently an alkyl group having 1 to 30 carbon atoms or a carbon number; It is an alkoxy group of 1 to 30.)
[18]根據[17]項所記載的液晶配向劑,其中聚醯胺酸是通過使至少一種芳香族四羧酸二酐和至少一種芳香族以外的四羧酸二酐的混合物與至少一種非側鏈型二胺反應而獲得的聚合物。 [18] The liquid crystal alignment agent according to [17], wherein the polyphthalic acid is a mixture of at least one aromatic tetracarboxylic dianhydride and at least one aromatic tetracarboxylic dianhydride and at least one non- A polymer obtained by reacting a side chain type diamine.
[19]根據[17]項所記載的液晶配向劑,其中聚醯胺酸是通過使至少一種芳香族四羧酸二酐和至少一種芳香族以外 的四羧酸二酐的混合物與至少一種非側鏈型二胺反應而獲得的聚合物、和通過使所述四羧酸二酐的混合物與至少一種非側鏈型二胺和至少一種側鏈型二胺的混合物反應而獲得的聚合物的混合物。 [19] The liquid crystal alignment agent according to [17], wherein the polyproline is made of at least one aromatic tetracarboxylic dianhydride and at least one aromatic a polymer obtained by reacting a mixture of tetracarboxylic dianhydride with at least one non-side chain type diamine, and by mixing a mixture of said tetracarboxylic dianhydride with at least one non-side chain type diamine and at least one side chain A mixture of polymers obtained by reacting a mixture of diamines.
[20]根據[17]項所記載的液晶配向劑,其中聚醯胺酸是選自如下聚合物中的至少一種,所述聚合物是通過使至少一種芳香族四羧酸二酐和至少一種芳香族以外的四羧酸二酐的混合物與至少一種非側鏈型二胺和至少一種側鏈型二胺的混合物反應而獲得。 [20] The liquid crystal alignment agent according to [17], wherein the polyproline is at least one selected from the group consisting of at least one aromatic tetracarboxylic dianhydride and at least one A mixture of tetracarboxylic dianhydrides other than aromatic is obtained by reacting a mixture of at least one non-side chain type diamine and at least one side chain type diamine.
[21]一種液晶配向膜,其是通過將根據[1]項所記載的液晶配向劑塗布在基板上並在膜的狀態下進行燒製而形成的。 [21] A liquid crystal alignment film which is formed by applying a liquid crystal alignment agent according to [1] onto a substrate and baking it in a state of a film.
[22]一種液晶顯示元件,其具有對向配置著的一對基板、在所述一對基板各自的相對向的面中的一面或兩面上形成的電極、在所述一對基板各自的相對向的面上形成的液晶配向膜、以及在所述一對基板間形成的液晶層,該液晶顯示元件的特徵在於:所述液晶配向膜是上述各項所記載的液晶配向膜。 [22] A liquid crystal display device comprising: a pair of substrates disposed opposite to each other; an electrode formed on one or both of opposite surfaces of the pair of substrates, and a relative of each of the pair of substrates A liquid crystal alignment film formed on the surface and a liquid crystal layer formed between the pair of substrates, wherein the liquid crystal alignment film is the liquid crystal alignment film described in the above.
以下,對本發明的液晶配向劑進行詳細的說明。本發明的液晶配向劑是含有烯基取代納迪克醯亞胺化合物、具有自由基聚合性不飽和雙鍵的化合物、以及聚醯胺酸的組成物。 Hereinafter, the liquid crystal alignment agent of the present invention will be described in detail. The liquid crystal alignment agent of the present invention is a composition containing an alkenyl-substituted nadic ylidene imine compound, a compound having a radical polymerizable unsaturated double bond, and polyglycine.
首先,最先對烯基取代納迪克醯亞胺化合物進行說明。烯基取代納迪克醯亞胺化合物,優選可以在溶解本發 明所使用的聚醯胺酸或者其衍生物的溶劑中溶解的化合物。這種烯基取代納迪克醯亞胺化合物的例子為以式(Ina)表示的化合物。 First, the alkenyl-substituted nadicilide compound is first described. Alkenyl substituted nadic quinone imine compound, preferably soluble in the hair A compound dissolved in a solvent of polylysine or a derivative thereof used. An example of such an alkenyl-substituted nadicylimine compound is a compound represented by the formula (Ina).
式(Ina)中的L1和L2各自獨立為氫、碳數為1~12的烷基、碳數為3~6的烯基、碳數為5~8的環烷基、芳基或者苄基,n為1或者2。 L 1 and L 2 in the formula (Ina) are each independently hydrogen, an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 3 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, an aryl group or Benzyl, n is 1 or 2.
當n=1時,W是碳數為1~12的烷基、碳數為2~6的烯基、碳數為5~8的環烷基、碳數為6~12的芳基、苄基、以-Z1-(O)q-(Z2O)r-Z3-H(Z1、Z2和Z3獨立為碳數為2~6的亞烷基,q為0或者1,並且r為1~30的整數)表示的基團、以-(Z4)s-B-Z5-H(Z4和Z5獨立為碳數為1~4的亞烷基或者碳數為5~8的亞環烷基,B為亞苯基,並且s為0或者1)表示的基團、以-B-T-B-H(B為亞苯基,並且T為-CH2-、-C(CH3)2-、-O-、-CO-、-S-或者-SO2-)表示的基團、或者這些基團的1個~3個氫經羥基取代的基團。 When n=1, W is an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, an aryl group having 6 to 12 carbon atoms, and benzyl group. a group of -Z 1 -(O) q -(Z 2 O) r -Z 3 -H (Z 1 , Z 2 and Z 3 are independently an alkylene group having 2 to 6 carbon atoms, and q is 0 or 1 And r is an integer represented by 1 to 30), and -(Z 4 ) s -BZ 5 -H (Z 4 and Z 5 are independently an alkylene group having 1 to 4 carbon atoms or a carbon number of 5 a cycloalkylene group of ~8, B is a phenylene group, and s is a group represented by 0 or 1), with -BTBH (B is a phenylene group, and T is -CH 2 -, -C(CH 3 ) a group represented by 2 -, -O-, -CO-, -S- or -SO 2 -), or a group in which one to three hydrogens of these groups are substituted with a hydroxyl group.
此時,優選的R3是碳數為1~8的烷基、碳數為3~4的烯基、環己基、苯基、苄基、碳數為4~10的聚(乙烯氧)乙基、苯氧基苯基、苯基甲基苯基、苯基異亞丙基苯基、 以及這些基團的1個或者2個氫經羥基取代的基團。 In this case, preferred R 3 is an alkyl group having 1 to 8 carbon atoms, an alkenyl group having 3 to 4 carbon atoms, a cyclohexyl group, a phenyl group, a benzyl group, and a poly(ethylene oxide) B having a carbon number of 4 to 10. a group, a phenoxyphenyl group, a phenylmethylphenyl group, a phenylisopropylidenephenyl group, and a group in which one or two hydrogens of these groups are substituted with a hydroxyl group.
當式(Ina)中n=2時,W是碳數為2~20的亞烷基、碳數為5~8的亞環烷基、碳數為6~12的亞芳基、以-Z1-O-(Z2O)r-Z3-(Z1~Z3和r的含義如上所述)表示的基團、以-Z4-B-Z5-(Z4、Z5和B的含義如上所述)表示的基團、以-B-(O-B)s-T-(B-O)s-B-(B為亞苯基,T是碳數為1~3的亞烷基、-O-或者-SO2-,s為0或者1)表示的基團、或者這些基團的1個~3個氫經羥基取代的基團。 When n=2 in the formula (Ina), W is an alkylene group having 2 to 20 carbon atoms, a cycloalkylene group having 5 to 8 carbon atoms, an arylene group having 6 to 12 carbon atoms, and -Z group (Z 1 ~ Z 3 and r meaning as described above) indicated to -Z 4 -BZ 5 - - 1 -O- (Z 2 O) r -Z 3 (Z 4, Z 5 , and B The meaning of the group as described above, with -B-(OB) s -T-(BO) s -B- (B is a phenylene group, T is an alkylene group having a carbon number of 1-3, -O - or -SO 2 -, s is a group represented by 0 or 1), or a group in which one to three hydrogens of these groups are substituted with a hydroxyl group.
此時,優選的W是碳數為2~12的亞烷基、亞環己基、亞苯基、甲代亞苯基(tolylene)、亞二甲苯基(xylylene)、以-C3H6-O-(Z2-O)r-O-C3H6-(Z2是碳數為2~6的亞烷基,r為1或者2)表示的基團、以-B-T-B-(B為亞苯基,並且T為-CH2-、-O-或者-SO2-)表示的基團、以-B-O-B-C3H6-B-O-B-(B為亞苯基)表示的基團、以及這些基團的1個或者2個氫經羥基取代的基團。 In this case, preferred W is an alkylene group having 2 to 12 carbon atoms, a cyclohexylene group, a phenylene group, a tolylene group, a xylylene group, and a -C 3 H 6 - group. O-(Z 2 -O) r -OC 3 H 6 -(Z 2 is an alkylene group having 2 to 6 carbon atoms, and r is 1 or 2), and -BTB-(B is phenylene) a group represented by -CH 2 -, -O- or -SO 2 -), a group represented by -BOBC 3 H 6 -BOB- (B is a phenylene group), and a group of these groups One or two hydrogen-substituted groups.
這種烯基取代納迪克醯亞胺化合物例如可以使用:如日本專利第2729565號公報所記載的那樣通過將烯基取代納迪克酸酐衍生物和二胺在80℃~220℃的溫度下保持0.5小時~20小時而合成所得的化合物,或者市售的化合物。烯基取代納迪克醯亞胺化合物的具體例可以列舉如下所示的化合物。 Such an alkenyl-substituted nadicylimine compound can be used, for example, by maintaining an alkenyl-substituted nadic anhydride derivative and a diamine at a temperature of from 80 ° C to 220 ° C as described in Japanese Patent No. 2729565. The resulting compound is synthesized in hours to 20 hours, or a commercially available compound. Specific examples of the alkenyl-substituted nadicylimine compound include the compounds shown below.
N-甲基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺(N-methyl-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide)、N-甲基-烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞 胺、N-甲基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-甲基-甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(2-乙基己基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺,N-(2-乙基己基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-烯丙基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-烯丙基-烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-烯丙基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-異丙烯基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-異丙烯基-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-異丙烯基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-環己基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-環己基-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-環己基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-苯基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺,N-苯基-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-苄基-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-苄基-烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-苄基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(2-羥基乙基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(2-羥基乙基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(2-羥基乙基)-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺,N-(2,2-二甲基-3-羥基丙基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(2,2-二甲基-3-羥基丙基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、 N-(2,3-二羥基丙基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(2,3-二羥基丙基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(3-羥基-1-丙烯基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(4-羥基環己基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺,N-(4-羥基苯基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(4-羥基苯基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(4-羥基苯基)-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(4-羥基苯基)-甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(3-羥基苯基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(3-羥基苯基)-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-(對羥基苄基)-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-{2-(2-羥基乙氧基)乙基}-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺,N-{2-(2-羥基乙氧基)乙基}-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-{2-(2-羥基乙氧基)乙基}-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-{2-(2-羥基乙氧基)乙基}-甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-[2-{2-(2-羥基乙氧基)乙氧基}乙基]-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-[2-{2-(2-羥基乙氧基)乙氧基}乙基]-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-[2-{2-(2-羥基乙氧基)乙氧基}乙基]-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-{4-(4-羥基苯基異亞丙基)苯基}-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-{4-(4-羥基苯基異亞丙基) 苯基}-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、N-{4-(4-羥基苯基異亞丙基)苯基}-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺,以及它們的低聚物(oligomer);N,N'-亞乙基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)(N,N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide))、N,N'-亞乙基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞乙基-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-三亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-六亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-十二亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-十二亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞環己基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞環己基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺),1,2-雙{3'-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)丙氧基}乙烷、1,2-雙{3'-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)丙氧基}乙烷、1,2-雙{3'-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)丙氧基}乙烷、雙[2'-{3'-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)丙氧基}乙基]醚、雙[2'-{3'-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)丙氧基}乙基]醚、1,4-雙{3'-(烯丙基雙環[2.2.1]庚-5-烯 -2,3-二甲醯亞胺)丙氧基}丁烷、1,4-雙{3'-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)丙氧基}丁烷,N,N'-對亞苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-{(1-甲基)-2,4-亞苯基}-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞二甲苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞二甲苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺),2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷,雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4-(烯丙基甲基雙環[2.2.1]庚 -5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}碸、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}碸,雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}碸、1,6-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-3-羥基-己烷、1,12-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-3,6-二羥基-十二烷、1,3-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-5-羥基-環己烷、1,5-雙{3'-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)丙氧基}-3-羥基-戊烷、1,4-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-2-羥基-苯,1,4-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-2,5-二羥基-苯、N,N'-對-(2-羥基)亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對-(2-羥基)亞二甲苯基-雙(烯丙基甲基環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間-(2-羥基)亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間-(2-羥基)亞二甲苯基-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對-(2,3-二羥基)亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺),2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-2-羥基-苯氧基}苯基]丙烷、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-2-羥基-苯基}甲烷、雙 {3-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-4-羥基-苯基}醚、雙{3-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)-5-羥基-苯基}碸、1,1,1-三{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)}苯氧基甲基丙烷、N,N',N"-三(亞乙基甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)異氰尿酸酯,以及它們的低聚物等。 N-methyl-allyl bicyclo[2.2.1]hept-5-ene-2,3-carboximine (N-methyl-allylbicyclo[2.2.1]hept-5-ene-2,3- Dicarboximide), N-methyl-allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylhydrazine Amine, N-methyl-methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-methyl-methylallylmethylbicyclo[2.2. 1]hept-5-ene-2,3-dimethylimine, N-(2-ethylhexyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylhydrazine Imine, N-(2-ethylhexyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-allyl-allyl Bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-allyl-allylmethylbicyclo[2.2.1]hept-5-ene-2,3- Dimethylimine, N-allyl-methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-isopropenyl-allylbicyclo[ 2.2.1]hept-5-ene-2,3-dimethylimine, N-isopropenyl-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-di Formamidine, N-isopropenyl-methylallyl bicyclo [2.2.1] hept-5-ene-2,3-dimethylimine, N-cyclohexyl-allyl bicyclo [2.2. 1]hept-5-ene-2,3-dimethylimine, N-cyclohexyl-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dimethylhydrazine Amine, N-cyclohexyl-methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-phenyl-allylbicyclo[2.2.1]heptane- 5-ene-2,3-dimethyl Imine, N-phenyl-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-benzyl-allyl bicyclo [2.2.1 Hept-5-ene-2,3-dimethylimine, N-benzyl-allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N -benzyl-methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(2-hydroxyethyl)-allylbicyclo[2.2.1] Hg-5-ene-2,3-dimethylimine, N-(2-hydroxyethyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-di Formamidine, N-(2-hydroxyethyl)-methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(2,2-di Methyl-3-hydroxypropyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(2,2-dimethyl-3-hydroxypropanol (Allyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(2,3-dihydroxypropyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(2,3-dihydroxypropyl) -allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-carboximine, N-(3-hydroxy-1-propenyl)-allylbicyclo[2.2. 1]hept-5-ene-2,3-dimethylimine, N-(4-hydroxycyclohexyl)-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3 -dimethylimine, N-(4-hydroxyphenyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(4-hydroxyphenyl) )-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(4-hydroxyphenyl)-methylallylbicyclo[2.2. 1]hept-5-ene-2,3-dimethylimine, N-(4-hydroxyphenyl)-methylallylmethylbicyclo[2.2.1]hept-5-ene-2,3 -dimethylimine, N-(3-hydroxyphenyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-(3-hydroxyphenyl) )-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-carboximine, N-(p-hydroxybenzyl)-allylbicyclo[2.2.1]g -5-ene-2,3-dimethylimine, N-{2-(2-hydroxyethoxy)ethyl}-allylbicyclo[2.2.1]hept-5-ene-2,3 -dimethylimine, N-{2-(2-hydroxyethoxy)ethyl}-allyl (Methyl)bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-{2-(2-hydroxyethoxy)ethyl}-methylallylbicyclo[ 2.2.1]hept-5-ene-2,3-dimethylimine, N-{2-(2-hydroxyethoxy)ethyl}-methylallylmethylbicyclo[2.2.1] Hg-5-ene-2,3-dimethylimine, N-[2-{2-(2-hydroxyethoxy)ethoxy}ethyl]-allylbicyclo[2.2.1]g -5-ene-2,3-dimethylimine, N-[2-{2-(2-hydroxyethoxy)ethoxy}ethyl]-allyl (methyl)bicyclo[2.2. 1]hept-5-ene-2,3-dimethylimine, N-[2-{2-(2-hydroxyethoxy)ethoxy}ethyl]-methylallylbicyclo[2.2 .1]hept-5-ene-2,3-dimethylimine, N-{4-(4-hydroxyphenylisopropylidene)phenyl}-allylbicyclo[2.2.1]heptane- 5-ene-2,3-dimethylimine, N-{4-(4-hydroxyphenylisopropylidene) Phenyl}-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-{4-(4-hydroxyphenylisopropylidene)benzene 5-methylallyl bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, and their oligomers; N,N'-ethylene-double (allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine) (N,N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2, 3-dicarboximide)), N,N'-ethylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N'- Ethylene-bis(methylallylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-trimethylene-bis(allylbicyclo[ 2.2.1] hept-5-ene-2,3-dimethylimine imine), N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2, 3-dimethylimine), N,N'-hexamethylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N , N'-docamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N'-dodecamethylene-double (allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-cyclohexylene-bis(allylbicyclo[2.2.1]g -5-ene-2,3-dimethylimine), N, N'-Asia Hexyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), 1,2-bis{3'-(allylbicyclo[2.2.1 Hept-5-ene-2,3-dimethylimine imine)propoxy}ethane, 1,2-bis{3'-(allylmethylbicyclo[2.2.1]hept-5-ene -2,3-dimethylimine imine)propoxy}ethane, 1,2-bis{3'-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-di Mercaptoimine) propoxy}ethane, bis[2'-{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimineimine)propoxy }ethyl]ether, bis[2'-{3'-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimineimine)propoxy}ethyl] Ether, 1,4-double {3'-(allylbicyclo[2.2.1]hept-5-ene -2,3-dimethylimine)propoxy}butane, 1,4-bis{3'-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-di Mercaptoimine) propoxy}butane, N,N'-p-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N'-p-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-m-phenylene group- Bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-m-phenylene-bis(allylmethylbicyclo[2.2.1 ]hept-5-ene-2,3-dimethylimine), N,N'-{(1-methyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1 ]hept-5-ene-2,3-dimethylimine), N,N'-p-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3- Dimethylimine), N,N'-p-xylylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N, N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-m-xylylene-bis ( Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), 2,2-bis[4-{4-(allylbicyclo[2.2.1]g -5-ene-2,3-dimethylimine imine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(allyl Bicyclo[2.2.1]hept-5-ene-2,3-carboximine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(methylallylbicyclo) [2.2.1]hept-5-ene-2,3-carboximine)phenoxy}phenyl]propane, bis{4-(allylbicyclo[2.2.1]hept-5-ene- 2,3-dimethylimine)phenyl}methane, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl} Methane, bis{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}methane, double {4-(methylallyl-methyl) Bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}methane, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2, 3-dimethylimine)phenyl}ether, bis{4-(allylmethylbicyclo[2.2.1]g -5-ene-2,3-dimethylimine)phenyl}ether, bis{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylhydrazine Amine)phenyl}ether, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimineimine)phenyl}indole, double {4-(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-carboximine)phenyl}indole, bis{4-(methylallylbicyclo[2.2.1]hept-5-ene -2,3-dimethylimine)phenyl}indole, 1,6-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)-3- Hydroxy-hexane, 1,12-bis(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)-3,6-dihydroxy-dodecane, 1,3-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine)-5-hydroxy-cyclohexane, 1,5-bis{3'-( Allyl bicyclo [2.2.1] hept-5-ene-2,3-dimethylimine imine) propoxy}-3-hydroxy-pentane, 1,4-bis(allylbicyclo[2.2. 1]hept-5-ene-2,3-carboximine)-2-hydroxy-benzene, 1,4-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2, 3-dimethylimine)-2,5-dihydroxy-benzene, N,N'-p-(2-hydroxy)xylylene-bis(allylbicyclo[2.2.1]hept-5- Alkene-2,3-dimethylimine), N,N'-p-(2-hydroxy)xylylene-bis(allyl) Base ring [2.2.1] hept-5-ene-2,3-dimethylimine), N,N'-m-(2-hydroxy)xylylene-bis(allylbicyclo[2.2. 1]hept-5-ene-2,3-dimethylimine), N,N'-m-(2-hydroxy)xylylene-bis(methylallylbicyclo[2.2.1]g -5-ene-2,3-dimethylimine), N,N'-p-(2,3-dihydroxy)xylylene-bis(allylbicyclo[2.2.1]hept-5 -ene-2,3-dimethylimine), 2,2-bis[4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine )-2-hydroxy-phenoxy}phenyl]propane, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimineimine)-2- Hydroxy-phenyl}methane, double {3-(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine)-4-hydroxy-phenyl}ether, bis{3-(methylallylbicyclo) [2.2.1]hept-5-ene-2,3-carboximine]-5-hydroxy-phenyl}indole, 1,1,1-tris{4-(allylmethylbicyclo[2.2 .1]hept-5-ene-2,3-dimethylimine)}phenoxymethylpropane, N,N',N"-tris(ethylene allylenylbicyclo[2.2.1 ]Hept-5-ene-2,3-dimethylimine imine) isocyanurate, and oligomers thereof and the like.
另外,本發明中使用的烯基取代納迪克醯亞胺化合物,也可以是含有非對稱的亞烷基、亞苯基的以下述結構式表示的化合物。 Further, the alkenyl-substituted nadicylimine compound used in the present invention may be a compound represented by the following structural formula containing an asymmetric alkylene group or a phenylene group.
本發明中,可以單獨使用這些烯基取代納迪克醯亞胺化合物,也可以使用它們中的兩種或者兩種以上的混合 物。以下列舉所述烯基取代納迪克醯亞胺化合物中的優選化合物。 In the present invention, these alkenyl groups may be used alone in place of the nadic ylidene imine compound, or a mixture of two or more of them may be used. Things. Preferred compounds among the alkenyl substituted nadic quinone imine compounds are listed below.
N,N'-亞乙基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞乙基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞乙基-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-三亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-六亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-十二亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-十二亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞環己基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞環己基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺),N,N'-對亞苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-{(1-甲基)-2,4-亞苯基}-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞二甲苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞二甲苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、2,2- 雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷,雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}碸、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}碸、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}碸。 N,N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-ethylene-bis(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-ethylidene-bis(methylallylbicyclo[2.2.1]heptane- 5-ene-2,3-dimethylimine), N,N'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine ), N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N'-hexamethylene- Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-dodecyl-bis(allylbicyclo[2.2. 1]hept-5-ene-2,3-carboximine), N,N'-dodecyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2 , 3-dimethylimine), N,N'-cyclohexylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N '-Cyclohexylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-p-phenylene-bis(allyl Bicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-p-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5 -ene-2,3-dimethylimine), N,N'-m-phenylene-bis(allylbicyclo[2.2.1 ]hept-5-ene-2,3-dimethylimine), N,N'-m-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3 -dimethylimine), N,N'-{(1-methyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1]hept-5-ene-2,3 -dimethylimine), N,N'-p-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N '-p-xylylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-m-xylylene-double (allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-m-xylylene-bis(allylmethylbicyclo[2.2.1 ]hept-5-ene-2,3-dimethylimine), 2,2- Bis[4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine)phenoxy}phenyl]propane, 2,2-bis[4- {4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine)phenoxy}phenyl]propane, 2,2-bis[4-{4 -(Methylallylbicyclo[2.2.1]hept-5-ene-2,3-carboximine)phenoxy}phenyl]propane, bis{4-(allylbicyclo[2.2. 1]hept-5-ene-2,3-dimethylimine)phenyl}methane, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-di Methylenimine)phenyl}methane, bis{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}methane, double {4 -(methylallylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}methane, bis{4-(allylbicyclo[2.2.1] Hg-5-ene-2,3-dimethylimine)phenyl}ether, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylhydrazine Imine)phenyl}ether, bis{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}ether, double {4-( Allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine)phenyl}indole, bis{4-(allylmethylbicyclo[2.2.1]hept-5- Alkene-2,3-dimethylimine)phenyl}indole, double {4-(methyl Propyl-bicyclo [2.2.1] hept-5-ene-2,3-acyl imine) phenyl} sulfone.
以下列舉更加優選的烯基取代納迪克醯亞胺化合物。 More preferred alkenyl substituted nadic quinone imine compounds are listed below.
N,N'-亞乙基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞乙基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞乙基-雙(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-三亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-六亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-十二亞甲基 -雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-十二亞甲基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞環己基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-亞環己基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺),N,N'-對亞苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-{(1-甲基)-2,4-亞苯基}-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-對亞二甲苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞二甲苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、N,N'-間亞二甲苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺),2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基甲 基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷。 N,N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-ethylene-bis(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-ethylidene-bis(methylallylbicyclo[2.2.1]heptane- 5-ene-2,3-dimethylimine), N,N'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine ), N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N'-hexamethylene- Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N'-dodecamethylene - bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-dodecamethylene-bis(allylmethylbicyclo[2.2 .1]hept-5-ene-2,3-dimethylimine), N,N'-cyclohexylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3- Dimethylimine), N,N'-cyclohexylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N' - p-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N'-p-phenylene-bis(allylyl) Bicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-m-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene -2,3-dimethylimine), N,N'-m-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine ,N,N'-{(1-methyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine ), N, N'-p-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N'-p-xylene Base-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), N,N'-m-xylylene-bis(allylbicyclo[ 2.2.1]hept-5-ene-2,3-dimethylimine), N,N'-m-xylylene-bis ( Allylmethylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), 2,2-bis[4-{4-(allylbicyclo[2.2.1]g -5-ene-2,3-dimethylimine imine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(allylmethylbicyclo[2.2.1]hept-5 -ene-2,3-dimethylimine imine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(methylallylbicyclo[2.2.1]hept-5-ene -2,3-dimethylimine)phenoxy}phenyl]propane, bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine) Phenyl}methane, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}methane, bis{4-(methylene) Propylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}methane, double {4-(methylallyl-methyl) Bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}methane.
而且,特別優選的烯基取代納迪克醯亞胺化合物可以列舉如下所示的以式(Ina-1)表示的雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷、以式(Ina-2)表示的N,N'-間亞苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、以及以式(Ina-3)表示的N,N'-六亞甲基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)。 Further, a particularly preferred alkenyl-substituted nadicylimine compound can be exemplified by the following double {4-(allylbicyclo[2.2.1]hept-5-ene-2 represented by the formula (Ina-1). , 3-dimethylimine)phenyl}methane, N,N'-m-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene represented by formula (Ina-2) 2,3-dimethylimine), and N,N'-hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2 represented by the formula (Ina-3), 3-dimethylimine).
接著,對本發明中使用的具有自由基聚合性不飽和雙鍵的化合物進行說明。雖然烯基取代納迪克醯亞胺化合物也具有自由基聚合性不飽和雙鍵,但是如上文所述,本發明所使用的具有自由基聚合性不飽和雙鍵的化合物中不包括烯基取代納迪克醯亞胺化合物。這種具有自由基聚合性不飽和雙鍵的化合物優選(甲基)丙烯酸酯、(甲基)丙烯醯胺 等(甲基)丙烯酸衍生物以及雙馬來醯亞胺(bismaleimide)。而且,更加優選具有兩個或兩個以上的自由基聚合性不飽和雙鍵的(甲基)丙烯酸衍生物。 Next, a compound having a radical polymerizable unsaturated double bond used in the present invention will be described. Although the alkenyl-substituted nadicilide compound also has a radically polymerizable unsaturated double bond, as described above, the compound having a radical polymerizable unsaturated double bond used in the present invention does not include an alkenyl-substituted sodium. Dickyimine compound. Such a compound having a radical polymerizable unsaturated double bond is preferably (meth) acrylate or (meth) acrylamide. (meth)acrylic acid derivatives and bismaleimide. Further, a (meth)acrylic acid derivative having two or more radically polymerizable unsaturated double bonds is more preferable.
(甲基)丙烯酸酯的具體例可以列舉:(甲基)丙烯酸環己酯、(甲基)丙烯酸2-甲基環己酯、(甲基)丙烯酸二環戊酯、(甲基)丙烯酸二環戊氧基乙酯、(甲基)丙烯酸異冰片酯(isobornyl(meta)acrylate)、(甲基)丙烯酸苯酯、(甲基)丙烯酸苄酯、(甲基)丙烯酸2-羥基乙酯、以及(甲基)丙烯酸2-羥基丙酯。 Specific examples of the (meth) acrylate include cyclohexyl (meth)acrylate, 2-methylcyclohexyl (meth)acrylate, dicyclopentanyl (meth)acrylate, and (meth)acrylic acid. Cyclopentyloxyethyl ester, isobornyl (meta) acrylate, phenyl (meth) acrylate, benzyl (meth) acrylate, 2-hydroxyethyl (meth) acrylate, And 2-hydroxypropyl (meth)acrylate.
雙官能(甲基)丙烯酸酯的具體例可以列舉:雙丙烯酸乙二酯,東亞合成化學工業股份有限公司的產品ARONIX M-210、ARONIX M-240和ARONIX M-6200,日本化藥股份有限公司的產品KAYARAD HDDA、KAYARAD HX-220、KAYARAD R-604和KAYARAD R-684,大阪有機化學工業股份有限公司的產品V260、V312和V335HP,以及共榮社油脂化學工業股份有限公司的產品Light Acrylate BA-4EA、Light Acrylate BP-4PA和Light Acrylate BP-2PA。 Specific examples of the difunctional (meth) acrylate include: ethylene diacrylate, products of East Asian Synthetic Chemical Co., Ltd., ARONIX M-210, ARONIX M-240, and ARONIX M-6200, Nippon Chemical Co., Ltd. Products KAYARAD HDDA, KAYARAD HX-220, KAYARAD R-604 and KAYARAD R-684, products of Osaka Organic Chemical Industry Co., Ltd. V260, V312 and V335HP, and products of Kyoritsu Oil & Fat Chemical Industry Co., Ltd. Light Acrylate BA -4EA, Light Acrylate BP-4PA and Light Acrylate BP-2PA.
三官能或者三官能以上的多官能(甲基)丙烯酸酯的具體例可以列舉:4,4'-亞甲基雙(N,N-二羥基亞乙基丙烯酸酯苯胺)、ARONIX M-400、ARONIX M-405、ARONIX M-450、ARONIX M-7100、ARONIX M-8030、ARONIX M-8060、KAYARAD TMPTA、KAYARAD DPCA-20、KAYARAD DPCA-30、KAYARAD DPCA-60、KAYARAD DPCA-120、以及大阪有機化學工業股份有限公司的產品VGPT。 Specific examples of the trifunctional or trifunctional or higher polyfunctional (meth) acrylate include 4,4'-methylenebis(N,N-dihydroxyethylene acrylate aniline), ARONIX M-400, ARONIX M-405, ARONIX M-450, ARONIX M-7100, ARONIX M-8030, ARONIX M-8060, KAYARAD TMPTA, KAYARAD DPCA-20, KAYARAD DPCA-30, KAYARAD DPCA-60, KAYARAD DPCA-120, and VGPT, a product of Osaka Organic Chemical Industry Co., Ltd.
(甲基)丙烯醯胺衍生物的具體例可以列舉:N-異丙基丙烯醯胺、N-異丙基甲基丙烯醯胺、N-正丙基丙烯醯胺、N-正丙基甲基丙烯醯胺、N-環丙基丙烯醯胺、N-環丙基甲基丙烯醯胺、N-乙氧基乙基丙烯醯胺、N-乙氧基乙基甲基丙烯醯胺、N-四氫糠基丙烯醯胺(N-tetrahydrofurfuryl acrylamide)、N-四氫糠基甲基丙烯醯胺、N-乙基丙烯醯胺、N-乙基-N-甲基丙烯醯胺、N,N-二乙基丙烯醯胺、N-甲基-N-正丙基丙烯醯胺、N-甲基-N-異丙基丙烯醯胺、N-丙烯醯基呱啶(N-acryloyl piperidine)、N-丙烯醯基吡咯烷(N-acryloyl pyrrolidine)、N,N'-亞甲基雙丙烯醯胺、N,N'-亞乙基雙丙烯醯胺、N,N'-二羥基亞乙基雙丙烯醯胺、N-(4-羥基苯基)甲基丙烯醯胺、N-苯基甲基丙烯醯胺、N-丁基甲基丙烯醯胺、N-(異丁氧基甲基)甲基丙烯醯胺、N-[2-(N,N-二甲基氨基)乙基]甲基丙烯醯胺、N,N-二甲基甲基丙烯醯胺、N-[3-(二甲基氨基)丙基]甲基丙烯醯胺、N-(甲氧基甲基)甲基丙烯醯胺、N-(羥基甲基)-2-甲基丙烯醯胺、N-苄基-2-甲基丙烯醯胺、以及N,N'-亞甲基雙甲基丙烯醯胺。 Specific examples of the (meth) acrylamide derivative include N-isopropyl acrylamide, N-isopropyl methacrylamide, N-n-propyl acrylamide, and N-n-propylmethyl Acrylamide, N-cyclopropyl acrylamide, N-cyclopropyl methacrylamide, N-ethoxyethyl acrylamide, N-ethoxyethyl methacrylamide, N - N-tetrahydrofurfuryl acrylamide, N-tetrahydrofurfuryl methacrylamide, N-ethyl acrylamide, N-ethyl-N-methyl acrylamide, N, N-diethyl acrylamide, N-methyl-N-n-propyl acrylamide, N-methyl-N-isopropyl acrylamide, N-acryloyl piperidine , N-acryloyl pyrrolidine, N,N'-methylenebis propylene amide, N,N'-ethylenebis propylene amide, N,N'-dihydroxy propylene Bis-acrylamide, N-(4-hydroxyphenyl)methacrylamide, N-phenylmethacrylamide, N-butylmethacrylamide, N-(isobutoxymethyl)methyl Acrylamide, N-[2-(N,N-dimethylamino)ethyl]methacrylamide, N,N-dimethylmethacrylamide, N-[3-(dimethyl Amino group )propyl]methacrylamide, N-(methoxymethyl)methacrylamide, N-(hydroxymethyl)-2-methylpropenamide, N-benzyl-2-methyl Acrylamide, and N,N'-methylenebismethacrylamide.
上述的(甲基)丙烯酸衍生物中,特別優選N,N'-亞甲基雙丙烯醯胺、N,N'-二羥基亞乙基-雙丙烯醯胺、雙丙烯酸乙二酯、以及4,4'-亞甲基雙(N,N-二羥基亞乙基丙烯酸酯苯胺)。 Among the above (meth)acrylic acid derivatives, N,N'-methylenebisacrylamide, N,N'-dihydroxyethylidene-bisacrylamide, ethylene diacrylate, and 4 are particularly preferable. , 4'-methylenebis(N,N-dihydroxyethylene acrylate aniline).
雙馬來醯亞胺的具體例可以列舉:KI CHEMICAL INDUSTRY股份有限公司製造的BMI-70和BMI-80,以及大和化成工業股份有限公司製造的BMI-1000、BMI-3000、BMI-4000、BMI-5000和BMI-7000。 Specific examples of the bismaleimide can be exemplified by KI CHEMICAL BMI-70 and BMI-80 manufactured by INDUSTRY Co., Ltd., and BMI-1000, BMI-3000, BMI-4000, BMI-5000 and BMI-7000 manufactured by Daiwa Chemical Industry Co., Ltd.
接著,對本發明中使用的聚醯胺酸以及其衍生物進行說明。 Next, the poly-proline and the derivative thereof used in the present invention will be described.
聚醯胺酸是通過使四羧酸二酐與二胺反應而獲得的聚合物,將該聚醯胺酸溶解在溶劑中並塗布在基板上,接著進行加熱,由此可以在基板表面上形成由聚醯亞胺薄膜所形成的液晶配向膜。這種聚醯胺酸的衍生物的例子為可溶性聚醯亞胺、聚醯胺酸酯以及聚醯胺酸醯胺。更具體來說,可以列舉:使聚醯胺酸的醯胺鍵和羧基完全地脫水閉環而成的聚醯亞胺、使聚醯胺酸的醯胺鍵和羧基部分地脫水閉環而成的部分聚醯亞胺、將聚醯胺酸的羧基轉變為酯而成的聚醯胺酸酯、將四羧酸二酐的一部分替換為二羧酸(或者其鹵化物或酸酐)而反應所得的聚醯胺酸-聚醯胺共聚物、以及使該聚醯胺酸-聚醯胺共聚物部分或者完全地脫水閉環所得的聚醯胺醯亞胺。另外,當將四羧酸二酐和二羧酸混合用作酸成分時,不僅可以獲得聚醯胺酸-聚醯胺共聚物,而且有可能獲得含有聚醯胺以及/或者聚醯胺酸的混合物,在本發明中,以這種可能性為前提而稱為聚醯胺酸-聚醯胺共聚物。在本發明中,使用選自這種聚醯胺酸以及其衍生物中的至少一種聚合物。而且,優選的是將至少兩種這樣的聚合物混合使用。 Polylysine is a polymer obtained by reacting a tetracarboxylic dianhydride with a diamine, which is dissolved in a solvent and coated on a substrate, followed by heating, thereby being formed on the surface of the substrate. A liquid crystal alignment film formed of a polyimide film. Examples of such derivatives of polylysine are soluble polyimine, polyphthalamide, and polyamidamine. More specifically, a polyimine which is obtained by completely dehydrating and ring-closing a decyl bond and a carboxyl group of polyproline, a part in which a guanamine bond and a carboxyl group of a polyglycolic acid are partially dehydrated and closed are exemplified. Polyimine, a polyphthalate obtained by converting a carboxyl group of a polyamic acid into an ester, and a polycondensation obtained by replacing a part of a tetracarboxylic dianhydride with a dicarboxylic acid (or a halide or an acid anhydride thereof) A proline-polyamine copolymer and a polyamidoximine obtained by partially or completely dehydrating the polyamido-polyamide copolymer. Further, when a tetracarboxylic dianhydride and a dicarboxylic acid are used in combination as an acid component, not only a poly-proline-polyamine copolymer but also a polyamine and/or a poly-proline may be obtained. The mixture, in the present invention, is referred to as a poly-proline-polyamine copolymer on the premise of this possibility. In the present invention, at least one polymer selected from the group consisting of such polyamic acid and derivatives thereof is used. Moreover, it is preferred to use at least two such polymers in combination.
四羧酸二酐可將以下內容作為條件而選擇:使用該四 羧酸二酐而獲得的聚醯胺酸可溶於液晶配向劑所使用的溶劑中。而且,這樣的四羧酸二酐中,優選的是使用至少一種芳香族四羧酸二酐。以下列舉芳香族四羧酸二酐的優選例。 Tetracarboxylic dianhydride can be selected as a condition: use the four The polyamic acid obtained by the carboxylic acid dianhydride is soluble in the solvent used for the liquid crystal alignment agent. Further, among such tetracarboxylic dianhydrides, it is preferred to use at least one aromatic tetracarboxylic dianhydride. Preferred examples of the aromatic tetracarboxylic dianhydride are listed below.
上述芳香族四羧酸二酐中,更加優選化合物(1)、化合物(2)、化合物(5)、化合物(6)、化合物(7)以及化合物(14),特別優選化合物(1)(均苯四甲酸二酐(pyromellitic dianhydride))。 Among the above aromatic tetracarboxylic dianhydrides, the compound (1), the compound (2), the compound (5), the compound (6), the compound (7), and the compound (14) are more preferable, and the compound (1) is particularly preferable. Pyromellitic dianhydride.
本發明中,可以並用至少一種所述芳香族四羧酸二酐和至少一種芳香族以外的四羧酸二酐。以下列舉芳香族以外的四羧酸二酐的優選例。 In the present invention, at least one of the aromatic tetracarboxylic dianhydride and at least one tetracarboxylic dianhydride other than aromatic may be used in combination. Preferred examples of the tetracarboxylic dianhydride other than aromatic are listed below.
上述芳香族以外的四羧酸二酐中,更加優選化合物(19)~化合物(39)以及化合物(49),再更加優選化合物(19)、化合物(23)、化合物(25)、化合物(35)~化合物(37)、化合物(39)、化合物(44)以及化合物(49)。而且,特別優選化合物(19)(1,2,3,4-環丁烷四甲酸二酐)。 Among the tetracarboxylic dianhydrides other than the above aromatic compounds, the compound (19) to the compound (39) and the compound (49) are more preferable, and the compound (19), the compound (23), the compound (25), and the compound (35) are more preferable. - Compound (37), Compound (39), Compound (44), and Compound (49). Further, the compound (19) (1,2,3,4-cyclobutanetetracarboxylic dianhydride) is particularly preferred.
另一方面,為了將本發明的聚醯胺酸或者其衍生物製成可溶於溶劑中的聚醯亞胺,優選使用以式(24)、式(35)~式(44)、式(49)、式(50)、式(53)以及式(60)表示的四羧酸二酐。 On the other hand, in order to form the polyaminic acid of the present invention or a derivative thereof into a solvent-soluble polyimine, it is preferred to use the formula (24), the formula (35) to the formula (44), and the formula ( 49) A tetracarboxylic dianhydride represented by the formula (50), the formula (53), and the formula (60).
而且,本發明中,優選的是組合使用至少一種所述芳香族四羧酸二酐和至少一種芳香族以外的四羧酸二酐,特 別優選的是組合使用化合物(1)(均苯四甲酸二酐)和化合物(19)(1,2,3,4-環丁烷四甲酸二酐)。使用含有這樣獲得的聚醯胺酸和化合物(A)的液晶配向劑來形成液晶配向膜時,可以對含有該液晶配向膜的液晶顯示元件賦予與電壓保持率相關的良好的長期可靠性。 Further, in the present invention, it is preferred to use at least one of the aromatic tetracarboxylic dianhydride and at least one aromatic tetracarboxylic dianhydride in combination. It is also preferred to use the compound (1) (pyromellitic dianhydride) and the compound (19) (1,2,3,4-cyclobutanetetracarboxylic dianhydride) in combination. When a liquid crystal alignment film is formed using the liquid crystal alignment agent containing the polyamic acid and the compound (A) thus obtained, it is possible to impart good long-term reliability in accordance with the voltage holding ratio to the liquid crystal display element including the liquid crystal alignment film.
另外,本發明中的四羧酸二酐也可以使用化合物(1)~化合物(67)以外的其他四羧酸二酐。只要在實現本發明目的之範圍內,則可以任意選擇其他四羧酸二酐,並且可以使用各種形態的四羧酸二酐,例如也可以使用具有側鏈結構的四羧酸二酐。將使用具有側鏈結構的四羧酸二酐而獲得的聚醯胺酸用於液晶配向劑中時,由該液晶配向劑所形成的液晶配向膜可以增大含有該液晶配向膜的液晶顯示元件的預傾角(pretilt angle)。 Further, as the tetracarboxylic dianhydride in the present invention, other tetracarboxylic dianhydrides other than the compound (1) to the compound (67) can be used. Other tetracarboxylic dianhydrides can be arbitrarily selected as long as the object of the present invention is achieved, and various forms of tetracarboxylic dianhydride can be used. For example, tetracarboxylic dianhydride having a side chain structure can also be used. When a polyphthalic acid obtained by using a tetracarboxylic dianhydride having a side chain structure is used in a liquid crystal alignment agent, a liquid crystal alignment film formed of the liquid crystal alignment agent can increase a liquid crystal display element containing the liquid crystal alignment film. Pretilt angle.
具有側鏈結構的四羧酸二酐並沒有特別限定,優選例可以列舉具有類固醇骨架的化合物(68)以及化合物(69)。 The tetracarboxylic dianhydride having a side chain structure is not particularly limited, and preferred examples thereof include a compound (68) having a steroid skeleton and a compound (69).
在本發明中,也可以將四羧酸二酐的一部分替換為羧酸酐而使用。通過將四羧酸二酐的一部分替換為羧酸酐,可以終止聚合反應,從而可以抑制反應進一步進行,因此可以容易地控制所獲得的聚醯胺酸的分子量。羧酸酐相對於四羧酸二酐的比例只要在不損及本發明效果的範圍即可,其基準優選四羧酸二酐總量的10 mol%(摩爾百分比)或者10 mol%以下。 In the present invention, a part of the tetracarboxylic dianhydride may be used instead of the carboxylic anhydride. By replacing a part of the tetracarboxylic dianhydride with a carboxylic acid anhydride, the polymerization reaction can be terminated, and the reaction can be further suppressed, so that the molecular weight of the obtained polyamic acid can be easily controlled. The ratio of the carboxylic anhydride to the tetracarboxylic dianhydride is not particularly limited as long as the effect of the present invention is not impaired, and 10 mol% (mol%) or 10 mol% or less of the total amount of the tetracarboxylic dianhydride is preferable.
在本發明中可以使用任意的二胺。但是,在VA型液晶顯示元件的情況下大多要求80°~90°左右的大預傾角,在OCB型液晶顯示元件的情況下大多要求7°~20°左右的預傾角,在TN型液晶顯示元件或者STN型液晶顯示元件的情況下大多要求3°~10°左右的預傾角,以及在IPS型液晶顯示元件的情況下要求大多要求0°~3°左右的小預傾 角。所以,必須考慮預傾角的調整。 Any diamine can be used in the present invention. However, in the case of a VA type liquid crystal display element, a large pretilt angle of about 80 to 90 degrees is required, and in the case of an OCB type liquid crystal display element, a pretilt angle of about 7 to 20 degrees is often required, and a TN type liquid crystal display is required. In the case of an element or an STN liquid crystal display element, a pretilt angle of about 3° to 10° is required, and in the case of an IPS type liquid crystal display element, a small pretilt of about 0° to 3° is required. angle. Therefore, the adjustment of the pretilt angle must be considered.
另外,二胺可以根據其結構的差異而分為兩種。也就是說,當將連結兩個氨基的骨架看作主鏈時,二胺是分為具有從主鏈上分支的基團也就是側鏈基團的二胺和不具有側鏈基團的二胺。通過使具有側鏈基的二胺與四羧酸二酐反應,可以獲得相對於聚合物主鏈而具有多個側鏈基團的聚醯胺酸或者聚醯亞胺。當使用這種相對於聚合物主鏈而具有側鏈基團的聚醯胺酸或者聚醯亞胺時,由含有該聚合物的液晶配向劑所形成的液晶配向膜可以增大液晶顯示元件的預傾角。也就是說,上述側鏈基團是具有增大預傾角的效果的基團,是選自碳數為3或3以上的烷基、碳數為3或3以上的烷氧基、碳數為3或3以上的烷氧基烷基、具有類固醇骨架的基團、以及末端具有含有碳數為1或1以上的烷基、碳數為1或1以上的烷氧基或者碳數為2或2以上的烷氧基烷基的環的基團中。本發明中將具有這種側鏈基團的二胺稱為側鏈型二胺。將不具有這種側鏈基團的二胺稱為非側鏈型二胺。 Further, diamines can be classified into two types depending on the difference in their structures. That is, when the skeleton linking the two amino groups is regarded as the main chain, the diamine is divided into a diamine having a group branched from the main chain, that is, a side chain group and a second group having no side chain group. amine. By reacting a diamine having a side chain group with a tetracarboxylic dianhydride, polylysine or polyimine having a plurality of side chain groups with respect to the polymer main chain can be obtained. When such a polyamic acid or a polyimine having a side chain group with respect to a polymer main chain is used, a liquid crystal alignment film formed of a liquid crystal alignment agent containing the polymer can increase a liquid crystal display element. Pretilt angle. That is, the above-mentioned side chain group is a group having an effect of increasing the pretilt angle, and is selected from an alkyl group having 3 or more carbon atoms, an alkoxy group having 3 or more carbon atoms, and a carbon number of 3 or more or more alkoxyalkyl groups, a group having a steroid skeleton, and an alkoxy group having a carbon number of 1 or 1 or more, a carbon number of 1 or more or a carbon number of 2 or 2 or more of the groups of the alkoxyalkyl group. The diamine having such a side chain group is referred to as a side chain type diamine in the present invention. A diamine having no such a side chain group is referred to as a non-side chain type diamine.
而且,通過適當地組合側鏈型二胺和非側鏈型二胺,可以與上述各種顯示元件各自所需要的預傾角相對應。也就是說,當不需要大預傾角時,只要使用至少一種非側鏈型二胺即可。在上述VA型液晶顯示元件、OCB型液晶顯示元件、STN型液晶顯示元件等用途的情況下,組合使用至少一種非側鏈型二胺和至少一種側鏈型二胺即可。此時,非側鏈型二胺與側鏈型二胺的調配比例只要根據目標 預傾角的大小來決定即可。當然,通過適當地選擇側鏈基團,也可以僅使用側鏈型二胺來與所需要的預傾角相對應。這樣,本發明的液晶配向劑可以應用於任意種類的液晶顯示元件中。另外,這種側鏈基團的效果對於所述四羧酸二酐來說也是相同的。 Further, by appropriately combining the side chain type diamine and the non-side chain type diamine, it is possible to correspond to the pretilt angle required for each of the above various display elements. That is, when a large pretilt angle is not required, it is sufficient to use at least one non-side chain type diamine. In the case of use of the above-described VA liquid crystal display device, OCB liquid crystal display device, or STN liquid crystal display device, at least one non-side chain type diamine and at least one side chain type diamine may be used in combination. At this time, the ratio of the non-side chain type diamine to the side chain type diamine is as long as the target is The size of the pretilt angle can be determined. Of course, by appropriately selecting the side chain groups, it is also possible to use only the side chain type diamine to correspond to the desired pretilt angle. Thus, the liquid crystal alignment agent of the present invention can be applied to any type of liquid crystal display element. In addition, the effect of such side chain groups is also the same for the tetracarboxylic dianhydride.
側鏈基團的具體例如下。 Specific examples of the side chain groups are as follows.
首先,最先可以列舉:烷基、烷氧基、烷氧基烷基、烷基羰基、烷基羰氧基、烷氧基羰基、烷基氨基羰基、烯基、烯氧基、烯基羰基、烯基羰氧基、烯氧基羰基、烯基氨基羰基、炔基、炔氧基、炔基羰基、炔基羰氧基、炔氧基羰基、炔基氨基羰基等。而且,這些基團中的烷基、烯基以及炔基均是碳數為3或3以上的基團。但是,烷氧基烷基只要整體碳數為3或3以上即可。另外,這些基團可以是直鏈狀,也可以是支鏈狀。 First, the first one can be exemplified: alkyl, alkoxy, alkoxyalkyl, alkylcarbonyl, alkylcarbonyloxy, alkoxycarbonyl, alkylaminocarbonyl, alkenyl, alkenyloxy, alkenylcarbonyl And alkenylcarbonyloxy, alkenyloxycarbonyl, alkenylaminocarbonyl, alkynyl, alkynyloxy, alkynylcarbonyl, alkynylcarbonyloxy, alkynyloxycarbonyl, alkynylaminocarbonyl and the like. Further, the alkyl group, the alkenyl group and the alkynyl group in these groups are each a group having a carbon number of 3 or more. However, the alkoxyalkyl group may have a total carbon number of 3 or more. Further, these groups may be linear or branched.
接著,在末端的環具有碳數為1或1以上的烷基、碳數為1或1以上的烷氧基或者碳數為2或2以上的烷氧基烷基作為取代基的條件下,可以列舉:苯基、苯基烷基、苯基烷氧基、苯氧基、苯基羰基、苯基羰氧基、苯氧基羰基、苯基氨基羰基、苯基環己氧基、碳數為3或3以上的環烷基、環己基烷基、環己氧基、環己氧基羰基、環己基苯基、環己基苯基烷基、環己基苯氧基、雙(環己基)氧基、雙(環己基)烷基、雙(環己基)苯基、雙(環己基)苯基烷基、雙(環己基)氧基羰基、雙(環己基)苯氧基羰基、以及環己基雙(苯基)氧基羰基等的環結構的基團。另外,雙(環己基) 以及雙(苯基)也可以分別通過亞烷基而不是單鍵來鍵結。 Next, when the terminal ring has an alkyl group having 1 or more carbon atoms, an alkoxy group having 1 or more carbon atoms, or an alkoxyalkyl group having 2 or more carbon atoms as a substituent, Examples thereof include a phenyl group, a phenylalkyl group, a phenylalkoxy group, a phenoxy group, a phenylcarbonyl group, a phenylcarbonyloxy group, a phenoxycarbonyl group, a phenylaminocarbonyl group, a phenylcyclohexyloxy group, and a carbon number. Is 3 or more cycloalkyl, cyclohexylalkyl, cyclohexyloxy, cyclohexyloxycarbonyl, cyclohexylphenyl, cyclohexylphenylalkyl, cyclohexylphenoxy, bis(cyclohexyl)oxy , bis(cyclohexyl)alkyl, bis(cyclohexyl)phenyl, bis(cyclohexyl)phenylalkyl, bis(cyclohexyl)oxycarbonyl, bis(cyclohexyl)phenoxycarbonyl, and cyclohexyl A group having a ring structure such as bis(phenyl)oxycarbonyl. In addition, bis(cyclohexyl) And bis(phenyl) can also be bonded via an alkylene group instead of a single bond, respectively.
另外,也可以列舉如下的集合環基:兩個或兩個以上的苯環或者環己烷環通過單鍵、-O-、-COO-、-OCO-、-CONH-或碳數為1~3的亞烷基而鍵結,且末端的環具有碳數為3或3以上的烷基、碳數為3或3以上的氟取代烷基、碳數為3或3以上的烷氧基、或者碳數為3或3以上的烷氧基烷基作為取代基。當然,具有類固醇骨架的基團也是有效的側鏈基團。 Further, a collection ring group may be mentioned: two or more benzene rings or a cyclohexane ring through a single bond, -O-, -COO-, -OCO-, -CONH- or a carbon number of 1~ The alkylene group of 3 is bonded, and the terminal ring has an alkyl group having 3 or more carbon atoms, a fluorine-substituted alkyl group having 3 or more carbon atoms, an alkoxy group having 3 or more carbon atoms, Or an alkoxyalkyl group having 3 or more carbon atoms as a substituent. Of course, groups having a steroid backbone are also effective side chain groups.
以下列舉非側鏈型二胺的優選例。 Preferred examples of the non-side chain type diamine are listed below.
H2N-X1-NH2 (I) H 2 NX 1 -NH 2 (I)
其中,X1是碳數為2~12的直鏈亞烷基;X2是碳數為1~12的直鏈亞烷基;X3獨立為單鍵、-O-、-CO-、-CONH-、-NHCO-、-C(CH3)2-、-C(CF3)2-、-O-(CH2)t-O-、-S-、-S-S-、 -SO2-、-S-(CH2)t-S-或者碳數為1~12的直鏈亞烷基,t為1~12的整數;環己烷環或者苯環的任意氫可以經-F、-CH3或者-OH、-COOH、-SO3H、或者-PO3H2、苄基或者羥基苄基取代。 Wherein X 1 is a linear alkylene group having 2 to 12 carbon atoms; X 2 is a linear alkylene group having 1 to 12 carbon atoms; and X 3 is independently a single bond, -O-, -CO-, - CONH-, -NHCO-, -C(CH 3 ) 2 -, -C(CF 3 ) 2 -, -O-(CH 2 ) t -O-, -S-, -SS-, -SO 2 -, -S-(CH 2 ) t -S- or a linear alkylene group having a carbon number of 1 to 12, and t is an integer of 1 to 12; any hydrogen of a cyclohexane ring or a benzene ring may be subjected to -F, -CH 3 or -OH, -COOH, -SO 3 H, or -PO 3 H 2, benzyl or hydroxybenzyl.
以下列舉以式(I)表示的二胺的優選例。 Preferred examples of the diamine represented by the formula (I) are listed below.
以下列舉以式(Ⅱ)表示的二胺的優選例。 Preferred examples of the diamine represented by the formula (II) are listed below.
以下列舉以式(Ⅲ)表示的二胺的優選例。 Preferred examples of the diamine represented by the formula (III) are listed below.
以下列舉以式(Ⅳ)表示的二胺的優選例。 Preferred examples of the diamine represented by the formula (IV) are listed below.
以下列舉以式(V)表示的二胺的優選例。 Preferred examples of the diamine represented by the formula (V) are listed below.
以下列舉以式(Ⅵ)表示的二胺的優選例。 Preferred examples of the diamine represented by the formula (VI) are listed below.
以下列舉以式(Ⅶ)表示的二胺的優選例。 Preferred examples of the diamine represented by the formula (VII) are listed below.
這些二胺中,更加優選的例子為化合物(Ⅳ-1)~化合物(Ⅳ-5)、化合物(Ⅳ-15)、化合物(Ⅳ-16)、化合物(V-1)~化合物(V-12)、化合物(V-26)、化合物(V-27)、化合物(V-31)、化合物(V-33)、化合物(Ⅵ-1)、化合物(Ⅵ-2)、化合物(Ⅵ-6)、以及化合物(Ⅶ-1)~化合物(Ⅶ-5),特別優選的例子為化合物(Ⅳ-1)、化合物(Ⅳ-2)、化合物(Ⅳ-15)、化合物(Ⅳ-16)、化合物(V-1)~化合物(V-12)、化合物(V-33)、以及化合物(Ⅶ-2)。 More preferable examples of these diamines are the compound (IV-1) to the compound (IV-5), the compound (IV-15), the compound (IV-16), and the compound (V-1) to the compound (V-12). ), Compound (V-26), Compound (V-27), Compound (V-31), Compound (V-33), Compound (VI-1), Compound (VI-2), Compound (VI-6) And a compound (VII-1) to a compound (VII-5), and particularly preferable examples are the compound (IV-1), the compound (IV-2), the compound (IV-15), the compound (IV-16), and the compound. (V-1)~ Compound (V-12), Compound (V-33), and Compound (VII-2).
本發明中使用的側鏈型二胺具體可以列舉以下述式(Ⅷ)~式(XII)表示的二胺。 Specific examples of the side chain type diamine used in the present invention include diamines represented by the following formulas (VIII) to (XII).
式(Ⅷ)中,R1為單鍵、-O-、-CO-、-COO-、-OCO-、-CONH-、-CH2O-、-CF2O-、或者碳數為1~6的亞烷基,所述亞烷基中的任意-CH2-可以經-O-、-CH=CH-或者-C≡C-取代;R2為具有類固醇骨架的基團、碳數為3~30的烷基、具有碳數為3~30的烷基或碳數為3~30的烷氧基作為取代基的苯基、或者以式(D-1)表示的基團,所述烷基中的任意-CH2-可以經-O-、-CH=CH-或者-C≡C-取代。 In the formula (Ⅷ), R 1 is a single bond, -O -, - CO -, - COO -, - OCO -, - CONH -, - CH 2 O -, - CF 2 O-, or a carbon number of 1 ~ An alkylene group of 6, any -CH 2 - in the alkylene group may be substituted by -O-, -CH=CH- or -C≡C-; R 2 is a group having a steroid skeleton, and the carbon number is a 3 to 30 alkyl group, a phenyl group having a carbon number of 3 to 30 or an alkoxy group having 3 to 30 carbon atoms as a substituent, or a group represented by the formula (D-1), Any -CH 2 - in the alkyl group may be substituted with -O-, -CH=CH- or -C≡C-.
其中,R13、R14和R15獨立為單鍵、-O-、-COO-、-OCO-、-CONH-、碳數為1~4的亞烷基、碳數為1~3的氧亞烷基、或者碳數為1~3的亞烷氧基;環B和環C獨立為1,4-亞苯基或者1,4-亞環己基;R16和R17獨立為氟或者甲基,並且m1和m2獨立為0、1或者2;e、f和g獨立為0~3的整數,並且它们的合計值為1或1以上;R18是碳數為1~30的烷基、碳數為1~30的烷氧基、或者碳數為2~30的烷氧基烷基,這些烷基、烷氧基以及烷氧基烷基中,任意氫可以氟所取代,並且任意-CH2-可以二氟亞甲基或者以式(D-2)表示的基團所取代。 Wherein R 13 , R 14 and R 15 are independently a single bond, -O-, -COO-, -OCO-, -CONH-, an alkylene group having 1 to 4 carbon atoms, and an oxygen having 1 to 3 carbon atoms. An alkylene group or an alkyleneoxy group having a carbon number of 1 to 3; a ring B and a ring C are independently a 1,4-phenylene group or a 1,4-cyclohexylene group; and R 16 and R 17 are independently a fluorine or a group a group, and m1 and m2 are independently 0, 1, or 2; e, f, and g are independently an integer of 0 to 3, and their total value is 1 or more; R 18 is an alkyl group having 1 to 30 carbon atoms. An alkoxy group having 1 to 30 carbon atoms or an alkoxyalkyl group having 2 to 30 carbon atoms. Any of these alkyl groups, alkoxy groups and alkoxyalkyl groups may be substituted by fluorine, and optionally -CH 2 - may be substituted with a difluoromethylene group or a group represented by the formula (D-2).
其中,R19、R20、R21和R22獨立為碳數為1~10的烷基或者苯基,並且n為1~100的整數。 Wherein R 19 , R 20 , R 21 and R 22 are independently an alkyl group having 1 to 10 carbon atoms or a phenyl group, and n is an integer of 1 to 100.
其中,R3獨立為氫或者甲基;R4為氫、碳數為1~30的烷基、或者碳數為2~30的烯基;而且,R5獨立為單鍵、-CO-或者-CH2-。優選的是,兩個氨基苯基-R5-O-基的其中一個鍵結在類固醇骨架的3位上,另一個鍵結在6位上。另外,兩個氨基在苯環上的鍵結位置優選的是,各自相對於R5的鍵結位置來說為間位或者對位。另外,形成類固醇骨架的碳上鍵結的任意氫可甲基取代。 Wherein R 3 is independently hydrogen or methyl; R 4 is hydrogen, an alkyl group having 1 to 30 carbon atoms, or an alkenyl group having 2 to 30 carbon atoms; and R 5 is independently a single bond, -CO- or -CH 2 -. Preferably, one of the two aminophenyl-R 5 -O- groups is bonded to the 3 position of the steroid backbone and the other is bonded to the 6 position. Further, it is preferred that the bonding positions of the two amino groups on the benzene ring are each a meta or a para position with respect to the bonding position of R 5 . Further, any hydrogen which is bonded to the carbon forming the steroid skeleton may be substituted with a methyl group.
其中,R3獨立為氫或者甲基;R4為氫、碳數為1~30的烷基、或者碳數為2~30的烯基;R5獨立為單鍵、-CO-或者-CH2-;並且,R6和R7獨立為氫、碳數為1~30的烷基、或者苯基。兩個經R7取代的氨基苯基-R5-O-基的在苯環上的鍵結位置優選的是,各自相對於類固醇骨架所鍵結的碳來說為間位或者對位。另外,兩個氨基的在苯環上的鍵結位置優選的是,各自相對於R5來說為間位或者對位。 Wherein R 3 is independently hydrogen or methyl; R 4 is hydrogen, an alkyl group having 1 to 30 carbon atoms, or an alkenyl group having 2 to 30 carbon atoms; and R 5 is independently a single bond, -CO- or -CH 2 -; and, R 6 and R 7 are independently hydrogen, alkyl having 1 to 30, or a phenyl group. The bonding positions of the two R 7 -substituted aminophenyl-R 5 -O- groups on the phenyl ring are preferably each a meta or para position relative to the carbon to which the steroid backbone is bonded. Further, the bonding positions of the two amino groups on the benzene ring are preferably each a meta or para position with respect to R 5 .
其中,R8是碳數為1~30的烷基,並且該烷基的任意-CH2-可以-O-、-CH=CH-或者-C≡C-所取代;R9獨立為-O-或者碳數為1~6的亞烷基;環A為1,4-亞苯基或者1,4-亞環己基;a為0或者1;b為0、1或者2;並且,c獨立為0或者1。兩個氨基的在苯環上的鍵結位置優選的是,各自相對於R9來說為間位或者對位。 Wherein R 8 is an alkyl group having 1 to 30 carbon atoms, and any -CH 2 - of the alkyl group may be substituted by -O-, -CH=CH- or -C≡C-; R 9 is independently -O - or an alkylene group having a carbon number of 1 to 6; ring A is a 1,4-phenylene group or a 1,4-cyclohexylene group; a is 0 or 1; b is 0, 1 or 2; and, c is independent It is 0 or 1. The bonding positions of the two amino groups on the benzene ring are preferably each a meta or para position relative to R 9 .
其中,R10是碳數為3~30的烷基或者碳數為3~30的氟化烷基;R11為氫、碳數為1~30的烷基或者碳數為1~30的氟化烷基;R12獨立為-O-或者碳數為1~6的亞烷基;並且,d獨立為0或者1。兩個氨基的在苯環上的鍵結位置優選的是,各自相對於R12來說為間位或者對位。 Wherein R 10 is an alkyl group having 3 to 30 carbon atoms or a fluorinated alkyl group having 3 to 30 carbon atoms; and R 11 is hydrogen, an alkyl group having 1 to 30 carbon atoms or a fluorine having 1 to 30 carbon atoms; Alkyl; R 12 is independently -O- or an alkylene group having 1 to 6 carbon atoms; and d is independently 0 or 1. The bonding positions of the two amino groups on the phenyl ring are preferably each a meta or para position relative to R 12 .
以式(Ⅷ)表示的二胺的例子可以列舉以式(Ⅷ-1)~式(Ⅷ-43)表示的二胺。 Examples of the diamine represented by the formula (VIII) include a diamine represented by the formula (VIII-1) to the formula (VIII-43).
在式(Ⅷ-1)~式(Ⅷ-11)中,R23和R24均優選碳數為3~30的烷基或者碳數為3~30的烷氧基,更加優選碳數為5~25的烷基或者碳數為5~25的烷氧基。 In the formulae (VIII-1) to (VIII-11), R 23 and R 24 are each preferably an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms, more preferably 5 carbon atoms. ~25 alkyl or alkoxy having 5 to 25 carbon atoms.
在式(Ⅷ-12)~式(Ⅷ-15)中,R25優選碳數為4~30的烷基,更加優選碳數為6~25的烷基。在式(Ⅷ-16)和(Ⅷ-17)中,R26優選碳數為6~30的烷基,更加優選碳數為8~25的烷基。 In the formula (VIII-12) to the formula (VIII-15), R 25 is preferably an alkyl group having 4 to 30 carbon atoms, more preferably an alkyl group having 6 to 25 carbon atoms. In the formulae (VIII-16) and (VIII-17), R 26 is preferably an alkyl group having 6 to 30 carbon atoms, more preferably an alkyl group having 8 to 25 carbon atoms.
在式(Ⅷ-18)~(Ⅷ-37)中,R27和R28均優選碳數為3~30的烷基或者碳數為3~30的烷氧基,更加優選碳數為5~25的烷基或者碳數為5~25的烷氧基。 In the formulae (VIII-18) to (VIII-37), R 27 and R 28 are each preferably an alkyl group having 3 to 30 carbon atoms or an alkoxy group having 3 to 30 carbon atoms, more preferably 5 to 30 carbon atoms. 25 alkyl or an alkoxy group having 5 to 25 carbon atoms.
上述二胺中,優選以式(Ⅷ-1)~式(Ⅷ-11)表示的二胺,更加優選以式(Ⅷ-2)、式(Ⅷ-4)、式(Ⅷ-5)以及式(Ⅷ-6)中的任一個表示的二胺。 Among the above diamines, a diamine represented by the formula (VIII-1) to the formula (VIII-11) is preferred, and a formula (VIII-2), a formula (VIII-4), a formula (VIII-5) and a formula are more preferred. A diamine represented by any one of (VIII-6).
以式(Ⅸ)表示的二胺的例子可以列舉以式(Ⅸ-1)~式(Ⅸ-4)表示的二胺。 Examples of the diamine represented by the formula (IX) include a diamine represented by the formula (IX-1) to the formula (IX-4).
以式(X)表示的二胺的例子可以列舉以式(X-1)~式(X-8)表示的二胺。 Examples of the diamine represented by the formula (X) include a diamine represented by the formula (X-1) to the formula (X-8).
以式(□)表示的二胺的例子可以列舉以式(XI-1)~式(XI-8)表示的二胺。 Examples of the diamine represented by the formula (□) include a diamine represented by the formula (XI-1) to the formula (XI-8).
在式(XI-1)~式(XI-3)中,R29優選碳數為1~30的烷基,在式(XI-4)~式(XI-8)中,R30優選碳數為1~20的烷基。 In the formula (XI-1) to the formula (XI-3), R 29 is preferably an alkyl group having 1 to 30 carbon atoms, and in the formula (XI-4) to the formula (XI-8), R 30 is preferably a carbon number. It is an alkyl group of 1 to 20.
以式(XII)表示的二胺的例子可以列舉以式(XII-1)~式(XII-3)表示的二胺。 Examples of the diamine represented by the formula (XII) include a diamine represented by the formula (XII-1) to the formula (XII-3).
這些式中,R31優選碳數為6~20的烷基,R32優選氫或者碳數為1~10的烷基。 In these formulas, R 31 is preferably an alkyl group having 6 to 20 carbon atoms, and R 32 is preferably hydrogen or an alkyl group having 1 to 10 carbon atoms.
在本發明中,也可以並用以式(I)~式(XII)表示的二胺以外的其他二胺。這種其他二胺的例子可以列舉:具有萘(naphthalene)結構的萘系二胺、具有茀(fluorene)結構的茀系二胺、以及具有矽氧烷鍵的矽氧烷系二胺,這些二胺也可以具有側鏈基團。 In the present invention, other diamines other than the diamine represented by the formula (I) to the formula (XII) may be used in combination. Examples of such other diamines include naphthalene-based diamines having a naphthalene structure, fluorene-based diamines having a fluorene structure, and fluorene-based diamines having a siloxane coupling. The amine may also have a side chain group.
矽氧烷系二胺的優選例是以下述式(XV)表示的化合物。 A preferred example of the decane-based diamine is a compound represented by the following formula (XV).
在式(XV)中,R33和R34各自獨立為碳數為1~3的烷基或者苯基,X4獨立為碳數為1~6的亞烷基或者亞苯基,m為1~10的整數。另外,所述亞苯基的任意氫可以經碳數為1~4的烷基取代。 In the formula (XV), R 33 and R 34 are each independently an alkyl group having 1 to 3 carbon atoms or a phenyl group, and X 4 is independently an alkylene group having 1 to 6 carbon atoms or a phenylene group, and m is 1 An integer of ~10. Further, any hydrogen of the phenylene group may be substituted with an alkyl group having 1 to 4 carbon atoms.
其他二胺的優選例除了所述矽氧烷系二胺以外,還可以列舉以下述式(1')~式(8')表示的化合物。 A preferred example of the other diamines is a compound represented by the following formula (1') to formula (8'), in addition to the alkoxyalkylene-based diamine.
在這些式中,R35和R36各自獨立為碳數為3~30的烷基。 In these formulas, R 35 and R 36 are each independently an alkyl group having 3 to 30 carbon atoms.
在本發明中,除了二胺以外還可以使用單胺。藉由使用單胺,可以終止聚合反應,從而可以抑制反應進一步進行,因此可以容易地控制聚合物(聚醯胺酸)的分子量。單胺相對於二胺的比例只要在不損及本發明效果的範圍內即可,其基準優選胺總量的10摩爾%(mol%)或者10 mol%以下。 In the present invention, a monoamine can be used in addition to the diamine. By using a monoamine, the polymerization reaction can be terminated, so that the reaction can be further inhibited, so that the molecular weight of the polymer (polyproline) can be easily controlled. The ratio of the monoamine to the diamine may be within a range that does not impair the effects of the present invention, and is preferably 10 mol% (mol%) or 10 mol% or less based on the total amount of the amine.
本發明中的聚醯胺酸或者其衍生物可以具有任意重量平均分子量。所述聚醯胺酸或者其衍生物的重量平均分子量並沒有特別的限定,當用作液晶配向劑的成分時優選5×103或者5×103以上,更加優選1×104或者1×104以上。 具有5×103或者5×103以上的重量平均分子量的聚醯胺酸或者其衍生物,在燒製液晶配向膜的步驟中不會蒸發,具有作為液晶配向劑的成分的優異物性。 The polyproline or the derivative thereof in the present invention may have any weight average molecular weight. The weight average molecular weight of the polyamic acid or a derivative thereof is not particularly limited, and when used as a component of the liquid crystal alignment agent, it is preferably 5 × 10 3 or 5 × 10 3 or more, more preferably 1 × 10 4 or 1 ×. 10 4 or more. The polyglycine having a weight average molecular weight of 5 × 10 3 or 5 × 10 3 or more or a derivative thereof does not evaporate in the step of firing the liquid crystal alignment film, and has excellent physical properties as a component of the liquid crystal alignment agent.
本發明中的聚醯胺酸或者其衍生物可以具有任意重量平均分子量。所述聚醯胺酸或者其衍生物的重量平均分子量並沒有特別的限定,當用作液晶配向劑的成分時優選5×103或者5×103以上,更加優選1×104或者1×104以上。具有5×103或者5×103以上的重量平均分子量的聚醯胺酸或者其衍生物,在燒製液晶配向膜的步驟中不會蒸發,具有作為液晶配向劑的成分的優異物性。 The polyproline or the derivative thereof in the present invention may have any weight average molecular weight. The weight average molecular weight of the polyamic acid or a derivative thereof is not particularly limited, and when used as a component of the liquid crystal alignment agent, it is preferably 5 × 10 3 or 5 × 10 3 or more, more preferably 1 × 10 4 or 1 ×. 10 4 or more. The polyglycine having a weight average molecular weight of 5 × 10 3 or 5 × 10 3 or more or a derivative thereof does not evaporate in the step of firing the liquid crystal alignment film, and has excellent physical properties as a component of the liquid crystal alignment agent.
所述重量平均分子量是利用凝膠滲透色譜(Gel Permeation Chromatography,GPC)法測定的。例如,用二甲基甲醯胺(Dimethyl Formamide,DMF)對所獲得的聚醯胺酸或者其衍生物進行稀釋,以使聚合物濃度達到約1 wt%,然後使用2695分離模組(separation module)和2414差示折射計(differential refractometer)(Waters公司製造),將DMF作為展開溶劑並使用凝膠滲透色譜分析(GPC)法進行測定,再通過聚苯乙烯換算來求出重量平均分子量。另外,有時為了高精度地進行聚醯胺酸或聚丙烯酸等的GPC測定,而製備使磷酸、鹽酸、硝酸、硫酸等無機酸或者溴化鋰(lithium bromide)、氯化鋰(lithium chloride)等無機鹽溶解在DMF溶劑中而成的展開溶劑。 The weight average molecular weight is determined by a gel permeation chromatography (GPC) method. For example, the obtained polyglycine or a derivative thereof is diluted with dimethylformamide (DMF) to a polymer concentration of about 1 wt%, and then a 2695 separation module is used. And a 2414 differential refractometer (manufactured by Waters Co., Ltd.), DMF was used as a developing solvent, and measured by a gel permeation chromatography (GPC) method, and the weight average molecular weight was determined by polystyrene conversion. In addition, in order to accurately measure GPC such as polyacrylic acid or polyacrylic acid, inorganic acids such as phosphoric acid, hydrochloric acid, nitric acid, and sulfuric acid, or inorganic substances such as lithium bromide and lithium chloride may be prepared. A developing solvent in which a salt is dissolved in a DMF solvent.
本發明中的聚醯胺酸或者其衍生物可以使用眾所周知的方法來製造。例如,在具備原料添加口、氮氣導入口、 溫度計、攪拌機和冷凝器的反應容器中,添加所需量的至少一種以式(I)~式(XII)表示的二胺,視情況添加所需量的選自其他二胺中的至少一種二胺,另外根據需要添加所需量的單胺。 The polyaminic acid or a derivative thereof in the present invention can be produced by a known method. For example, it has a raw material supply port, a nitrogen gas inlet, and In a reaction vessel of a thermometer, a stirrer, and a condenser, a desired amount of at least one diamine represented by the formula (I) to the formula (XII) is added, and a desired amount of at least one selected from the other diamines is optionally added. The amine is additionally added in the required amount of monoamine as needed.
接著,添加溶劑(例如醯胺系極性溶劑N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidone)或者二甲基甲醯胺等)和一種或者兩種或兩種以上的四羧酸二酐,另外根據需要添加羧酸酐。此時,四羧酸二酐的總添加量優選的是與二胺的總摩爾數大致為等摩爾(摩爾比為0.9~1.1左右)。 Next, a solvent (for example, a guanamine-based polar solvent such as N-methyl-2-pyrrolidone or dimethylformamide) and one or two or more kinds of tetracarboxylic acids are added. The dianhydride is additionally added with a carboxylic anhydride as needed. In this case, the total addition amount of the tetracarboxylic dianhydride is preferably approximately equimolar to the total number of moles of the diamine (molar ratio is about 0.9 to 1.1).
可以通過在攪拌狀態下在0℃~70℃的溫度下反應1小時~48小時來獲得聚醯胺酸的溶液。另外,也可以通過加熱,提高反應溫度(例如50℃~80℃)來獲得分子量小的聚醯胺酸。所獲得的聚醯胺酸的溶液可以用溶劑稀釋後使用,以調整成所需的粘度。 A solution of polyglycine can be obtained by reacting at a temperature of from 0 ° C to 70 ° C for 1 hour to 48 hours under stirring. Further, it is also possible to obtain a polylysine having a small molecular weight by heating and increasing the reaction temperature (for example, 50 ° C to 80 ° C). The obtained solution of polylysine can be used after dilution with a solvent to adjust to a desired viscosity.
使用大量的不良溶劑使本發明中的聚醯胺酸沉澱,並通過進行過濾等而將固體成分和溶劑完全分離,再通過紅外光譜(InfraRed Spectra,IR)、核磁共振(Nuclear Magnetic Resonance,NMR)分析對聚醯胺酸進行鑒定。另外,在KOH或NaOH等強鹼的水溶液中分解固態聚醯胺酸之後,用有機溶劑進行萃取,並進行氣相色譜(Gas Chromatograph,GC)、高效液相色譜(High Performance Liquid Chromatography,HPLC)或者氣相色譜-質譜(Gas Chromatography-Mass Spectrometry,GC-MS)分析,由此可以對所使用的單體進行鑒定。 The polyproline is precipitated by using a large amount of a poor solvent, and the solid component and the solvent are completely separated by filtration or the like, and then passed through infrared spectroscopy (IR), nuclear magnetic resonance (NMR) (Nuclear Magnetic Resonance, NMR). The analysis identified polylysine. In addition, after decomposing the solid polyamic acid in an aqueous solution of a strong alkali such as KOH or NaOH, extraction is carried out with an organic solvent, and gas chromatography (GC) and high performance liquid chromatography (HPLC) are performed. Or Gas Chromatography-Mass Spectrometry (GC-MS) analysis, whereby the monomers used can be identified.
當使本發明中的聚醯胺酸成為聚醯胺酸衍生物即可溶性聚醯亞胺時,可以使聚醯胺酸溶液與脫水劑即醋酸酐、丙酸酐、三氟醋酸酐等酸酐和脫水閉環催化劑即三乙胺、吡啶、三甲基吡啶(collidine)等三級胺一起,在20℃~150℃的溫度下進行醯亞胺化反應而獲得。 When the poly-proline in the present invention is a poly-proline derivative, that is, a soluble polyimine, an acid anhydride solution such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride can be used as a dehydrating agent and a dehydrating agent. A closed-loop catalyst, that is, a tertiary amine such as triethylamine, pyridine or collidine, is obtained by carrying out a hydrazine imidization reaction at a temperature of from 20 ° C to 150 ° C.
也可以使用大量的不良溶劑(poor solvent)(甲醇、乙醇、異丙醇等醇系溶劑或二醇系溶劑),使聚醯胺酸自聚醯胺酸溶液中析出,並使所析出的聚醯胺酸在甲苯(toluene)、二甲苯(xylene)等溶劑中,與和上述相同的脫水劑以及脫水閉環催化劑一起在20℃~150℃的溫度下進行醯亞胺化反應而獲得。 It is also possible to use a large amount of a poor solvent (an alcohol solvent such as methanol, ethanol or isopropyl alcohol or a glycol solvent) to precipitate the polyamic acid from the polyaminic acid solution and to precipitate the precipitated polymer. The valine acid is obtained by performing a hydrazine imidization reaction in a solvent such as toluene or xylene with a dehydrating agent and a dehydration ring-closure catalyst as described above at a temperature of from 20 ° C to 150 ° C.
在所述醯亞胺化反應中,脫水劑與脫水閉環催化劑的比例優選為0.1~10(摩爾比)。相對於所使用的四羧酸二酐中所含有的酸二酐的總摩爾量,脫水劑與脫水閉環催化劑的合計使用量優選為1.5倍~10倍摩爾。通過調整該化學醯亞胺化的脫水劑、催化劑量、反應溫度以及反應時間,可以控制醯亞胺化的程度,獲得部分聚醯亞胺。 In the hydrazine imidization reaction, the ratio of the dehydrating agent to the dehydration ring-closure catalyst is preferably 0.1 to 10 (molar ratio). The total amount of the dehydrating agent and the dehydration ring-closure catalyst to be used is preferably 1.5 to 10 times by mole based on the total molar amount of the acid dianhydride contained in the tetracarboxylic dianhydride to be used. By adjusting the chemical hydrazide dehydrating agent, the amount of the catalyst, the reaction temperature, and the reaction time, the degree of hydrazide can be controlled to obtain a partial polyimine.
所獲得的聚醯亞胺可以與溶劑分離,然後和改良劑一起再次溶解於後述溶劑中而用作液晶配向劑,其中所述改良劑是將所述烯基取代納迪克醯亞胺化合物與選自所述雜環化合物中的至少一種組合而成的,或者,也可以不與溶劑分離而添加所述改良劑,用作液晶配向劑。 The obtained polyimine can be separated from the solvent and then redissolved in a solvent to be used as a liquid crystal alignment agent together with a modifier, wherein the modifier is a substituted naphthyl imine compound and the selected one. The modifier may be added from at least one of the heterocyclic compounds or may be added as a liquid crystal alignment agent without being separated from the solvent.
另外,如上所述,本發明的四羧酸二酐中使用的酸二酐的一部分可以替換為有機二羧酸。如果使用有機二羧酸 和四羧酸二酐來製造本發明的聚醯胺酸,那麼可以獲得聚醯胺酸-聚醯胺共聚物。在這裏,有機二羧酸相對於四羧酸二酐的比例只要在不損及本發明效果的範圍內即可,其基準優選10 mol%或者10 mol%以下。 Further, as described above, a part of the acid dianhydride used in the tetracarboxylic dianhydride of the present invention may be replaced with an organic dicarboxylic acid. If using organic dicarboxylic acids And the tetracarboxylic dianhydride to produce the poly-proline of the present invention, then a poly-proline-polyamine copolymer can be obtained. Here, the ratio of the organic dicarboxylic acid to the tetracarboxylic dianhydride may be within a range that does not impair the effects of the present invention, and the basis thereof is preferably 10 mol% or less.
另外,可以通過對所述聚醯胺酸-聚醯胺共聚物進行化學醯亞胺化而製造聚醯胺醯亞胺。 Further, polyamidoquinone imine can be produced by chemically imidating the polyproline-polyamide copolymer.
接著,對本發明的液晶配向劑進行說明。本發明的液晶配向劑是含有烯基取代納迪克醯亞胺化合物、具有自由基聚合性不飽和雙鍵的化合物、以及聚醯胺酸或者其衍生物的組成物。從粘度等物性的調整、使用的容易性、步驟的簡化等觀點來考慮,本發明的液晶配向劑可以進一步含有溶劑,也可以進一步含有普通的液晶配向劑中所含有的各種添加劑。 Next, the liquid crystal alignment agent of the present invention will be described. The liquid crystal alignment agent of the present invention is a composition containing an alkenyl-substituted nadic ylidene compound, a compound having a radical polymerizable unsaturated double bond, and a poly-proline or a derivative thereof. The liquid crystal alignment agent of the present invention may further contain a solvent, or may further contain various additives contained in a general liquid crystal alignment agent, from the viewpoints of physical properties such as viscosity, ease of use, and simplification of the steps.
從使液晶顯示元件的電特性長期穩定的觀點來考慮,本發明的液晶配向劑中的烯基取代納迪克醯亞胺化合物的比例以相對於液晶配向劑中的聚醯胺酸或者其衍生物的重量比計,優選0.01~1.00,更加優選0.01~0.70,再更加優選0.01~0.50。 From the viewpoint of stabilizing the electrical characteristics of the liquid crystal display element for a long period of time, the ratio of the alkenyl group substituted nadic ruthenium compound in the liquid crystal alignment agent of the present invention is relative to the polylysine or its derivative in the liquid crystal alignment agent. The weight ratio is preferably 0.01 to 1.00, more preferably 0.01 to 0.70, still more preferably 0.01 to 0.50.
從使液晶顯示元件的電特性長期穩定的觀點來考慮,具有自由基聚合性不飽和雙鍵的化合物在本發明的液晶配向劑中的比例以相對於聚醯胺酸或者其衍生物的重量比計,優選0.01~1.00,更加優選0.01~0.70,再更加優選0.01~0.50。 From the viewpoint of stabilizing the electrical characteristics of the liquid crystal display element for a long period of time, the ratio of the compound having a radical polymerizable unsaturated double bond in the liquid crystal alignment agent of the present invention in a weight ratio relative to polyglycine or a derivative thereof It is preferably 0.01 to 1.00, more preferably 0.01 to 0.70, still more preferably 0.01 to 0.50.
從降低液晶顯示元件的離子密度、抑制離子密度的隨 時間增加、以及抑制殘像的觀點來考慮,具有自由基聚合性不飽和雙鍵的化合物相對於烯基取代納迪克醯亞胺化合物的比例以重量比計,優選0.1~10,更加優選0.5~5。 From reducing the ion density of the liquid crystal display element and suppressing the ion density From the viewpoint of increasing the time and suppressing the afterimage, the ratio of the compound having a radical polymerizable unsaturated double bond to the alkenyl-substituted nadic ylidene compound is preferably 0.1 to 10, more preferably 0.5 to the weight ratio. 5.
本發明的液晶配向劑中的聚醯胺酸或者其衍生物的含有率,可以根據將液晶配向劑塗布在基板上的塗布方法而適當地選擇。例如,用於普通液晶顯示元件的製造步驟中的印刷機(包括膠版印刷機(offset printer)和噴墨印刷機(inkjet printer)。以下有時簡稱為“印刷機”)所使用的液晶配向劑中的聚醯胺酸或者其衍生物的含有率,優選的是以總量計為0.5 wt%~30 wt%,更加優選的是以總量計為1 wt%~15 wt%,但要考慮與液晶配向劑的粘度的關係而適當地調整。 The content ratio of the polyamic acid or the derivative thereof in the liquid crystal alignment agent of the present invention can be appropriately selected depending on the coating method in which the liquid crystal alignment agent is applied onto the substrate. For example, a printing machine used in a manufacturing step of a general liquid crystal display element (including an offset printer and an inkjet printer. Hereinafter, simply referred to as a "printing machine"), a liquid crystal alignment agent. The content of the poly-proline or the derivative thereof is preferably 0.5% by weight to 30% by weight based on the total amount, and more preferably 1% by weight to 15% by weight based on the total amount, but it is considered It is appropriately adjusted in relation to the viscosity of the liquid crystal alignment agent.
本發明中使用的溶劑廣泛地包括聚醯胺酸、可溶性聚醯亞胺以及聚醯胺醯亞胺等高分子成分的製造步驟或用途中通常使用的溶劑,是根據使用目的而適當選擇的。溶劑優選的是,含有1)對於聚醯胺酸或可溶性聚醯亞胺來說為易溶性的非質子性極性有機溶劑、以及2)改變表面張力以改善塗布性等的溶劑的混合溶劑。以下例示這些溶劑。 The solvent used in the present invention broadly includes a solvent which is usually used in a production step or a use of a polymer component such as polyacrylamide, soluble polyimine, or polyamidoximine, and is appropriately selected depending on the purpose of use. The solvent is preferably a mixed solvent containing 1) an aprotic polar organic solvent which is easily soluble for polyphthalic acid or soluble polyimide, and 2) a solvent which changes surface tension to improve coatability and the like. These solvents are exemplified below.
1)對於聚醯胺酸或可溶性聚醯亞胺來說為良溶劑的非質子性極性有機溶劑(以下稱為非質子性極性有機溶劑):例如N-甲基-2-吡咯烷酮、二甲基咪唑烷酮(dimethyl imidazolidinone)、N-甲基己內醯胺(N-methyl caprolactam)、N-甲基丙醯胺(N-methyl propionamide)、N,N-二甲基乙醯胺、二甲基亞碸(dimethyl sulfoxide)、N,N- 二甲基甲醯胺、N,N-二乙基甲醯胺、二乙基乙醯胺、γ-丁內酯(γ-butyrolactone)以及γ-戊內酯(γ-valerolactone)。這些溶劑中,優選N-甲基-2-吡咯烷酮、二甲基咪唑烷酮、γ-丁內酯以及γ-戊內酯。 1) An aprotic polar organic solvent (hereinafter referred to as an aprotic polar organic solvent) which is a good solvent for polyaminic acid or soluble polyimine: for example, N-methyl-2-pyrrolidone, dimethyl Dimethyl imidazolidinone, N-methyl caprolactam, N-methyl propionamide, N,N-dimethylacetamide, dimethyl Dimethyl sulfoxide, N, N- Dimethylformamide, N,N-diethylformamide, diethylacetamide, γ-butyrolactone, and γ-valerolactone. Among these solvents, N-methyl-2-pyrrolidone, dimethylimidazolidinone, γ-butyrolactone, and γ-valerolactone are preferable.
2)改變表面張力以改善塗布性等的溶劑(以下稱為其他溶劑):例如乳酸烷基酯、3-甲基-3-甲氧基丁醇、萘滿(tetralin)、異佛爾酮(isophorone)、乙二醇單丁醚等乙二醇單烷基醚、二乙二醇單乙醚等二乙二醇單烷基醚、乙二醇單烷基醚或者苯醚乙酸酯、三乙二醇單烷基醚、丙二醇單丁醚等丙二醇單烷基醚、丙二酸二乙酯(diethyl malonate)等丙二酸二烷基酯、二丙二醇單甲醚等二丙二醇單烷基醚、它們的乙酸酯類等酯化合物。這些溶劑中,優選乙二醇單丁醚、二乙二醇單乙醚、丙二醇單丁醚、以及二丙二醇單甲醚。 2) A solvent (hereinafter referred to as another solvent) which changes the surface tension to improve coating properties and the like: for example, alkyl lactate, 3-methyl-3-methoxybutanol, tetralin, isophorone ( Isophorone), ethylene glycol monoalkyl ether such as ethylene glycol monobutyl ether, diethylene glycol monoalkyl ether such as diethylene glycol monoethyl ether, ethylene glycol monoalkyl ether or phenyl ether acetate, triethyl a dipropylene glycol monoalkyl ether such as a diol monoalkyl ether or a propylene glycol monoalkyl ether such as propylene glycol monobutyl ether; a dialkyl malonate such as diethyl malonate; or a dipropylene glycol monomethyl ether; Their ester compounds such as acetates. Among these solvents, ethylene glycol monobutyl ether, diethylene glycol monoethyl ether, propylene glycol monobutyl ether, and dipropylene glycol monomethyl ether are preferable.
非質子性極性溶劑和其他溶劑的種類以及比例,可以考慮液晶配向劑的印刷性、塗布性、溶解性和保存穩定性等而適當地設定。與其他溶劑相比,非質子性極性溶劑的溶解性和保存穩定性相對優異,而其他溶劑的印刷性和塗布性優異。 The type and ratio of the aprotic polar solvent and other solvents can be appropriately set in consideration of printability, coatability, solubility, storage stability, and the like of the liquid crystal alignment agent. The aprotic polar solvent is relatively superior in solubility and storage stability as compared with other solvents, and the other solvents are excellent in printability and coatability.
如上文所述,本發明的液晶配向劑也可以含有各種添加劑。各種添加劑可以根據各自的目的而選擇使用聚醯胺酸或者其衍生物以外的高分子化合物、或者低分子化合物。 As described above, the liquid crystal alignment agent of the present invention may also contain various additives. Various additives may be selected from polymer compounds other than polyamine or derivatives thereof, or low molecular compounds, depending on the respective purpose.
例如,也可以將在有機溶劑中為可溶性的聚合物作為添加劑,通過添加這些添加劑,可以控制所形成的液晶配 向膜的電特性或者配向性。這種聚合物的例子可以列舉聚醯胺、聚氨基甲酸乙酯(polyurethane)、聚脲(Polyurea)、聚酯、聚環氧化物(polyepoxide)、聚酯多元醇(polyester polyol)、矽酮改性聚氨基甲酸乙酯以及矽酮改性聚酯。 For example, a polymer which is soluble in an organic solvent can also be used as an additive, and by adding these additives, the formed liquid crystal can be controlled. Electrical properties or alignment to the film. Examples of such polymers include polyamines, polyurethanes, polyureas, polyesters, polyepoxides, polyester polyols, and ketones. Polyurethane and anthrone modified polyester.
另外,對於低分子化合物添加劑,例如,1)當希望提高塗布性時可以遵照該目的而使用介面活性劑,2)當必須提高防靜電性時可以使用防靜電劑,3)當希望提高與基板的密著性或者耐摩擦性時可以使用矽烷偶合劑或者鈦系偶合劑,另外,4)當在低溫下進行醯亞胺化時可以使用醯亞胺化催化劑。 Further, for the low molecular compound additive, for example, 1) an interfacial agent may be used in accordance with the purpose when it is desired to improve the coatability, 2) an antistatic agent may be used when it is necessary to improve the antistatic property, and 3) when it is desired to improve the substrate A decane coupling agent or a titanium coupling agent may be used for the adhesion or rubbing resistance, and 4) a hydrazine imidization catalyst may be used when the hydrazine imidization is carried out at a low temperature.
所述矽烷偶合劑的例子可以列舉:乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、N-(2-氨基乙基)-3-氨基丙基甲基二甲氧基矽烷、N-(2-氨基乙基)-3-氨基丙基甲基三甲氧基矽烷、對氨基苯基三甲氧基矽烷、對氨基苯基三乙氧基矽烷、間氨基苯基三甲氧基矽烷、間氨基苯基三乙氧基矽烷、3-氨基丙基三甲氧基矽烷、3-氨基丙基三乙氧基矽烷、3-縮水甘油氧基丙基三甲氧基矽烷、3-縮水甘油氧基丙基甲基二甲氧基矽烷、2-(3,4-環氧環己基)乙基三甲氧基矽烷、3-氯丙基甲基二甲氧基矽烷、3-氯丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-巰基丙基三甲氧基矽烷、N-(1,3-二甲基亞丁基)-3-(三乙氧基矽烷基)-1-丙胺、N,N'-雙[3-(三甲氧基矽烷基)丙基]乙二胺等。 Examples of the decane coupling agent include vinyl trimethoxy decane, vinyl triethoxy decane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxy decane, and N- (2-Aminoethyl)-3-aminopropylmethyltrimethoxydecane, p-aminophenyltrimethoxydecane, p-aminophenyltriethoxydecane, m-aminophenyltrimethoxydecane, m-amino Phenyltriethoxydecane, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 3-glycidoxypropyltrimethoxydecane, 3-glycidoxypropyl Methyldimethoxydecane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxydecane, 3-chloropropylmethyldimethoxydecane, 3-chloropropyltrimethoxydecane, 3-methacryloxypropyltrimethoxydecane, 3-mercaptopropyltrimethoxydecane, N-(1,3-dimethylbutylidene)-3-(triethoxydecylalkyl)- 1-propylamine, N,N'-bis[3-(trimethoxydecyl)propyl]ethylenediamine, and the like.
所述醯亞胺化催化劑的例子優選添加:三甲胺、三乙胺、三丙胺、三丁胺等脂肪族胺類;N,N-二甲基苯胺、N,N- 二乙基苯胺、甲基取代苯胺、羥基取代苯胺等芳香族胺類;吡啶、甲基取代吡啶、羥基取代吡啶、喹啉、甲基取代喹啉、羥基取代喹啉、異喹啉、甲基取代異喹啉、羥基取代異喹啉、咪唑(imidazole)、甲基取代咪唑、羥基取代咪唑等環式胺類等催化劑。特別可以列舉N,N-二甲基苯胺、鄰羥基苯胺、間羥基苯胺、對羥基苯胺、鄰羥基吡啶、間羥基吡啶、對羥基吡啶、異喹啉等。 An example of the ruthenium amide catalyst is preferably an aliphatic amine such as trimethylamine, triethylamine, tripropylamine or tributylamine; N,N-dimethylaniline, N,N- Aromatic amines such as diethyl aniline, methyl substituted aniline, hydroxy substituted aniline; pyridine, methyl substituted pyridine, hydroxy substituted pyridine, quinoline, methyl substituted quinoline, hydroxy substituted quinoline, isoquinoline, methyl A catalyst such as a cyclic amine such as an isoquinoline, a hydroxy-substituted isoquinoline, an imidazole, a methyl-substituted imidazole or a hydroxy-substituted imidazole. Specific examples thereof include N,N-dimethylaniline, o-hydroxyaniline, m-hydroxyaniline, p-hydroxyaniline, o-hydroxypyridine, m-hydroxypyridine, p-hydroxypyridine, and isoquinoline.
矽烷偶合劑的添加量通常以相對於聚醯胺酸或者其衍生物的重量比計為0~0.10,優選0.001~0.03。 The amount of the decane coupling agent to be added is usually from 0 to 0.10, preferably from 0.001 to 0.03, based on the weight ratio of the polyamic acid or the derivative thereof.
醯亞胺化催化劑的添加量通常相對於聚醯胺酸或者其衍生物的羰基為0.01~5當量,優選0.05~3當量。 The amount of the ruthenium imidization catalyst to be added is usually 0.01 to 5 equivalents, preferably 0.05 to 3 equivalents, to the carbonyl group of the polyglycine or a derivative thereof.
其他添加劑的添加量根據用途而不同,通常以相對於聚醯胺酸或者其衍生物的重量比計為0~0.30,優選0.001~0.10。 The amount of the other additives to be added varies depending on the use, and is usually from 0 to 0.30, preferably from 0.001 to 0.10, based on the weight ratio of the polyglycine or the derivative thereof.
本發明的液晶配向劑的其他優選形態為含有兩種或兩種以上聚醯胺酸的組成物。例如可以列舉含有第1聚醯胺酸和第2聚醯胺酸的液晶配向劑,其中所述第1聚醯胺酸是四羧酸二酐以及二胺均不使用具有側鏈基團的化合物而獲得的,第2聚醯胺酸是四羧酸二酐以及二胺的一方或者兩方使用具有側鏈基團的化合物而獲得的。更具體來說,所述聚醯胺酸中的一種,是使至少一種芳香族四羧酸二酐(優選所述化合物(1)~化合物(18))以及至少一種芳香族以外的四羧酸二酐(優選所述化合物(19)~化合物(67))的一方或者兩方,與至少一種非側鏈型二胺(優選 化合物(I)~化合物(Ⅶ))反應而獲得的聚醯胺酸或者其衍生物(以下有時稱為“聚醯胺酸I”),另一種聚醯胺酸是所述芳香族四羧酸二酐以及芳香族以外的四羧酸二酐的一方或者兩方,與至少一種側鏈型二胺(優選化合物(Ⅷ)~化合物(XII)、或者至少一種所述側鏈型二胺和至少一種非側鏈型二胺的混合物反應而獲得的聚醯胺酸或者其衍生物(以下有時稱為“聚醯胺酸Ⅱ”)。 Another preferred embodiment of the liquid crystal alignment agent of the present invention is a composition containing two or more kinds of polyamic acid. For example, a liquid crystal alignment agent containing a first polyamic acid and a second polyamic acid, wherein the first polyamic acid is a tetracarboxylic dianhydride and a diamine, and a compound having a side chain group is not used. Further, the second poly-proline is obtained by using one of the tetracarboxylic dianhydride and the diamine or a compound having a side chain group. More specifically, one of the polylysines is at least one aromatic tetracarboxylic dianhydride (preferably the compound (1) to the compound (18)) and at least one aromatic tetracarboxylic acid One or both of a dianhydride (preferably the compound (19) to the compound (67)), and at least one non-side chain type diamine (preferably a polylysine obtained by reacting the compound (I) to the compound (VII) or a derivative thereof (hereinafter sometimes referred to as "polyamido acid I"), and another poly-proline is the aromatic tetracarboxylic acid One or both of acid dianhydride and tetracarboxylic dianhydride other than aromatic, and at least one side chain type diamine (preferably compound (VIII) to compound (XII), or at least one of the side chain type diamines and Polylysine obtained by reacting at least one mixture of non-side chain type diamines or a derivative thereof (hereinafter sometimes referred to as "polyglycolic acid II").
本發明的含有聚醯胺酸I以及聚醯胺酸Ⅱ的組成物,是通過混合所述聚醯胺酸I和聚醯胺酸Ⅱ而製備的。所混合的聚醯胺酸I與聚醯胺酸Ⅱ的重量比優選I/Ⅱ=99/1~50/50,更優選I/Ⅱ=95/5~80/20。該重量比只要根據所需要的預傾角來適當地調整即可,如果增加聚醯胺酸Ⅱ的比例,則可以增大預傾角。 The composition containing polylysine I and polyphthalic acid II of the present invention is prepared by mixing the polyaminic acid I and polylysine II. The weight ratio of the mixed polyaminic acid I to polylysine II is preferably I/II = 99/1 to 50/50, more preferably I/II = 95/5 to 80/20. The weight ratio may be appropriately adjusted according to the required pretilt angle, and if the ratio of the polyamic acid II is increased, the pretilt angle can be increased.
另外,本發明的液晶配向劑可以僅含有聚醯胺酸I和聚醯胺酸Ⅱ,也可以進一步含有聚醯胺酸I和聚醯胺酸Ⅱ以外的聚醯胺酸或者其衍生物。 Further, the liquid crystal alignment agent of the present invention may contain only polyamic acid I and polyamic acid II, and may further contain polyamic acid other than polyamine acid I and polyamine acid II or a derivative thereof.
另一方面,所述聚醯胺酸Ⅱ具有對含有如下液晶配向膜的液晶顯示元件賦予合適的預傾角的效果,所述液晶配向膜是使用含有所述聚醯胺酸Ⅱ的液晶配向劑而形成的。合成聚醯胺酸Ⅱ時也可以並用具有側鏈的二胺以外的二胺。可以並用的二胺的例子可以列舉所述的化合物(I)~化合物(Ⅶ)、茀系二胺以及矽氧烷系二胺。 On the other hand, the polyamic acid II has an effect of imparting a suitable pretilt angle to a liquid crystal display element containing a liquid crystal alignment film which is a liquid crystal alignment agent containing the polyamic acid II. Forming. When the polyamic acid II is synthesized, a diamine other than the diamine having a side chain may be used in combination. Examples of the diamine which can be used in combination include the above-mentioned compound (I) to the compound (VII), an anthracene diamine, and a decane-based diamine.
通過組合(摻合)所述聚醯胺酸I和聚醯胺酸Ⅱ,可以賦予作為本發明液晶配向劑的優異特性。具體來說,可 以通過對於作為聚醯胺酸的原料的二胺,適當地選擇所使用的二胺的種類和其組合,來對使用本發明的組成物所形成的液晶配向膜賦予更加良好的長期可靠性和合適的預傾角。 By combining (blending) the polyamic acid I and polyphthalic acid II, it is possible to impart excellent characteristics as a liquid crystal alignment agent of the present invention. Specifically, The liquid crystal alignment film formed using the composition of the present invention is imparted with better long-term reliability by appropriately selecting the kind of the diamine to be used and a combination thereof for the diamine which is a raw material of polylysine. A suitable pretilt angle.
本發明的液晶配向膜例如可以通過以下的方式來形成:將本發明的液晶配向劑塗布在液晶顯示元件用基板、或者氟化鈣或矽等的測定用基板上,然後將該液晶配向劑的膜加熱到例如150℃~400℃、優選180℃~280℃。在這裏,液晶配向膜的膜厚優選10 nm~300 nm,更加優選30 nm~150 nm。另外,液晶配向膜優選經摩擦處理。 The liquid crystal alignment film of the present invention can be formed, for example, by applying the liquid crystal alignment agent of the present invention to a substrate for a liquid crystal display element or a substrate for measurement such as calcium fluoride or ruthenium, and then applying the liquid crystal alignment agent. The film is heated to, for example, 150 ° C to 400 ° C, preferably 180 ° C to 280 ° C. Here, the film thickness of the liquid crystal alignment film is preferably 10 nm to 300 nm, and more preferably 30 nm to 150 nm. Further, the liquid crystal alignment film is preferably subjected to a rubbing treatment.
所述液晶配向膜的膜厚可以根據液晶配向劑的粘度或者液晶配向劑的塗布方法來調整。另外,液晶配向膜的膜厚可以利用輪廓儀(profilometer)或者偏振光橢圓率測量儀(ellipsometer)等眾所周知的膜厚測定裝置來測定。另外,液晶配向膜中的成分可以根據需要而進行水解等的處理,並利用IR或者MS等普通的分析方法來進行分析。 The film thickness of the liquid crystal alignment film can be adjusted according to the viscosity of the liquid crystal alignment agent or the coating method of the liquid crystal alignment agent. Further, the film thickness of the liquid crystal alignment film can be measured by a known film thickness measuring device such as a profilometer or an ellipsometer. Further, the components in the liquid crystal alignment film may be subjected to hydrolysis or the like as needed, and analyzed by an ordinary analytical method such as IR or MS.
本發明的液晶顯示元件包含:1)對向配置著的一對基板、2)在所述一對基板各自的相對向的面上形成的本發明的液晶配向膜、以及3)夾在所述一對基板間的液晶層。 The liquid crystal display device of the present invention comprises: 1) a pair of substrates disposed oppositely, 2) a liquid crystal alignment film of the present invention formed on a surface facing each of the pair of substrates, and 3) sandwiched between A liquid crystal layer between a pair of substrates.
所述對向配置著的一對附有電極的基板優選透明基板(例如玻璃基板)。 The pair of electrode-attached substrates disposed opposite each other is preferably a transparent substrate (for example, a glass substrate).
在所述一對基板的至少一片或者兩片基板的表面上,與液晶顯示元件的形態相對應地設置著電極。所述電極只要是在基板的一個面上形成的電極,則沒有特別的限定。 這樣的電極例如可以列舉氧化銦錫(Indium Tin Oxides,ITO)或者金屬的蒸鍍膜等。電極既可以形成在基板的整個表面上,也可以形成為例如經圖案化的特定形狀。沒有設置電極的基板是在基板表面上形成本發明的液晶配向膜,而設置著電極的基板是在電極上形成本發明的液晶配向膜。關於本發明的液晶配向膜的形成,是如上文中所述。 Electrodes are provided on the surface of at least one or both of the pair of substrates in correspondence with the form of the liquid crystal display element. The electrode is not particularly limited as long as it is an electrode formed on one surface of the substrate. Examples of such an electrode include indium tin oxide (ITO) or a vapor deposited film of a metal. The electrode may be formed on the entire surface of the substrate or may be formed, for example, in a patterned specific shape. The substrate on which no electrode is provided is a liquid crystal alignment film of the present invention formed on the surface of the substrate, and the substrate on which the electrode is provided is a liquid crystal alignment film of the present invention formed on the electrode. The formation of the liquid crystal alignment film of the present invention is as described above.
所述夾在一對基板間的液晶層含有液晶組成物。在這裏,液晶組成物並沒有特別的限制,可以根據驅動模式,來使用介電常數各向異性(dielectric constant anisotropy)為正的液晶組成物以及介電常數各向異性為負的液晶組成物中的任意組成物。 The liquid crystal layer sandwiched between the pair of substrates contains a liquid crystal composition. Here, the liquid crystal composition is not particularly limited, and a liquid crystal composition having a positive dielectric anisotropy and a liquid crystal composition having a negative dielectric anisotropy may be used depending on the driving mode. Any composition.
介電常數各向異性為正的優選液晶組成物的例子,公開在日本專利第3086228號公報、日本專利第2635435號公報、日本專利特表平5-501735號公報、日本專利特開平8-157826號公報、日本專利特開平8-231960號公報、日本專利特開平9-241644號公報(EP885272A1)、日本專利特開平9-302346號公報(EP806466A1)、日本專利特開平8-199168號公報(EP722998A1)、日本專利特開平9-235552號公報、日本專利特開平9-255956號公報、日本專利特開平9-241643號公報(EP885271A1)、日本專利特開平10-204016號公報(EP844229A1)、日本專利特開平10-204436號公報、日本專利特開平10-231482號公報、日本專利特開2000-087040號公報和日本專利特開2001-48822號公報等中。 An example of a liquid crystal composition having a positive dielectric anisotropy is disclosed in Japanese Patent No. 3086228, Japanese Patent No. 2635435, Japanese Patent Laid-Open No. Hei 5-501735, and Japanese Patent Laid-Open No. Hei 8-157826 Japanese Patent Laid-Open No. Hei 8-231960, Japanese Patent Laid-Open No. Hei 9-241644 (EP 885 272 A1), Japanese Patent Laid-Open No. Hei 9-302346 (EP 806 466 A1), and Japanese Patent Laid-Open No. Hei 8-199168 (EP722998A1) Japanese Patent Laid-Open No. Hei 9-235552, Japanese Patent Laid-Open No. Hei 9-255956, Japanese Patent Laid-Open No. Hei 9-241643 (EP885271A1), Japanese Patent Laid-Open No. Hei 10-204016 (EP844229A1), Japanese Patent Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei.
VA型液晶顯示元件中使用的液晶組成物,可以是介電常數各向異性為負的各種液晶組成物。優選液晶組成物的例子公開在日本專利特開昭57-114532號公報、日本專利特開平2-4725號公報、日本專利特開平4-224885號公報、日本專利特開平8-40953號公報、日本專利特開平8-104869號公報、日本專利特開平10-168076號公報、日本專利特開平10-168453號公報、日本專利特開平10-236989號公報、日本專利特開平10-236990號公報、日本專利特開平10-236992號公報、日本專利特開平10-236993號公報、日本專利特開平10-236994號公報、日本專利特開平10-237000號公報、日本專利特開平10-237004號公報、日本專利特開平10-237024號公報、日本專利特開平10-237035號公報、日本專利特開平10-237075號公報、日本專利特開平10-237076號公報、日本專利特開平10-237448號公報(EP967261A1)、日本專利特開平10-287874號公報、日本專利特開平10-287875號公報、日本專利特開平10-291945號公報、日本專利特開平11-029581號公報、日本專利特開平11-080049號公報、日本專利特開2000-256307號公報、日本專利特開2001-019965號公報、日本專利特開2001-072626號公報和日本專利特開2001-192657號公報等中。 The liquid crystal composition used in the VA liquid crystal display element may be various liquid crystal compositions having a negative dielectric anisotropy. An example of a liquid crystal composition is disclosed in Japanese Laid-Open Patent Publication No. Sho 57-114532, Japanese Patent Laid-Open No. Hei No. 2-4725, Japanese Patent Application Laid-Open No. Hei-4-224885 Japanese Patent Laid-Open No. Hei 10-104076, Japanese Patent Laid-Open No. Hei 10-168076, Japanese Patent Publication No. Hei 10-168453 Japanese Patent Laid-Open No. Hei 10-236993, Japanese Patent Laid-Open No. Hei 10-236993, Japanese Patent Laid-Open No. Hei 10-236994, Japanese Patent Laid-Open No. Hei 10--237000, Japanese Patent Laid-Open No. Hei 10-237004, Japan Japanese Laid-Open Patent Publication No. Hei 10-237025, Japanese Patent Laid-Open No. Hei 10-237035, Japanese Patent Laid-Open No. Hei 10-237075, Japanese Patent Laid-Open No. Hei 10-237076, and Japanese Patent Laid-Open No. Hei 10-237448 (EP967261A1) Japanese Patent Laid-Open No. Hei 10-287874, Japanese Patent Laid-Open No. Hei 10-287875, Japanese Patent Laid-Open No. Hei 10-291945, and Japanese Patent Laid-Open No. Hei 11-029581 Japanese Patent Laid-Open No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. 2001-192. Bulletin, etc.
在所述介電常數各向異性為正或者負的液晶組成物中,也可以添加一種或者一種以上的光學活性化合物而使用。 In the liquid crystal composition in which the dielectric anisotropy is positive or negative, one or more optically active compounds may be added and used.
本發明的液晶顯示元件當然可以含有其他構件。例如,在使用薄膜電晶體的彩色顯示的TFT型液晶元件中,可以在第1透明基板上形成薄膜電晶體、絕緣膜、保護膜、信號電極和畫素電極等,且在第2透明基板上具有將圖元區域以外的光遮蔽的黑色矩陣(black matrix)、彩色濾光片、平坦化膜和畫素電極等。 The liquid crystal display element of the present invention may of course contain other members. For example, in a TFT-type liquid crystal element using a color display of a thin film transistor, a thin film transistor, an insulating film, a protective film, a signal electrode, a pixel electrode, and the like can be formed on the first transparent substrate, and on the second transparent substrate. A black matrix, a color filter, a planarization film, a pixel electrode, and the like that shield light outside the primitive region.
另外,在VA型液晶顯示元件、特別是MVA型液晶顯示元件中,在第1透明基板上形成有被稱為領域(domain)的微小突起物。另外,也可以形成用來調整基板間的液晶單元間隙(cell gap)的間隔物(spacer)。 Further, in the VA liquid crystal display device, particularly the MVA liquid crystal display device, a microscopic projection called a domain is formed on the first transparent substrate. Further, a spacer for adjusting a cell gap of the liquid crystal cell between the substrates may be formed.
本發明的液晶顯示元件是用任意方法製作的,例如是用包括以下步驟的方法製作的:1)在所述兩片透明基板上塗布液晶配向劑;2)對所塗布的液晶配向劑進行乾燥,3)對經乾燥的液晶配向劑進行必要的加熱處理以使其進行脫水、閉環反應;4)對所獲得的配向膜進行配向處理;以及5)保有特定間隙而將兩片基板相貼合之後在基板間的間隙中封入液晶,或者在一片基板上滴落液晶之後與另一片基板相貼合。 The liquid crystal display element of the present invention is produced by any method, for example, by a method comprising the steps of: 1) coating a liquid crystal alignment agent on the two transparent substrates; and 2) drying the applied liquid crystal alignment agent. 3) performing necessary heat treatment on the dried liquid crystal alignment agent to perform dehydration and ring closure reaction; 4) orienting the obtained alignment film; and 5) adhering the two substrates while maintaining a specific gap Then, liquid crystal is sealed in the gap between the substrates, or the liquid crystal is dropped on one of the substrates, and then bonded to the other substrate.
所述塗布液晶配向劑的步驟中的塗布方法通常已知旋轉器法、印刷法、浸漬法(dipping method)、落滴法(falling-drop method)、噴墨法等。這些方法在本發明中也可以使用。 The coating method in the step of coating the liquid crystal alignment agent is generally known as a spinner method, a printing method, a dipping method, a falling-drop method, an inkjet method, or the like. These methods can also be used in the present invention.
另外,所述乾燥步驟和實施脫水反應所必需的加熱處理的步驟的方法,通常已知在烘箱(oven)或者紅外爐中 進行加熱處理的方法、在熱板(hot plate)上進行加熱處理的方法等。這些方法在本發明中也可以使用。乾燥步驟優選的是,在溶劑可蒸發的範圍內的較低溫度(50℃~140℃)下實施。加熱處理的步驟通常優選的是在150℃~300℃左右的溫度下進行。 Further, the drying step and the method of performing the heat treatment step necessary for the dehydration reaction are generally known in an oven or an infrared furnace. A method of performing heat treatment, a method of performing heat treatment on a hot plate, or the like. These methods can also be used in the present invention. The drying step is preferably carried out at a lower temperature (50 ° C to 140 ° C) in the range in which the solvent can be evaporated. The step of heat treatment is usually preferably carried out at a temperature of from about 150 ° C to about 300 ° C.
對於IPS型液晶顯示元件、OCB型液晶顯示元件、TN型液晶顯示元件和STN型液晶顯示元件來說,對液晶配向膜的配向處理通常是進行摩擦處理。VA型液晶顯示元件大多不進行摩擦處理,但也可以進行摩擦處理。 For the IPS type liquid crystal display element, the OCB type liquid crystal display element, the TN type liquid crystal display element, and the STN type liquid crystal display element, the alignment treatment of the liquid crystal alignment film is usually performed by rubbing treatment. Most of the VA liquid crystal display elements are not subjected to rubbing treatment, but rubbing treatment may be performed.
接著,在一片基板上塗布粘著劑並進行貼合,在真空中注入液晶。在落滴注入法的情況下,在貼合之前將液晶滴落到基板上,然後貼合另一片基板。利用熱或者紫外線使貼合所使用的粘著劑硬化,從而製作出本發明的液晶顯示元件。 Next, an adhesive is applied onto one of the substrates and bonded, and liquid crystal is injected in a vacuum. In the case of the drop dropping method, the liquid crystal is dropped onto the substrate before bonding, and then the other substrate is bonded. The liquid crystal display element of the present invention is produced by hardening the adhesive used for bonding by heat or ultraviolet rays.
本發明的液晶顯示元件上,可以安裝偏光板(偏光膜)、波長板、光散射膜、驅動電路等。 A polarizing plate (polarizing film), a wavelength plate, a light-scattering film, a driving circuit, and the like can be mounted on the liquid crystal display element of the present invention.
以下,通過實施例來說明本發明,但是本發明並不限定於這些實施例。實施例中使用的化合物如下。 Hereinafter, the present invention will be described by way of examples, but the invention is not limited to these examples. The compounds used in the examples are as follows.
化合物(1):均苯四甲酸二酐 Compound (1): pyromellitic dianhydride
化合物(19):1,2,3,4-環丁烷四甲酸二酐 Compound (19): 1,2,3,4-cyclobutanetetracarboxylic dianhydride
化合物(23):1,2,3,4-丁烷四甲酸二酐 Compound (23): 1,2,3,4-butanetetracarboxylic dianhydride
化合物(V-1):4,4'-二氨基二苯基甲烷 Compound (V-1): 4,4'-diaminodiphenylmethane
化合物(V-7):1,2-雙(4-氨基苯基)乙烷 Compound (V-7): 1,2-bis(4-aminophenyl)ethane
化合物(Ⅶ-2):1,3-雙(4-(4-氨基苄基)苯基)丙烷 Compound (VII-2): 1,3-bis(4-(4-aminobenzyl)phenyl)propane
化合物(XI-6-1):1,1-雙[4-(4-氨基苯氧基)苯基]-4-[(4-庚基環己基)乙基]環己烷 Compound (XI-6-1): 1,1-bis[4-(4-aminophenoxy)phenyl]-4-[(4-heptylcyclohexyl)ethyl]cyclohexane
化合物(XI-4-1):1,1-雙[4-(4-氨基苯氧基)苯基-4-(反式-4-正戊基環己基)環己烷 Compound (XI-4-1): 1,1-bis[4-(4-aminophenoxy)phenyl-4-(trans-4-n-pentylcyclohexyl)cyclohexane
化合物(XI-6-2):1,1-雙[4-(4-氨基苯氧基)苯基]-4-[(4-乙基環己基)乙基]環己烷 Compound (XI-6-2): 1,1-bis[4-(4-aminophenoxy)phenyl]-4-[(4-ethylcyclohexyl)ethyl]cyclohexane
化合物(XI-2-1):1,1-雙[4-(4-氨基苯基)甲基苯基]-4-正戊基環己烷 Compound (XI-2-1): 1,1-bis[4-(4-aminophenyl)methylphenyl]-4-n-pentylcyclohexane
化合物(Ina-1):雙{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烷 Compound (Ina-1): bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}methane
EBA:雙丙烯酸乙二酯 EBA: ethylene diacrylate
NEBA:N,N'-亞乙基雙丙烯醯胺 NEBA: N, N'-ethylene bis acrylamide
HEA:N,N'-二羥基亞乙基雙丙烯醯胺 HEA: N, N'-dihydroxyethylene bis acrylamide
MHA:4,4'-亞甲基雙(N,N-二羥基亞乙基丙烯酸酯苯胺) MHA: 4,4'-methylenebis(N,N-dihydroxyethylene acrylate aniline)
NMP:N-甲基-2-吡咯烷酮 NMP: N-methyl-2-pyrrolidone
GBL:γ-丁內酯 GBL: γ-butyrolactone
BC:丁基溶纖劑(乙二醇單丁醚) BC: butyl cellosolve (ethylene glycol monobutyl ether)
在具備溫度計、攪拌機、原料添加口和氮氣導入口的100 mL四口燒瓶中,添加化合物(V-1)(2.91 g)、脫水NMP(54 g)和GBL(15 g),在乾燥氮氣流下進行攪拌溶解。接著,添加化合物(19)(1.01 g)和化合物(1)(2.08 g),在室溫環境下反應30小時。當反應過程中反應溫度上升時,將反應溫度抑制在約70℃或70℃以下而進行反應。然後在所獲得的溶液中添加BC(25 g),製備出濃度為6 wt%的聚醯胺酸溶液(PA1)。所獲得的聚醯胺酸的重量平均分子量為57,000。 Compound (V-1) (2.91 g), dehydrated NMP (54 g) and GBL (15 g) were added to a 100 mL four-necked flask equipped with a thermometer, a stirrer, a raw material addition port, and a nitrogen inlet, under a dry nitrogen stream. Stir and dissolve. Next, the compound (19) (1.01 g) and the compound (1) (2.08 g) were added, and the mixture was reacted at room temperature for 30 hours. When the reaction temperature rises during the reaction, the reaction is carried out by suppressing the reaction temperature to about 70 ° C or lower. Then, BC (25 g) was added to the obtained solution to prepare a polyglycine solution (PA1) having a concentration of 6 wt%. The polyamic acid obtained had a weight average molecular weight of 57,000.
聚醯胺酸的重量平均分子量是通過以下方式求出的:使用磷酸-DMF混合溶液(以重量比計,磷酸/DMF=0.6/100)對所獲得的聚醯胺酸進行稀釋,以使聚醯胺酸濃度達到約1 wt%,然後使用2695分離模組和2414差示折射計(Waters製造),將上述混合溶液作為展開劑並使用GPC法進行測定,再進行聚苯乙烯換算。另外,管柱是使用HSPgel RT MB-M(Waters製造),在管柱溫度為40℃、流速為0.35 mL/min的條件下進行測定。 The weight average molecular weight of polylysine is determined by diluting the obtained polyamic acid with a phosphoric acid-DMF mixed solution (phosphoric acid/DMF=0.6/100 by weight ratio) to cause polymerization. The concentration of valine was about 1 wt%, and then the mixed solution was used as a developing solvent using a 2695 separation module and a 2414 differential refractometer (manufactured by Waters), and the mixture was measured by a GPC method, and then converted into polystyrene. Further, the column was measured using HSPgel RT MB-M (manufactured by Waters) under the conditions of a column temperature of 40 ° C and a flow rate of 0.35 mL / min.
除了如表1所示那樣變更四羧酸二酐和二胺以外,以 合成例1作為基準而製備出聚醯胺酸溶液(PA2)~聚醯胺酸溶液(PA8)。包括合成例1,將原料的調配比例和所獲得的聚醯胺酸的重量平均分子量總結於表1。 In addition to changing the tetracarboxylic dianhydride and the diamine as shown in Table 1, Synthesis Example 1 As a standard, a polyamic acid solution (PA2) to a polyaminic acid solution (PA8) was prepared. Including Synthesis Example 1, the blending ratio of the raw materials and the weight average molecular weight of the obtained polyglycine were summarized in Table 1.
以8/2的重量比將合成例1中製備的濃度為6 wt%的聚醯胺酸溶液(PA1)和合成例2中製備的濃度為6 wt%的聚醯胺酸溶液(PA2)混合。接著在所獲得的混合物中,以相對於每100重量份聚醯胺酸而各自為10重量份的比 例,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即MHA。然後,添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑來製作液晶顯示元件,製作方法如下。 The polyglycine solution (PA1) having a concentration of 6 wt% prepared in Synthesis Example 1 and the polyglycine solution (PA2) having a concentration of 6 wt% prepared in Synthesis Example 2 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, the ratio is 10 parts by weight per 100 parts by weight of the polyglycolic acid. For example, a compound in which an alkenyl group is substituted with a nadic ylidene compound (Ina-1) and a compound having a radical polymerizable unsaturated double bond, that is, MHA are separately added. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added and diluted to prepare a liquid crystal alignment agent having a polyglycine concentration of 4 wt%. A liquid crystal display element was produced using the obtained liquid crystal alignment agent, and the manufacturing method was as follows.
用旋轉器將液晶配向劑塗布在兩片附有ITO電極的玻璃基板上,形成膜厚為70 nm的膜。進行塗膜之後,在80℃下加熱乾燥約5分鐘,然後在210℃下進行20分鐘加熱處理,接著進行摩擦處理,形成液晶配向膜。在超純水中對所述基板進行5分鐘超聲波清洗之後,在烘箱中在120℃下乾燥30分鐘。 The liquid crystal alignment agent was applied onto two glass substrates with an ITO electrode by a spinner to form a film having a film thickness of 70 nm. After coating, the film was dried by heating at 80 ° C for about 5 minutes, and then heat-treated at 210 ° C for 20 minutes, followed by rubbing treatment to form a liquid crystal alignment film. After ultrasonic cleaning of the substrate in ultrapure water for 5 minutes, it was dried in an oven at 120 ° C for 30 minutes.
在這些玻璃基板的其中一片上散佈7 μm的間隙材料(gap material),並以形成了液晶配向膜的面為內側來對向配置另一片玻璃基板,以使摩擦方向為反平行(antiparallel)。然後,用環氧硬化劑來密封液晶配向膜的周圍,製作間隙為7 μm的反平行液晶單元(antiparallel cell)。在這個液晶單元中注入如下所示的液晶組成物,接著使用光硬化劑來密封液晶組成物用的注入口。然後,在110℃下進行30分鐘加熱處理,製作出液晶顯示元件。 A gap material of 7 μm was spread on one of the glass substrates, and another glass substrate was disposed opposite to the inner side of the surface on which the liquid crystal alignment film was formed so that the rubbing direction was antiparallel. Then, an epoxy hardener was used to seal the periphery of the liquid crystal alignment film to form an antiparallel cell having a gap of 7 μm. A liquid crystal composition shown below was injected into this liquid crystal cell, and then a light hardening agent was used to seal the injection port for the liquid crystal composition. Then, heat treatment was performed at 110 ° C for 30 minutes to prepare a liquid crystal display element.
以8/2的重量比將合成例1中製備的濃度為6 wt%的聚醯胺酸溶液(PA1)和合成例3中製備的濃度為6 wt%的聚醯胺酸溶液(PA3)混合。接著在所獲得的混合物中,以相對於每100重量份聚醯胺酸而各自為10重量份的比例,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即HEA。 然後,添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 The polyglycine solution (PA1) having a concentration of 6 wt% prepared in Synthesis Example 1 and the polyglycine solution (PA3) having a concentration of 6 wt% prepared in Synthesis Example 3 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, an alkenyl-substituted nadic quinone imine compound (Ina-1) and a radical are respectively added in a ratio of 10 parts by weight per 100 parts by weight of the polyaminic acid. The compound which is a polymerizable unsaturated double bond is HEA. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added and diluted to prepare a liquid crystal alignment agent having a polyglycine concentration of 4 wt%. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
以8/2的重量比將合成例1中製備的濃度為6 wt%的聚醯胺酸溶液(PA1)和合成例2中製備的濃度為6 wt%的聚醯胺酸溶液(PA2)混合。接著在所獲得的混合物中,以相對於每100重量份聚醯胺酸而各自為10重量份的比例,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即NEBA。然後,添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 The polyglycine solution (PA1) having a concentration of 6 wt% prepared in Synthesis Example 1 and the polyglycine solution (PA2) having a concentration of 6 wt% prepared in Synthesis Example 2 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, an alkenyl-substituted nadic quinone imine compound (Ina-1) and a radical are respectively added in a ratio of 10 parts by weight per 100 parts by weight of the polyaminic acid. The compound which is a polymerizable unsaturated double bond is NEBA. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added and diluted to prepare a liquid crystal alignment agent having a polyglycine concentration of 4 wt%. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
以8/2的重量比將合成例1中製備的濃度為6 wt%的聚醯胺酸溶液(PA1)和合成例2中製備的濃度為6 wt%的聚醯胺酸溶液(PA2)混合。接著在所獲得的混合物中,以相對於每100重量份聚醯胺酸而各自為10重量份的比例,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即MHA,使由這些化合物組成的改良劑的總量為20重量份。然後,添加NMP/BC=1/1(重量比)的混合溶劑,將聚醯胺酸相對於溶液整體而稀釋為4 wt%,製成液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元 件。 The polyglycine solution (PA1) having a concentration of 6 wt% prepared in Synthesis Example 1 and the polyglycine solution (PA2) having a concentration of 6 wt% prepared in Synthesis Example 2 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, an alkenyl-substituted nadic quinone imine compound (Ina-1) and a radical are respectively added in a ratio of 10 parts by weight per 100 parts by weight of the polyaminic acid. The compound which is a polymerizable unsaturated double bond, that is, MHA, has a total amount of the modifier composed of these compounds of 20 parts by weight. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polylysine was diluted to 4 wt% with respect to the whole solution to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. Pieces.
在合成例4中製備的濃度為6 wt%的聚醯胺酸溶液(PA4)中,以相對於每100重量份聚醯胺酸而各自為10重量份的比例,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即MHA。然後,添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 In the polyglycine solution (PA4) having a concentration of 6 wt% prepared in Synthesis Example 4, an alkenyl group was substituted with Nadick, respectively, in a ratio of 10 parts by weight per 100 parts by weight of the polyglycolic acid. The quinone imine compound is a compound (Ina-1) and a compound having a radical polymerizable unsaturated double bond, that is, MHA. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added and diluted to prepare a liquid crystal alignment agent having a polyglycine concentration of 4 wt%. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
在合成例4中製備的濃度為6 wt%的聚醯胺酸溶液(PA4)中,以相對於每100重量份聚醯胺酸而各自為10重量份的比例,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即EBA。然後,添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 In the polyglycine solution (PA4) having a concentration of 6 wt% prepared in Synthesis Example 4, an alkenyl group was substituted with Nadick, respectively, in a ratio of 10 parts by weight per 100 parts by weight of the polyglycolic acid. The quinone imine compound is a compound (Ina-1) and a compound having a radical polymerizable unsaturated double bond, that is, EBA. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added and diluted to prepare a liquid crystal alignment agent having a polyglycine concentration of 4 wt%. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
以8/2的重量比將合成例1中製備的濃度為6 wt%的聚醯胺酸溶液(PA1)和合成例6中製備的濃度為6 wt%的聚醯胺酸溶液(PA6)混合。接著在所獲得的混合物中,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1) 和具有自由基聚合性不飽和雙鍵的化合物即HEA,其中相對於每100重量份聚醯胺酸,添加20重量份的化合物(Ina-1),且添加5重量份的HEA。然後,添加NMP/BC=1/1(重量比)的混合溶劑,將聚醯胺酸相對於溶液整體而稀釋為4 wt%,製成液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 The polyglycine solution (PA1) having a concentration of 6 wt% prepared in Synthesis Example 1 and the polyglycine solution (PA6) having a concentration of 6 wt% prepared in Synthesis Example 6 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, an alkenyl group-substituted nadic ylidene compound, that is, a compound (Ina-1), is separately added. And a compound having a radically polymerizable unsaturated double bond, that is, HEA, wherein 20 parts by weight of the compound (Ina-1) is added per 100 parts by weight of the polyglycolic acid, and 5 parts by weight of HEA is added. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polylysine was diluted to 4 wt% with respect to the whole solution to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
以8/2的重量比將合成例5中製備的濃度為6 wt%的聚醯胺酸溶液(PA5)和合成例6中製備的濃度為6 wt%的聚醯胺酸溶液(PA6)混合。接著在所獲得的混合物中,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即HEA,其中相對於每100重量份聚醯胺酸,添加20重量份的化合物(Ina-1),且添加5重量份的HEA。然後,添加NMP/BC=1/1(重量比)的混合溶劑,將聚醯胺酸相對於溶液整體而稀釋為4 wt%,製成液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 The polyglycine solution (PA5) having a concentration of 6 wt% prepared in Synthesis Example 5 and the polyglycine solution (PA6) having a concentration of 6 wt% prepared in Synthesis Example 6 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, an alkenyl-substituted nadic ylidene compound, that is, a compound (Ina-1) and a compound having a radical polymerizable unsaturated double bond, that is, HEA, are added, respectively, wherein the polymer is present per 100 parts by weight of the polyfluorene. Amino acid, 20 parts by weight of the compound (Ina-1) was added, and 5 parts by weight of HEA was added. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polylysine was diluted to 4 wt% with respect to the whole solution to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
以8/2的重量比將合成例5中製備的濃度為6 wt%的聚醯胺酸溶液(PA5)和合成例7中製備的濃度為6 wt%的聚醯胺酸溶液(PA7)混合。接著在所獲得的混合物中,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即HEA,其中相對於每100重量份聚醯胺酸,添加30重量份的化合物(Ina -1),且添加20重量份的HEA。然後,添加NMP/BC=1/1(重量比)的混合溶劑,將聚醯胺酸相對於溶液整體而稀釋為4 wt%,製成液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 The polyglycine solution (PA5) having a concentration of 6 wt% prepared in Synthesis Example 5 and the polyglycine solution (PA7) having a concentration of 6 wt% prepared in Synthesis Example 7 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, an alkenyl-substituted nadic ylidene compound, that is, a compound (Ina-1) and a compound having a radical polymerizable unsaturated double bond, that is, HEA, are added, respectively, wherein the polymer is present per 100 parts by weight of the polyfluorene. Amino acid, adding 30 parts by weight of compound (Ina -1), and 20 parts by weight of HEA was added. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polylysine was diluted to 4 wt% with respect to the whole solution to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
以8/2的重量比將合成例5中製備的濃度為6 wt%的聚醯胺酸溶液(PA5)和合成例7中製備的濃度為6 wt%的聚醯胺酸溶液(PA7)混合。接著在所獲得的混合物中,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即HEA,其中相對於每100重量份聚醯胺酸,添加20重量份的化合物(Ina-1),且添加10重量份的HEA。然後,添加NMP/BC=1/1(重量比)的混合溶劑,將聚醯胺酸相對於溶液整體而稀釋為4 wt%,製成液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 The polyglycine solution (PA5) having a concentration of 6 wt% prepared in Synthesis Example 5 and the polyglycine solution (PA7) having a concentration of 6 wt% prepared in Synthesis Example 7 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, an alkenyl-substituted nadic ylidene compound, that is, a compound (Ina-1) and a compound having a radical polymerizable unsaturated double bond, that is, HEA, are added, respectively, wherein the polymer is present per 100 parts by weight of the polyfluorene. Amino acid, 20 parts by weight of the compound (Ina-1) was added, and 10 parts by weight of HEA was added. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polylysine was diluted to 4 wt% with respect to the whole solution to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
在合成例8中製備的濃度為6 wt%的聚醯胺酸溶液(PA8)中,分別添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)和具有自由基聚合性不飽和雙鍵的化合物即HEA,其中相對於每100重量份聚醯胺酸,添加20重量份的化合物(Ina-1),且添加10重量份的HEA。然後,添加NMP/BC=1/1(重量比)的混合溶劑,將聚醯胺酸相對於溶液整體而稀釋為4 wt%,製成液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元 件。 In the polyglycine solution (PA8) having a concentration of 6 wt% prepared in Synthesis Example 8, an alkenyl-substituted nadic ylidene compound (Ina-1) and a radical polymerizable unsaturated double were respectively added. The compound of the bond, HEA, was added with 20 parts by weight of the compound (Ina-1) per 100 parts by weight of the polyglycolic acid, and 10 parts by weight of HEA was added. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added, and polylysine was diluted to 4 wt% with respect to the whole solution to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. Pieces.
以8/2的重量比將合成例1中製備的濃度為6 wt%的聚醯胺酸溶液(PA1)和合成例2中製備的濃度為6 wt%的聚醯胺酸溶液(PA2)混合。接著在所獲得的混合物中添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 The polyglycine solution (PA1) having a concentration of 6 wt% prepared in Synthesis Example 1 and the polyglycine solution (PA2) having a concentration of 6 wt% prepared in Synthesis Example 2 were mixed at a weight ratio of 8/2. . Next, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, followed by dilution to prepare a liquid crystal alignment agent having a polyglycine concentration of 4 wt%. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
以8/2的重量比將合成例1中製備的濃度為6 wt%的聚醯胺酸溶液(PA1)和合成例2中製備的濃度為6 wt%的聚醯胺酸溶液(PA2)混合。接著在所獲得的混合物中,以相對於每100重量份聚醯胺酸而為10重量份的比例,添加具有自由基聚合性不飽和雙鍵的化合物即MHA。然後在所獲得的混合物中添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 The polyglycine solution (PA1) having a concentration of 6 wt% prepared in Synthesis Example 1 and the polyglycine solution (PA2) having a concentration of 6 wt% prepared in Synthesis Example 2 were mixed at a weight ratio of 8/2. . Next, in the obtained mixture, MHA having a radical polymerizable unsaturated double bond, that is, MHA, was added in a ratio of 10 parts by weight per 100 parts by weight of the polyaminic acid. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture to carry out dilution to prepare a liquid crystal alignment agent having a polyglycine concentration of 4 wt%. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
在合成例4中製備的濃度為6 wt%的聚醯胺酸溶液(PA4)中,添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 In a polyglycine solution (PA4) having a concentration of 6 wt% prepared in Synthesis Example 4, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added and diluted to prepare a polyglycine concentration of 4 Wt% liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
在合成例4中製備的濃度為6 wt%的聚醯胺酸溶液(PA4)中,以相對於每100重量份聚醯胺酸而為10重量份的比例,添加烯基取代納迪克醯亞胺化合物即化合物(Ina-1)。然後在所獲得的混合物中添加NMP/BC=1/1(重量比)的混合溶劑進行稀釋,製成聚醯胺酸濃度為4 wt%的液晶配向劑。使用所獲得的液晶配向劑,與實施例1同樣地製作出液晶顯示元件。 In the polyglycine solution (PA4) having a concentration of 6 wt% prepared in Synthesis Example 4, an alkenyl group was substituted with Nadickia at a ratio of 10 parts by weight per 100 parts by weight of the polyglycolic acid. The amine compound is a compound (Ina-1). Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture to carry out dilution to prepare a liquid crystal alignment agent having a polyglycine concentration of 4 wt%. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent.
對實施例1~實施例11和比較例1~比較例4中製作的液晶顯示元件測定離子密度(電特性的長期可靠性),並使用無閃爍(flicker free)法來測定殘留DC,測定方式如下。 The liquid crystal display elements produced in Examples 1 to 11 and Comparative Examples 1 to 4 were measured for ion density (long-term reliability of electrical characteristics), and residual DC was measured using a flicker free method. as follows.
使用Toyo Technica製造的液晶物性評價裝置6254型來進行離子密度的測定。測定單位是微微庫倫(pico coulomb,pC)。測定條件為:波形為三角波,頻率為0.01 Hz,電壓為±10 V,測定溫度是設定為60℃。測定值越小,則可以說電特性越為良好。將結果示於表2中。 The ion density was measured using a liquid crystal property evaluation device 6254 manufactured by Toyo Technica. The unit of measurement is pico coulomb (pC). The measurement conditions were as follows: the waveform was a triangular wave, the frequency was 0.01 Hz, the voltage was ±10 V, and the measurement temperature was set to 60 °C. The smaller the measured value, the better the electrical characteristics can be said. The results are shown in Table 2.
對所製作的液晶顯示元件隨時間求出離子密度,並評價離子密度的保持特性。保持特性的試驗方法是採用如下方法:將液晶顯示元件放置在溫度為60℃的環境中,在放置過程中隨時間取出液晶顯示元件並測定離子密度。離子 密度的增加量越小(例如,如果在所述條件下放置500小時後的離子密度的增加量為100 pC或100 pC以下),則可以說離子密度的保持特性越為良好,另外可以說電特性的長期可靠性越為良好。將放置245小時後和500小時後的資料示於表2中。 The ion density of the liquid crystal display element produced was determined over time, and the retention characteristics of the ion density were evaluated. The test method for maintaining characteristics is to adopt a method in which a liquid crystal display element is placed in an environment at a temperature of 60 ° C, and a liquid crystal display element is taken out over time during the standing and the ion density is measured. ion The smaller the increase in density (for example, if the increase in ion density after 500 hours of standing under the conditions is 100 pC or less), it can be said that the retention property of the ion density is better, and it can be said that electricity The longer the reliability of the characteristics, the better. The data after 245 hours and 500 hours were shown in Table 2.
使用橫河電機股份有限公司製造的FG-110,將3 V的直流電壓與30 Hz、1.64 V的矩形波重疊,施加30分鐘。從施加剛結束後起測定閃爍消除電壓30分鐘。表中記錄了施加結束後5分鐘後的閃爍消除電壓。另外,測定溫度是設定為25℃。測定值越接近0,則可以說電特性越為良好。將結果示於表2中。 Using a FG-110 manufactured by Yokogawa Electric Co., Ltd., a DC voltage of 3 V was superimposed on a rectangular wave of 30 Hz and 1.64 V, and applied for 30 minutes. The flicker elimination voltage was measured for 30 minutes from the end of the application. The table shows the flicker elimination voltage 5 minutes after the end of application. In addition, the measurement temperature was set to 25 °C. The closer the measured value is to 0, the better the electrical characteristics are. The results are shown in Table 2.
如表2所示,在聚醯胺酸中混合將烯基取代納迪克醯亞胺化合物和具有自由基聚合性不飽和雙鍵的化合物組合而成的改良劑來製備液晶配向劑時,使用由該液晶配向劑所得的液晶配向膜的液晶顯示元件,可見抑制離子密度隨時間增大的效果,殘像特性也得到了顯著的改善。 As shown in Table 2, when a liquid crystal alignment agent is prepared by mixing a modified agent obtained by combining an alkenyl-substituted nadicylimine compound and a compound having a radical polymerizable unsaturated double bond in polyamic acid, The liquid crystal display element of the liquid crystal alignment film obtained by the liquid crystal alignment agent can suppress the effect of increasing the ion density with time, and the afterimage characteristics are also remarkably improved.
雖然本發明已以實施例揭露如上,然其並非用以限定本發明,任何所屬技術領域中具有通常知識者,在不脫離本發明之精神和範圍內,當可作些許之更動與潤飾,故本發明之保護範圍當視後附之申請專利範圍所界定者為準。 Although the present invention has been disclosed in the above embodiments, it is not intended to limit the invention, and any one of ordinary skill in the art can make some modifications and refinements without departing from the spirit and scope of the invention. The scope of the invention is defined by the scope of the appended claims.
Claims (22)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007263072 | 2007-10-09 | ||
| JP2008226964A JP5062109B2 (en) | 2007-10-09 | 2008-09-04 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200923012A TW200923012A (en) | 2009-06-01 |
| TWI384029B true TWI384029B (en) | 2013-02-01 |
Family
ID=40571764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW97137949A TWI384029B (en) | 2007-10-09 | 2008-10-02 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP5062109B2 (en) |
| CN (1) | CN101408697B (en) |
| TW (1) | TWI384029B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5459052B2 (en) * | 2009-06-25 | 2014-04-02 | Jnc株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| JP5994257B2 (en) * | 2011-03-17 | 2016-09-21 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| WO2013015407A1 (en) * | 2011-07-27 | 2013-01-31 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
| CN103748506B (en) * | 2011-08-31 | 2016-07-06 | Jsr株式会社 | Manufacturing method of liquid crystal display element, liquid crystal aligning agent, and liquid crystal display element |
| JP5696699B2 (en) | 2012-08-29 | 2015-04-08 | コニカミノルタ株式会社 | Planar heating element and image fixing apparatus having the same |
| TWI525130B (en) * | 2013-12-23 | 2016-03-11 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element having thereof |
| TWI529242B (en) * | 2014-06-12 | 2016-04-11 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device |
| JP6701661B2 (en) * | 2014-12-25 | 2020-05-27 | Jsr株式会社 | Liquid crystal aligning agent, method for producing liquid crystal element, liquid crystal aligning film and liquid crystal element |
| WO2019013339A1 (en) * | 2017-07-14 | 2019-01-17 | 日産化学株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using same |
| CN112888714B (en) * | 2018-10-19 | 2023-02-28 | 富士胶片株式会社 | Method for producing cured film, resin composition, cured film, method for producing laminate, and method for producing semiconductor element |
| WO2020195993A1 (en) * | 2019-03-22 | 2020-10-01 | 富士フイルム株式会社 | Curable resin composition, cured film, laminate, method for manufacturing cured film, and semiconductor device |
| TW202039637A (en) * | 2019-03-27 | 2020-11-01 | 日商大阪曹達股份有限公司 | Polyamic acid composition, polyimide composition, and polyimide molded body |
| CN114502695B (en) * | 2019-10-07 | 2024-12-27 | 日产化学株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| JP7605851B2 (en) * | 2020-09-25 | 2024-12-24 | 富士フイルム株式会社 | Resin composition, cured product, laminate, method for producing cured product, and semiconductor device |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW553980B (en) * | 2000-12-19 | 2003-09-21 | Elsicon Inc | Reactive side-chain polyimides, polyamic acids and esters thereof and their uses in optical alignment layers and liquid crystal displays |
| JP2004341030A (en) * | 2003-05-13 | 2004-12-02 | Chisso Corp | Liquid crystal aligning agent varnish, alignment film using the varnish, and liquid crystal display device having the alignment film |
| TWI226363B (en) * | 2001-05-29 | 2005-01-11 | Ind Tech Res Inst | Liquid crystal aligning film composition used for liquid crystal display |
-
2008
- 2008-09-04 JP JP2008226964A patent/JP5062109B2/en not_active Expired - Fee Related
- 2008-10-02 TW TW97137949A patent/TWI384029B/en not_active IP Right Cessation
- 2008-10-07 CN CN2008101488708A patent/CN101408697B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW553980B (en) * | 2000-12-19 | 2003-09-21 | Elsicon Inc | Reactive side-chain polyimides, polyamic acids and esters thereof and their uses in optical alignment layers and liquid crystal displays |
| TWI226363B (en) * | 2001-05-29 | 2005-01-11 | Ind Tech Res Inst | Liquid crystal aligning film composition used for liquid crystal display |
| JP2004341030A (en) * | 2003-05-13 | 2004-12-02 | Chisso Corp | Liquid crystal aligning agent varnish, alignment film using the varnish, and liquid crystal display device having the alignment film |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101408697A (en) | 2009-04-15 |
| CN101408697B (en) | 2011-08-17 |
| JP2009109987A (en) | 2009-05-21 |
| TW200923012A (en) | 2009-06-01 |
| JP5062109B2 (en) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI384029B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI385241B (en) | Light alignment agent, alignment film, and liquid crystal display element using the same | |
| TWI454529B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| JP5387428B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| TWI450914B (en) | Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device | |
| TWI494292B (en) | Diamine, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device | |
| CN101373297B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
| TWI387622B (en) | Liquid crystal alignment agent and liquid crystal display element | |
| TW202311504A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| JP5245329B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| KR101415544B1 (en) | Liquid crystal aligning agent, liquid crystal alining film and liquid crystal display device | |
| CN104969123B (en) | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element | |
| JP2006267823A (en) | Liquid crystal aligning agent and vertical alignment liquid crystal display element for vertical alignment liquid crystal display element | |
| TWI388594B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| JP5403016B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
| JP5194342B2 (en) | Liquid crystal aligning agent and vertical alignment liquid crystal display element for vertical alignment liquid crystal display element | |
| KR20080025316A (en) | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element | |
| JP5315765B2 (en) | Allyl-substituted nadiimide compound, liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element | |
| JP4894237B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
| JP4561607B2 (en) | Liquid crystal aligning agent and liquid crystal display element | |
| TW202317740A (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| JP5034411B2 (en) | Tetracarboxylic dianhydride, liquid crystal aligning agent, and liquid crystal display element | |
| KR101106083B1 (en) | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element | |
| CN118725877A (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, and method for producing the same | |
| JP5013069B2 (en) | Diamine, alignment film and liquid crystal display element |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |